Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,40058,-0.205291606081193,0.00519497997351949,-0.215473766829291,-0.195109445333095,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.129842114943505,0.00308289645516804,0.123799637891376,0.135884591995635,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,39477,-0.525415971610316,0.0117633996610916,-0.548472234946055,-0.502359708274576,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,37437,-0.334549430159808,0.00791461877094291,-0.350062082950856,-0.31903677736876,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,39882,-0.233426568180327,0.00500863278784321,-0.2432434884445,-0.223609647916155,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,39858,-0.219911241234905,0.00409485571740534,-0.22793715844102,-0.211885324028791,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,40030,-0.260695957678608,0.00641695713908049,-0.273273193671206,-0.24811872168601,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,37437,-0.164591624722048,0.0038588129895664,-0.172154898181598,-0.157028351262498,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,0.105398119732474,0.00273846092211321,0.100030736325132,0.110765503139816,1.13439053028325e-308
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,39805,-0.141377795728638,0.00391416768014912,-0.14904956438173,-0.133706027075546,1.14925229871562e-274
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,-0.0979190259191987,0.00285512824386607,-0.103515077277176,-0.0923229745612212,9.63060489793589e-249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,39854,-0.26141360853769,0.00782286973376982,-0.276746433215879,-0.246080783859501,1.00258838794285e-236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,39868,0.152837386951826,0.00465443704323647,0.143714690347083,0.16196008355657,6.39587988781531e-229
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,37021,-0.29392459406235,0.00908046427456883,-0.311722304040505,-0.276126884084195,3.13018423830395e-221
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C9,Complement component C9,37445,0.168688743758233,0.00522080301521124,0.158455969848419,0.178921517668047,9.92740675461334e-221
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.096023905504664,0.00300252827066743,0.0901389500941558,0.101908860915172,1.33585271915433e-217
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,0.38279890389606,0.012128367882915,0.359027302845547,0.406570504946573,3.19722741308119e-212
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,39758,-0.23552502865781,0.00754179923631476,-0.250306955160986,-0.220743102154633,7.66921573816479e-208
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,39788,-0.273562661792585,0.00880262899876086,-0.290815814630157,-0.256309508955014,6.49596075573396e-206
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,-0.16848354595961,0.00550143446138927,-0.179266357503933,-0.157700734415287,3.34191205854288e-199
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,39585,-0.19243650719132,0.0063450460894059,-0.204872797526556,-0.180000216856084,2.07935907543731e-196
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,40009,-0.411428053748542,0.013718355296383,-0.438316030129452,-0.384540077367631,2.32050245392258e-192
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,-0.139741762201785,0.00467477551203369,-0.148904322205371,-0.130579202198199,3.95486216401138e-191
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,37453,0.195571805524337,0.00653526466401322,0.182762686782871,0.208380924265803,1.29560972542119e-190
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,37445,0.0761688104112384,0.00256266762131485,0.0711459818734613,0.0811916389490156,3.87462953956071e-188
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,39866,-0.153703734952233,0.00524349280320318,-0.163980980846511,-0.143426489057955,4.94976100610602e-184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,39858,-0.120327960070535,0.00410523283542013,-0.128374216427958,-0.112281703713111,5.31477281272253e-184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,39976,0.101964243559085,0.00356214095173044,0.0949824472936938,0.108946039824477,8.11590206259479e-176
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FURIN,Furin,39913,-0.0952978937998017,0.00335945497553118,-0.101882425551843,-0.0887133620477606,9.14740666029958e-173
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,0.0831195904987876,0.00298926319539014,0.077260634635823,0.0889785463617523,1.93907620251731e-165
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,37039,-0.220368246125021,0.00793557843668682,-0.235921979860927,-0.204814512389115,5.39967459048177e-165
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,39868,-0.171651314360905,0.00621101749089578,-0.183824908643061,-0.159477720078749,2.83275439122477e-164
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,39955,-0.0939180920661724,0.0034234279682926,-0.100628010884026,-0.0872081732483189,5.61666965945288e-162
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,39899,-0.0808435804051284,0.00297702259460187,-0.0866785446905481,-0.0750086161197087,8.24795061220145e-159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,40011,-0.321537711328297,0.011853436915879,-0.34477044768342,-0.298304974973174,1.6899722394573e-158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,39868,-0.16354011388956,0.00614345480894352,-0.17558128531509,-0.151498942464031,8.23706106914396e-153
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,37124,-0.0764211367076306,0.00286700270995997,-0.0820404620191521,-0.0708018113961091,1.55519930273154e-152
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,39839,-0.0748412739992825,0.00288075765906643,-0.0804875590110527,-0.0691949889875123,8.78823165234004e-146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,39949,0.0715567375738032,0.00276158980954274,0.0661440215470994,0.076969453600507,4.60783693397144e-145
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,-0.0652518062789819,0.00255042272767319,-0.0702506348252213,-0.0602529777327424,5.34737711667695e-141
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,40052,-0.132226856294617,0.00519985816515199,-0.142418578298315,-0.122035134290919,6.63148584510523e-140
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,39858,0.0674474476497575,0.00265979243413208,0.0622342544788586,0.0726606408206563,4.03081875880062e-139
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,39904,-0.0843390607502858,0.00332666921475587,-0.0908593324112073,-0.0778187890893643,4.55823481957857e-139
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,39840,0.112977727215083,0.00451250939854902,0.104133208793927,0.121822245636239,9.96569629325854e-136
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,-0.210077122811014,0.00841499653829331,-0.226570516026069,-0.193583729595959,6.19869688236391e-135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,40030,0.0873264813666045,0.00350304886189555,0.0804605055972892,0.0941924571359198,1.25062861211923e-134
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,-0.0808982688979303,0.00326239882872777,-0.0872925706022367,-0.0745039671936238,2.93308773358695e-133
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,39644,0.132935605914413,0.0053801681738025,0.12239047629376,0.143480735535066,2.79383158510715e-132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,39919,-0.14480512563619,0.00586383402661622,-0.156298240328358,-0.133312010944022,3.52781109461861e-132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,0.0836337282066965,0.00339183774916089,0.0769857262183411,0.0902817301950518,8.19047769847296e-132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,-0.354335717726113,0.0144570141058405,-0.38267146537356,-0.325999970078665,3.19941317049904e-130
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,39908,-0.044464050213777,0.00181708883632922,-0.0480255443329822,-0.0409025560945717,7.32093154357655e-130
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,39858,0.0894027185895175,0.00365662638038173,0.0822357308839693,0.0965697062950657,1.20599067371626e-129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,-0.187038611281302,0.00766446289995261,-0.202060958565209,-0.172016263997394,9.38115196680419e-129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,-0.123595367371373,0.00510181747763179,-0.133594929627532,-0.113595805115215,2.62136138500029e-127
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,-0.128779790795664,0.00533632358136536,-0.13923898501514,-0.118320596576188,2.06781639104029e-126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,40030,-0.0796486099010251,0.00331090621367565,-0.0861379860798294,-0.0731592337222209,1.14371959456261e-125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,39587,-0.189253814959333,0.00790602991947133,-0.204749633601497,-0.173757996317169,2.05427539217111e-124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,39841,-0.202976782129222,0.00848794449503543,-0.219613153339491,-0.186340410918953,3.33478915226034e-124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,37437,-0.220493718099846,0.00920972486376563,-0.238544778832826,-0.202442657366865,4.16776007465237e-124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,-0.158236025471734,0.00665041574902109,-0.171270840339815,-0.145201210603653,5.41813574426944e-123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,-0.0755747543601166,0.0031985298235196,-0.081843872814215,-0.0693056359060182,6.96281088371537e-121
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,0.146265234387289,0.00620986050851578,0.134093907790598,0.15843656098398,1.23254430420071e-120
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,40003,-0.0451639635814343,0.00193296313242456,-0.0489525713209865,-0.0413753558418822,8.97557921963888e-119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,39826,-0.233559835044393,0.0100132061444746,-0.253185719087563,-0.213933951001222,2.3276951253912e-118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,-0.184908613684073,0.00794763413802005,-0.200485976594592,-0.169331250773554,8.97194233135322e-118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,-0.137846660887642,0.00592490226282407,-0.149459469322778,-0.126233852452507,9.84600698333274e-118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,-0.0719633958602106,0.00311148143073785,-0.0780618994644568,-0.0658648922559644,1.89228053023745e-116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,38721,-0.0904454955494956,0.00392835056667163,-0.098145062660172,-0.0827459284388193,2.77578538929441e-115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,-0.143428233022715,0.00625164787672668,-0.155681462861099,-0.13117500318433,1.36350209315971e-114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,39931,-0.0940011547798044,0.00411500429439831,-0.102066563196825,-0.0859357463627837,1.0888001735351e-113
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,-0.191069430110064,0.00845974944082726,-0.207650539014085,-0.174488321206042,6.69497603853083e-111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,37445,0.115298630336229,0.00517281417563368,0.105159914551987,0.125437346120471,4.02393787047994e-108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,-0.184365830392539,0.00828228249563591,-0.200599104083985,-0.168132556701093,4.27955390961213e-108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,-0.121767186484335,0.00548238848590617,-0.132512667916711,-0.111021705051959,1.21833199575662e-107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,-0.0667354010763575,0.00302566217727126,-0.0726656989438091,-0.0608051032089058,3.14775745484099e-106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,-0.191690770405644,0.00870206127862263,-0.208746810511744,-0.174634730299543,5.87253613956891e-106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,39788,-0.12295915690724,0.00561043195000282,-0.133955603529245,-0.111962710285234,6.43599882704409e-105
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,-0.101803631434746,0.00465848584542573,-0.11093426369178,-0.0926729991777112,2.50704409479363e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,-0.0737232936306763,0.0033970296289933,-0.0803814717035031,-0.0670651155578494,5.7273816112568e-103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,39477,-0.166409098206297,0.0076696101632465,-0.181441534126261,-0.151376662286334,7.16879470709897e-103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFM,Afamin,37453,-0.0413511912030267,0.00190438248179432,-0.0450837808673435,-0.0376186015387098,8.42637787203175e-103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,-0.081085692668492,0.00373889273203594,-0.0884139224232825,-0.0737574629137016,1.62408050716891e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,-0.107454495469802,0.00499115243926204,-0.117237154250755,-0.0976718366888481,2.40900167624668e-101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,0.0705054564113275,0.0032804595094345,0.0640757557728359,0.0769351570498192,4.81479457308264e-101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,-0.228282786700193,0.0106870022963199,-0.24922931120098,-0.207336262199406,7.75323348161737e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,40009,0.0454160857351233,0.00213848771972531,0.0412246498044617,0.0496075216657849,9.6069893257226e-99
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,37043,-0.092527969903675,0.00438560303402217,-0.101123751850358,-0.0839321879569915,3.31964359173885e-97
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,37437,0.121809903936998,0.00584001667337325,0.110363471257187,0.13325633661681,3.99068232264513e-95
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,-0.0725303083383179,0.00349363099842473,-0.0793778250952304,-0.0656827915814055,1.70491563559795e-94
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MME,Neprilysin,39788,-0.163931068833148,0.00789882857833478,-0.179412772846685,-0.148449364819612,2.00343683082711e-94
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,37088,-0.0786782867524332,0.00380311294649721,-0.0861323881275677,-0.0712241853772987,1.34141487872247e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,37437,-0.058333128057163,0.00284083969259386,-0.063901173854647,-0.052765082259679,2.69778254103178e-92
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,39862,-0.108330301070876,0.00529247701976445,-0.118703556029615,-0.0979570461121381,6.13859115824225e-92
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,-0.0650182184771203,0.00318295017383831,-0.0712568008178434,-0.0587796361363972,1.43878772689216e-91
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,37043,-0.106631628746192,0.00524641077101479,-0.116914593857381,-0.0963486636350033,1.88086140172471e-90
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,37309,-0.0514473804848284,0.00253238958066932,-0.0564108640629403,-0.0464838969067166,2.10980792452276e-90
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,40058,-0.0523802708864045,0.00258482610956562,-0.0574465300611531,-0.0473140117116559,3.46302141585319e-90
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,-0.0866710564694496,0.00428726726914042,-0.0950741003169648,-0.0782680126219344,9.12697079558116e-90
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,37411,-0.0904280317858034,0.00446881957851872,-0.0991869181597001,-0.0816691454119067,1.00733932100374e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,36780,0.0881545030587619,0.00436394244359585,0.079601175869314,0.0967078302482097,2.30301866261679e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,37382,-0.223575379470083,0.01110936246289,-0.245349729897347,-0.201801029042818,8.85785128049221e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,40009,-0.118733858752903,0.00590902138832508,-0.13031554067402,-0.107152176831786,1.01609911620977e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,37124,-0.083285878341218,0.00416176315741103,-0.0914429341297436,-0.0751288225526923,8.48190776851274e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,39858,-0.0476118112521517,0.00238222826549156,-0.0522809786525151,-0.0429426438517882,8.53412577039582e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,-0.0451241871265096,0.00226631979680244,-0.0495661739282423,-0.0406822003247768,3.70246454007828e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,40058,-0.0679734215300037,0.00341517834247131,-0.0746671710812475,-0.06127967197876,4.1777472221617e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,-0.104114054891656,0.00525503682595535,-0.114413927070529,-0.0938141827127839,2.47071494931734e-86
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,39489,-0.100302801161744,0.00509322016450809,-0.11028551268418,-0.0903200896393086,2.65200225441044e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,-0.160799587133921,0.0081761063767802,-0.17682475563241,-0.144774418635431,4.21887399203257e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,39908,0.0526676859229112,0.0026783412399959,0.0474181370925192,0.0579172347533032,4.37032728286167e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,39749,-0.070735775914611,0.00360785028893071,-0.0778071624809152,-0.0636643893483068,1.36875306272884e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,-0.127340159141912,0.00650077595913255,-0.140081680021812,-0.114598638262012,2.81504867264032e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,0.0755758724763478,0.00386663887481928,0.067997260281702,0.0831544846709936,4.25045123517634e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,39858,-0.110833391751556,0.00568428577076667,-0.121974591862258,-0.0996921916408531,1.06290028264058e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,39984,-0.096061938536017,0.00494570977172915,-0.105755529688606,-0.0863683473834279,4.35850098668645e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,37382,-0.140176955752716,0.00721048724923008,-0.154309510761207,-0.126044400744225,4.73368515339905e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,-0.177246499060234,0.0091424937302854,-0.195165786771594,-0.159327211348875,9.15375548457128e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,-0.0585121115090981,0.00302804812230331,-0.0644470858288126,-0.0525771371893837,2.98042726233913e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,-0.0764197654342712,0.00398957562561921,-0.0842393336604849,-0.0686001972080576,7.33783433304302e-81
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELE,E-selectin,40052,-0.0950902063769385,0.0050090025615688,-0.104907851397613,-0.0852725613562637,1.69150943628426e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,40058,-0.0571607587546441,0.00301281319912478,-0.0630658726249287,-0.0512556448843595,2.08631964645595e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,37424,-0.0534752012680772,0.00283898182273471,-0.0590396056406372,-0.0479107968955172,3.78950968692099e-78
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,-0.10281397541623,0.00547891986528457,-0.113552658352187,-0.0920752924802719,1.02259283871813e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,-0.101907800173883,0.00543708410637608,-0.11256448502238,-0.0912511153253854,1.51033383635156e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,0.0542364925750539,0.00289551652192601,0.0485612801920789,0.0599117049580288,1.84477265776682e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,-0.135590039619933,0.00724709100195663,-0.149794337983768,-0.121385741256098,2.80790051101726e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,-0.0697563997976757,0.00374858529028442,-0.0771036269666331,-0.0624091726287182,1.71650994057564e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,40058,-0.143592784244787,0.00772904168607264,-0.15874170594949,-0.128443862540085,2.9799172824881e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,-0.107397289734117,0.0057919957127414,-0.11874960133109,-0.0960449781371436,8.62338052147212e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,39866,-0.0852034146325371,0.00460465773294788,-0.094228543789115,-0.0761782854759593,1.18390524501716e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,39908,-0.0626374720007108,0.00339018303704648,-0.0692822307533219,-0.0559927132480997,1.94544885171766e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,37296,-0.0513346698798979,0.0027855190272458,-0.0567942871732997,-0.0458750525864962,6.41234490617601e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,37043,-0.120358633357579,0.00653769565295721,-0.133172516837375,-0.107544749877783,9.42741630982166e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,-0.139187330369144,0.00757480734852194,-0.154033952772247,-0.124340707966041,1.2619905395341e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,0.0892684860259085,0.00487602481991364,0.0797114773788778,0.0988254946729392,5.59444014487248e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,40002,-0.0911214545683352,0.00498973469558373,-0.100901334571679,-0.0813415745649911,9.21361885180049e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,-0.125742932121429,0.00689499404063523,-0.139257120441074,-0.112228743801784,2.10451258123531e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,39858,-0.0596994439730716,0.00328580405152052,-0.0661396199140518,-0.0532592680320913,4.93213794439002e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,0.115756272786064,0.00637367821995592,0.10326386347495,0.128248682097178,5.65980154822464e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,40012,0.0962825254969968,0.00530479479000256,0.0858851277085918,0.106679923285402,6.79064822427207e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,39464,-0.10777497352282,0.00594227550635369,-0.119421833515273,-0.0961281135303663,9.08744136447513e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,40030,-0.0511548333793361,0.00283043948634171,-0.0567024947725658,-0.0456071719861063,2.66958678256259e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,-0.0391981937978283,0.00217016605770349,-0.0434517192709272,-0.0349446683247295,3.27267187464907e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,39933,-0.116956700591675,0.00649164900846341,-0.129680332648263,-0.104233068535087,7.36067869739318e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,-0.0891570379457862,0.00494699891671709,-0.0988531558225517,-0.0794609200690207,9.29984474487977e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,39949,-0.0562322722813654,0.00313305833325652,-0.0623730666145481,-0.0500914779481826,2.46488345486352e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,-0.0573990430858061,0.00320933422188067,-0.0636893381606922,-0.05110874801092,1.01879023558831e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,40058,-0.058496935982006,0.00327965608392327,-0.0649250619064956,-0.0520688100575164,1.74297273937484e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,39979,-0.106370120079912,0.00596543776155501,-0.11806237809256,-0.0946778620672641,1.92501979939406e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,-0.0743176978138354,0.00421375937976033,-0.0825766661981657,-0.0660587294295052,5.91196710636668e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,-0.0930682847708386,0.0052821506053723,-0.103421299957368,-0.0827152695843089,1.02474400629153e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,39868,-0.0451007341971071,0.00257194869976759,-0.0501417536486516,-0.0400597147455626,3.32331078137768e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,39865,-0.054763227501013,0.00312608555399208,-0.0608903551868375,-0.0486360998151885,4.49428466321841e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,-0.0372366390381605,0.00213306410873019,-0.0414174446912717,-0.0330558333850493,1.27496452159738e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.0471764209611763,0.00270413691458633,0.0418763126085871,0.0524765293137655,1.55476370314219e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,39879,0.0341735615469286,0.00196846759407372,0.0303153650625441,0.0380317580313131,6.72603913962398e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,40030,-0.224839976526889,0.0129922256745238,-0.250304738848955,-0.199375214204822,1.69094977072962e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,37124,-0.0473210619661273,0.00274015537713921,-0.0526917665053202,-0.0419503574269345,4.21172726344966e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,39846,0.313846027122737,0.0181983527362484,0.27817725575969,0.349514798485784,4.75848792888957e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,-0.191206399601334,0.0111080887257381,-0.212978253503781,-0.169434545698887,8.54124520709452e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,40058,-0.0788670858831439,0.00458472188997338,-0.0878531407874917,-0.0698810309787961,9.81283017126637e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELN,Elastin,37437,-0.0583817324228113,0.00339372005305455,-0.0650334237267982,-0.0517300411188244,1.25202442391952e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,39846,-0.0487701880882162,0.00284419388659447,-0.0543448081059413,-0.043195568070491,2.52738609338658e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,39931,0.0749918030990997,0.00438041341103031,0.0664061928134803,0.0835774133847191,3.9912130601387e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POSTN,Periostin,37437,0.064164789733268,0.00375079169215322,0.0568132380166477,0.0715163414498883,6.29653461219848e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,39868,-0.108956418217222,0.00638698271724981,-0.121474904343032,-0.0964379320914127,1.11433463569553e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,37437,-0.0978373766660834,0.0057309890603339,-0.109070115224338,-0.0866046381078289,1.13994371771004e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,-0.0816931224680126,0.0047957385094379,-0.0910927699465108,-0.0722934749895143,2.20278925101539e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,-0.115780406617557,0.00682005440458963,-0.129147713250553,-0.102413099984562,4.60364808599123e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,-0.121588193155871,0.00718237742242778,-0.13566565290383,-0.107510733407913,1.24133323343487e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,39788,-0.124035315784914,0.00735691523732034,-0.138454869650062,-0.109615761919766,3.14615053430106e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,37453,-0.0339474564834544,0.00201725256672003,-0.0379012715142257,-0.0299936414526831,6.52381513096535e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,-0.0840988421093591,0.00500738618107865,-0.0939133190242732,-0.0742843651944449,9.18210138011321e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,0.0451923639712383,0.0026926223208335,0.0399148242224046,0.050469903720072,1.10229945790133e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,-0.125200309393279,0.00747008912115023,-0.139841684070733,-0.110558934715824,1.6411076013883e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,-0.0438373277262811,0.00262317485960912,-0.048978750451115,-0.0386959050014472,3.66133290107812e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,40052,-0.0713025231119425,0.00427682013176342,-0.0796850905701988,-0.0629199556536862,6.88722519035474e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,37437,-0.187513440336287,0.0112487217732024,-0.209560935011764,-0.165465945660811,8.93344121346917e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,40058,-0.0464946827348151,0.00279462439329453,-0.0519721465456724,-0.0410172189239578,1.21697139648131e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,-0.0469101174767445,0.00282498316846899,-0.0524470844869437,-0.0413731504665453,2.06677015475492e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,40052,-0.0960924934241471,0.00579272429011416,-0.107446233032771,-0.0847387538155234,2.70531369528612e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,-0.0606676303342781,0.00366176889458827,-0.0678446973676711,-0.0534905633008851,3.78992994471913e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,-0.0642511137551819,0.00388369933194264,-0.0718631644457895,-0.0566390630645743,5.62191769260612e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,-0.0564068242090727,0.00341488206691908,-0.063099993060234,-0.0497136553579113,8.589992922443e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,-0.0547451261643194,0.00331737474768857,-0.061247180669789,-0.0482430716588498,1.11502223983346e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,37241,-0.0388551020562129,0.00236580369550795,-0.0434920772994085,-0.0342181268130173,5.00427838422898e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,39738,-0.0611700195866356,0.0037277071159991,-0.0684763255339939,-0.0538637136392774,5.09518696879953e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,-0.0646898856162112,0.00394951869760234,-0.0724309422635118,-0.0569488289689106,8.30018013059222e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,37445,-0.0439332195302964,0.00268189442566233,-0.0491897326045945,-0.0386767064559982,9.69791994598784e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,40052,-0.07154860466755,0.00437363338358968,-0.0801209260993858,-0.0629762832357142,1.1280464997471e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,39974,-0.0419775043813621,0.0025722205556829,-0.0470190566705006,-0.0369359520922236,2.14534551809928e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,39897,-0.0437558936853683,0.00268138133990238,-0.049011401111577,-0.0385003862591596,2.19665387623006e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,-0.0458167658361486,0.00280930564623538,-0.05132300490277,-0.0403105267695273,2.56468998367291e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,40003,-0.0539328458001247,0.00331644909896891,-0.0604330860341038,-0.0474326055661456,5.38532404759523e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,39963,-0.112319712765839,0.00691201979312576,-0.125867271560366,-0.0987721539713125,6.57991282230868e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,-0.11396323713147,0.00700872477013839,-0.127700337680942,-0.100226136581999,6.84877063421607e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,-0.0892417628030385,0.00551230056549246,-0.100045871911404,-0.0784376536946733,1.79474919578985e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,39993,-0.0924976694482003,0.00575194365576172,-0.103771479013493,-0.0812238598829073,9.72631945403715e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,-0.139995790039333,0.00870589661660473,-0.157059347407878,-0.122932232670788,1.23108310082124e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,-0.14761234833014,0.00920672373166122,-0.165657526844196,-0.129567169816084,2.09388526400225e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,39788,-0.111268519433401,0.00694847084335887,-0.124887522286384,-0.0976495165804171,2.88396625235084e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,-0.0321854441799221,0.00201092628425824,-0.0361268596970682,-0.0282440286627759,3.27228218161202e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,-0.0583129092670054,0.00364464626385524,-0.0654564159441617,-0.0511694025898491,3.52572217226165e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,39866,-0.0651603326844626,0.00408475921447759,-0.0731664607448386,-0.0571542046240865,7.55808492022387e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,37437,-0.146356633827884,0.00923593234447725,-0.164459061223059,-0.128254206432708,4.72744924027703e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,-0.0588216927234212,0.00371677923459626,-0.0661065800232298,-0.0515368054236125,5.47349223539012e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,37056,-0.13503634253617,0.00855830941425877,-0.151810628988117,-0.118262056084223,1.41051962683629e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,37043,-0.0965009282122778,0.00611687305406088,-0.108489999398237,-0.0845118570263185,1.46134366212318e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,40058,-0.0654299149271745,0.00415855718399841,-0.0735806870078114,-0.0572791428465376,2.28002944461559e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,39868,-0.0556216965491288,0.00354289740983076,-0.0625657754723971,-0.0486776176258605,3.92914384699998e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEP,Leptin,39868,-0.107214738422545,0.00684140858694065,-0.120623899252949,-0.0938055775921414,6.07095218540642e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,-0.196943960304521,0.0125706111800058,-0.221582358217332,-0.17230556239171,6.5323915037108e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,-0.105503599695252,0.00674082674924446,-0.118715620123771,-0.0922915792667329,8.20970650853781e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,-0.0410724917352676,0.00262403362010808,-0.0462155976306794,-0.0359293858398557,9.65997091245676e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,39931,-0.0810251520887814,0.00518654387637993,-0.091190778086486,-0.0708595260910767,1.29627804910569e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,-0.0742703955223456,0.00476317907205001,-0.0836062265035636,-0.0649345645411276,2.42676555674985e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,39839,-0.0762574904898682,0.00489535811581681,-0.0858523923968692,-0.0666625885828673,2.59619070174977e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,39995,-0.0589022430776906,0.00378311236508084,-0.066317143313249,-0.0514873428421321,2.89871038751612e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,-0.0994355753499882,0.00638865337867113,-0.111957335972184,-0.0869138147277927,3.17204900430746e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MLN,Promotilin,39866,-0.139821238817162,0.00900296000260006,-0.157467040422258,-0.122175437212066,5.33590792545522e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,39885,0.0605791123727856,0.00392152866519195,0.0528929161890094,0.0682653085565618,1.89443461615559e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,39836,-0.142569490839611,0.00925778897814586,-0.160714757236777,-0.124424224442445,3.94448601707892e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,-0.104878459991404,0.00683348982032331,-0.118272100039238,-0.0914848199435701,8.63237362870266e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,39788,-0.176179641766411,0.011515101383765,-0.198749240478591,-0.153610043054232,1.80840003131309e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,-0.0920354450258766,0.00602652491377625,-0.103847433856878,-0.0802234561948752,2.76854260133737e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,-0.0451323963907142,0.00296136438449002,-0.0509366705843146,-0.0393281221971137,4.4203090079567e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,-0.0337584158184993,0.0022149380737305,-0.038099694443011,-0.0294171371939875,5.06772979979521e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,-0.0430854842476913,0.002829905857913,-0.0486320997292007,-0.0375388687661818,5.57798534351513e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,40030,-0.0996297373762023,0.0065655053352138,-0.112498127833221,-0.0867613469191833,1.17956649650783e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,-0.130613387788352,0.00860584511900543,-0.147480844221602,-0.113745931355101,1.36374708262365e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,-0.0651662189004387,0.00429736652500675,-0.0735890572894519,-0.0567433805114255,1.38805124891375e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,-0.0486735672342697,0.00321270131348701,-0.0549704618087042,-0.0423766726598351,1.98331400666596e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,-0.104496140536755,0.00690712560500827,-0.118034106722571,-0.0909581743509388,2.38028452120079e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,37437,-0.105204492632783,0.00695377895403284,-0.118833899382688,-0.0915750858828789,2.72491331263983e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,-0.0294034651434078,0.0019452496521597,-0.0332161544616408,-0.0255907758251748,2.96342447520791e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,37124,0.0340646477030352,0.00225261142225942,0.0296495293154068,0.0384797660906637,3.08551518027713e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGRN,Agrin,39931,-0.0497423087833421,0.00329236862786777,-0.0561953512939629,-0.0432892662727212,3.20617881454041e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,-0.130044577205703,0.0086114663797616,-0.146923051310036,-0.11316610310137,3.62504188625549e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,-0.0886871005823287,0.00587756277849234,-0.100207123628174,-0.0771670775364837,4.96015939977412e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PXN,Paxillin,39489,-0.0783889152433228,0.00522531601279931,-0.0886305346284095,-0.0681472958582362,1.60668280488494e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0824116743485407,0.00549435851806472,-0.0931806170439476,-0.0716427316531338,1.64085202568521e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,-0.0768522005500083,0.00512546890622713,-0.0868981196062135,-0.0668062814938031,1.76443191236147e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,0.0593555498463766,0.00396073449236326,0.0515925102413446,0.0671185894514086,1.99317764535381e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,39866,-0.0808360240954601,0.0053951279519913,-0.0914104748813631,-0.0702615733095572,2.07828184141425e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,39866,0.0515159131380585,0.00343918337889862,0.0447751137154172,0.0582567125606998,2.20669686474988e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,-0.157472285169079,0.0105535679677905,-0.178157278385948,-0.13678729195221,5.22564865372338e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,37043,-0.0914737799409397,0.00613867473837367,-0.103505582428152,-0.0794419774537273,8.22572619113435e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,0.0911809593458988,0.0061384680385263,0.0791495619903873,0.10321235670141,1.6461074165193e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,37390,-0.164813205332629,0.011098259891354,-0.186565794719683,-0.143060615945575,1.69685254155628e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,39749,-0.133593960606554,0.0090106196922764,-0.151254775203415,-0.115933146009692,2.1189007384733e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OCLN,Occludin,37411,-0.0645479694050963,0.00435271825079493,-0.0730792971766543,-0.0560166416335382,2.30640584283379e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,40052,0.0398896976183396,0.00269171014081999,0.0346139457423325,0.0451654494943468,2.30927552839112e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,-0.085416615032283,0.00577556308903337,-0.0967367186867884,-0.0740965113777776,4.15587978536177e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,40030,-0.0684598701337266,0.00463478509893524,-0.0775440489276397,-0.0593756913398135,4.71281720627694e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,-0.12389654238909,0.00839407893296059,-0.140348937097693,-0.107444147680487,5.67134540280889e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,-0.0518892311950159,0.00351788261616829,-0.0587842811227058,-0.0449941812673261,6.43169347687117e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,-0.0917120166886749,0.00621481797794675,-0.10389305992545,-0.0795309734518992,6.81701225795806e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,-0.105760324543338,0.00717578848598518,-0.119824869975869,-0.0916957791108072,7.76451048858036e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,-0.0654710513054636,0.00445121655810174,-0.074195435759343,-0.0567466668515842,1.18408473956949e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,-0.145099167712977,0.00986707764056603,-0.164438639888486,-0.125759695537467,1.24045246776798e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,37124,-0.0683837067957496,0.00466125790214844,-0.0775197722839605,-0.0592476413075386,2.37640336149809e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,40009,-0.0883617486657781,0.00603246870440582,-0.100185387326414,-0.0765381100051427,2.84318806548299e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,-0.0775837918750449,0.00530814904891757,-0.0879877640109234,-0.0671798197391665,4.53410509379001e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,-0.0644490511569722,0.00441023238403619,-0.0730931066296831,-0.0558049956842613,4.71264143536385e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,0.0378664943509588,0.00259262875380632,0.0327849419934984,0.0429480467084191,5.98518075751127e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,-0.11204302941314,0.00768615558151369,-0.127107894352907,-0.0969781644733734,9.17111167934761e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,-0.106313023967171,0.00731934311484296,-0.120658936472263,-0.091967111462079,1.6800937658205e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAST,Gastrin,37388,-0.170798337986318,0.0117650041967415,-0.193857746211931,-0.147738929760705,2.13197418337481e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,39868,0.0750849397255249,0.00517584434770181,0.0649402848040293,0.0852295946470204,2.19226582139958e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,-0.120319970157651,0.00830899784358794,-0.136605605931083,-0.104034334384218,3.61949003158802e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,-0.14076196560629,0.00973207331902232,-0.159836829311574,-0.121687101901007,4.04670227717302e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,37056,-0.0651946936837233,0.00451341585399719,-0.0740409887575578,-0.0563483986098888,6.17642564322485e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,37051,-0.038026830447067,0.00263397479473755,-0.0431894210447526,-0.0328642398493814,6.88620591900337e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,-0.116284149981293,0.00809803802734592,-0.132156304514891,-0.100411995447695,2.03838933104994e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,0.0562882715106228,0.00392786560917433,0.0485896549166412,0.0639868881046045,2.72871616942e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,36763,-0.034227324254629,0.00238900142431097,-0.0389097670462785,-0.0295448814629795,3.35266768547116e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,39660,-0.0543381176646859,0.00379744151735894,-0.0617811030387094,-0.0468951322906624,3.72758504639306e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,39585,-0.0759814461603109,0.00531140419967633,-0.0863917983916765,-0.0655710939289453,3.946398531454e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,-0.12933151198055,0.0090485386877889,-0.147066647808616,-0.111596376152484,4.66955306783938e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,40009,-0.053687156388021,0.00375982008644644,-0.0610564037574561,-0.046317909018586,5.62055721976551e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.0498481093785829,0.00349162431854871,-0.0566916930429384,-0.0430045257142274,5.86215929943881e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,-0.0744620312158741,0.0052158656994245,-0.0846851279867461,-0.064238934445002,6.0005742866552e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,-0.0861939946840286,0.00604856587125537,-0.0980491837916891,-0.0743388055763681,9.56386140016587e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,0.0500854403241852,0.00351684364307158,0.0431924267837649,0.0569784538646055,9.62239325778246e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,-0.174692905122623,0.0122681216788175,-0.198738423613105,-0.150647386632141,1.13477644908467e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,-0.0509404292668139,0.00358228374720609,-0.0579617054113379,-0.04391915312229,1.30745910208797e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,37382,-0.153194952155904,0.0107832450717526,-0.174330112496539,-0.132059791815269,1.76661390598541e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,40052,-0.0848797376050852,0.0059787355348693,-0.096598059253429,-0.0731614159567413,1.79376626511602e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,-0.124692010991567,0.00878951138012308,-0.141919453296608,-0.107464568686526,2.13150941984454e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,-0.114186016613957,0.00806315505207761,-0.129989800516029,-0.0983822327118851,3.39911027229361e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,39846,-0.041244854933329,0.00292786329566468,-0.0469834669928318,-0.0355062428738263,8.45927290537792e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,39477,-0.105274297871137,0.00747503530836264,-0.119925367075528,-0.090623228666746,9.02078816153767e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,39843,-0.0480390804713174,0.00341437947148048,-0.0547312642354191,-0.0413468967072156,1.07859282492223e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,-0.0386686757010591,0.00275288062887808,-0.0440643217336602,-0.0332730296684581,1.50764734444275e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,39788,-0.0508612885054757,0.00363079844530199,-0.0579776534582676,-0.0437449235526838,2.54140189750091e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,40058,-0.107410196842417,0.00767295341821647,-0.122449185542121,-0.0923712081427127,2.88127217171597e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,40030,-0.0372178342109632,0.00266062092521633,-0.0424326512243872,-0.0320030171975392,3.32087045496528e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,-0.0697726000347551,0.00499019572657466,-0.0795533836588414,-0.0599918164106687,3.70917647095041e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,-0.0421755553556165,0.00301622358576699,-0.0480873535837198,-0.0362637571275132,4.04495514236093e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,-0.119176389001233,0.00854856352813593,-0.135931573516379,-0.102421204486086,6.45612933719583e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,-0.0541243045154888,0.00389565162373422,-0.0617597816980079,-0.0464888273329698,1.38137706894569e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,40009,-0.0587775334101903,0.00423810224897589,-0.067084213818183,-0.0504708530021975,1.7375146290586e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,0.0277254670653885,0.00200256530121297,0.0238004390750111,0.0316504950557659,2.43197123957951e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,37453,-0.0287572033111522,0.00208101826602027,-0.0328359991125519,-0.0246784075097525,3.84115703295534e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,-0.139411405396129,0.0101361812431119,-0.159278320632628,-0.11954449015963,8.61242430110904e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,40030,0.022988970808275,0.00167189611703011,0.0197120544188959,0.026265887197654,8.83534987876513e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,39866,-0.0638720819354772,0.00464594150190863,-0.0729781272792181,-0.0547660365917363,9.16986191494188e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,-0.196565239659874,0.0142927475157056,-0.224579024790657,-0.168551454529091,9.50132313765177e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,37124,-0.0885216832371033,0.00644577807419901,-0.101155408262533,-0.0758879582116733,1.25535328583619e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,-0.0673085119886403,0.0049085226830365,-0.0769292164473918,-0.0576878075298887,1.47588991019161e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,39906,0.0533802460063388,0.00390059778385232,0.0457350743499883,0.0610254176626894,2.15470339187559e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,37437,-0.0388818971907853,0.00283967309352964,-0.0444476564541034,-0.0333161379274672,2.1557492939249e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,39866,-0.0771606314453015,0.00565494541957592,-0.0882443244676703,-0.0660769384229326,3.73137698296182e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,-0.103541068927712,0.00759273657576223,-0.118422832616206,-0.088659305239218,4.66711901284609e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,39875,-0.0649298030331186,0.0047707468928253,-0.0742804669430562,-0.055579139123181,5.97762325806293e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,-0.0877887311890098,0.0064661138074692,-0.100462314251649,-0.0751151481263701,9.4942222509293e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,-0.0294802289829011,0.0021725845479376,-0.0337384946968587,-0.0252219632689434,1.0310788800848e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,39866,-0.0547313732347554,0.0040372364907815,-0.0626443567566872,-0.0468183897128237,1.22864399368151e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,37383,0.025641692348746,0.00189352956142807,0.0219303744083469,0.029353010289145,1.65277734234743e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,37368,-0.136862077603304,0.0101089393000644,-0.15667559863143,-0.117048556575178,1.722513015941e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,-0.0962514989084562,0.00710924457225749,-0.110185618270081,-0.0823173795468315,1.74416974578391e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,-0.0787063214338546,0.00581758777209503,-0.0901087934671609,-0.0673038494005483,1.7752973107632e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,39858,0.0389978266647354,0.00288281157807322,0.0333475159717119,0.0446481373577589,1.81429003229862e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,39931,-0.0900829896783364,0.0066613181810222,-0.10313917331314,-0.0770268060435329,1.92051594599541e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.0454015040009999,0.00336265843944257,0.0388106934596924,0.0519923145423073,2.5717899148668e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,39798,-0.0415655095374536,0.00307860772161978,-0.0475995806718284,-0.0355314384030788,2.58845813544625e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD248,Endosialin,37437,0.0541207493085545,0.00401815746860349,0.0462451606700917,0.0619963379470173,4.36688255270583e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,-0.0375018993138774,0.00278953671506949,-0.0429693912754136,-0.0320344073523412,5.61861285505596e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,39788,-0.06936099856589,0.00517091976693549,-0.0794960013090835,-0.0592259958226964,8.3740064530075e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,-0.148496726161684,0.0110724838184528,-0.170198794445851,-0.126794657877517,9.46166543706165e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,40009,-0.0785133850508243,0.00586401710199764,-0.0900068585707397,-0.0670199115309089,1.15514516066938e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,37169,-0.174827544037878,0.0130506695276285,-0.20040685631203,-0.149248231763726,1.16902916402574e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,39315,-0.0543829262044205,0.00407733388624185,-0.0623745006214546,-0.0463913517873865,2.33006790175969e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,39749,0.0448056374063158,0.00336753026574184,0.0382052780854618,0.0514059967271698,3.54239123238108e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,39866,0.0576969049727733,0.0043368526950712,0.0491966736904337,0.0661971362551128,3.59220264357828e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.0419353458504306,0.00315540258308721,0.0357507567875797,0.0481199349132816,4.30992161202737e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,-0.0761323333464324,0.00572948820041011,-0.0873621302192362,-0.0649025364736286,4.44209408103579e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,39749,-0.0566576025318158,0.0042649366876897,-0.0650168784396876,-0.048298326623944,4.65638205809546e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,-0.0488036587889585,0.00367531718272276,-0.0560072804670951,-0.0416000371108219,5.03505246851558e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,37437,-0.0592661036479082,0.00446437214536153,-0.0680162730528168,-0.0505159342429996,5.7091812146778e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,39913,-0.0354661592436337,0.0026747892935121,-0.0407087462589174,-0.03022357222835,6.45258887877371e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,37333,-0.0468493002655491,0.00353191823045254,-0.0537718599972361,-0.0399267405338621,6.6110908169195e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,0.0327427650914962,0.00247104048940566,0.0278995257322611,0.0375860044507313,7.21896277143368e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,39455,-0.0525794357704905,0.00397657835739595,-0.0603735293509865,-0.0447853421899944,1.06719936254621e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,-0.0355137155594649,0.00268913759971472,-0.0407844252549057,-0.030243005864024,1.29958266985123e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,-0.109946249643849,0.00832632364560072,-0.126265843989227,-0.0936266552984719,1.3230845917602e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,-0.130868902238396,0.00992849701532856,-0.15032875638844,-0.111409048088353,1.96971750037494e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,-0.0670669872446971,0.00509142974048976,-0.077046189536057,-0.0570877849533372,2.02580044979007e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,39866,-0.0988913320214679,0.00750935629416406,-0.113609670358029,-0.0841729936849063,2.11885338687756e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,-0.110487667977742,0.00839585470449706,-0.126943543198557,-0.0940317927569281,2.6353871255974e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,39720,-0.0684513906590522,0.00520660007499903,-0.0786563268060503,-0.0582464545120541,2.83970595723794e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,39931,-0.134352802537525,0.010221152996891,-0.154386262411431,-0.114319342663618,2.91447835552002e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,0.040949895122585,0.00311911736945185,0.0348364250784594,0.0470633651667106,3.57558368517218e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,-0.0671332251939397,0.00511352520020146,-0.0771557345863346,-0.0571107158015449,3.64068064420823e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,-0.0968267074953921,0.00738770042180733,-0.111306600322134,-0.0823468146686497,5.29929892836167e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,37382,-0.128759841723714,0.00983310881954205,-0.148032735010016,-0.109486948437411,6.10530556302602e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELP,P-selectin,39931,-0.0760096575252825,0.0058084399330947,-0.0873941997941481,-0.0646251152564169,6.25475794051017e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,-0.0672536205528885,0.00514788472563935,-0.0773434746151417,-0.0571637664906354,8.41062414504531e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,39859,-0.0415639284237521,0.00318244968468678,-0.0478015298057381,-0.035326327041766,8.75765521542388e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,-0.0362613939139075,0.00277718673812546,-0.0417046799206334,-0.0308181079071816,9.16269893405711e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,-0.0855013318329116,0.00656586952124067,-0.0983704360945433,-0.0726322275712798,1.4549871410472e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,37453,-0.0225763234391294,0.00173314301865614,-0.0259732837556954,-0.0191793631225633,1.47648731758005e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,39913,-0.0748067874080418,0.00574891549568114,-0.0860746617795768,-0.0635389130365067,1.63060643935579e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,39847,0.0673790467190618,0.00518739750193027,0.0572117476152785,0.0775463458228452,2.20964283164897e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,39785,-0.0939197971495296,0.00723696001741422,-0.108104238783661,-0.0797353555153977,2.55790036681394e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EZR,Ezrin,40009,-0.0315445145798417,0.00243086278374893,-0.0363090056359896,-0.0267800235236938,2.57931912788133e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,39504,-0.0651819406465553,0.0050226720347493,-0.0750263778346639,-0.0553375034584467,2.58687316569388e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,-0.0805993267667107,0.00621173787599732,-0.0927743330036654,-0.0684243205297559,2.66405775345648e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,0.0562183553968956,0.00433350829407707,0.0477246791405046,0.0647120316532867,2.72316048156674e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,-0.0805500402461988,0.0062151992613409,-0.092731830798427,-0.0683682496939706,3.2064945580447e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,39913,-0.108643679331299,0.00839819382578622,-0.12510413922984,-0.0921832194327582,4.33894117006719e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,-0.148995022157168,0.0115187400192359,-0.17157175259487,-0.126418291719465,4.84079878730918e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,39880,-0.0762984454453565,0.0059161897940965,-0.0878941774417857,-0.0647027134489274,7.26387715710368e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,-0.0678796500476628,0.00526482577450231,-0.0781987085656873,-0.0575605915296383,7.5923611886509e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,-0.113422720797424,0.00880390289757725,-0.130678370476676,-0.0961670711181727,8.62075470118451e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,-0.0921201655436171,0.00716795403417794,-0.106169355450606,-0.0780709756366283,1.30157040597725e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,39720,-0.0359712533998177,0.00280042123181237,-0.0414600790141699,-0.0304824277854654,1.41334320273392e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,-0.0304978174729041,0.00237496467737788,-0.0351527482405648,-0.0258428867052435,1.4738416850191e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,0.0441657520550158,0.00344642177204318,0.0374107653818111,0.0509207387282204,2.06521667713188e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,39713,-0.103149745259583,0.00808022384845882,-0.118986984002562,-0.0873125065166036,3.88259204336255e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,39788,-0.132702406264671,0.0104015505270187,-0.153089445297628,-0.112315367231715,4.27655635558758e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,-0.0813085828097632,0.00637623354421943,-0.0938060005564333,-0.0688111650630931,4.97071724171578e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,-0.12653542388664,0.00994099832916553,-0.146019780611805,-0.107051067161476,6.19050308405544e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,-0.102636049591842,0.00806310130934181,-0.118439728158152,-0.0868323710255322,6.21561868896506e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,-0.146004754480799,0.0114798002794765,-0.168505163028573,-0.123504345933025,7.05173648850378e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,39913,-0.0692747198258649,0.00544939509320629,-0.0799555342085493,-0.0585939054431806,7.59907134866193e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,-0.0687282051629146,0.00540792641266733,-0.0793277409317426,-0.0581286693940867,7.984603413008e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,37124,-0.149878348717217,0.0117937839368656,-0.172994165233473,-0.12676253220096,8.71790735517834e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,39868,0.0476077181638969,0.00375165863024321,0.0402544672486202,0.0549609690791736,1.01245332443556e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,-0.0790617120784254,0.00623256262937797,-0.0912775348320062,-0.0668458893248445,1.08243297318591e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,-0.0530758046549528,0.00418249421881911,-0.0612734933238383,-0.0448781159860674,1.08741430341971e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,37021,-0.0866461957065245,0.00683556206968077,-0.100043897363099,-0.0732484940499502,1.31788970807161e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,-0.0656097679234437,0.00517751314799876,-0.0757576936935213,-0.0554618421533662,1.3827138580634e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,-0.0376492010238004,0.00297242790648029,-0.0434751597205018,-0.031823242327099,1.46620696852652e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,40030,0.0577545220430647,0.00456706653233029,0.0488030716396974,0.0667059724464321,1.75505001913643e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,-0.109242798849077,0.00863854923434781,-0.126174355348399,-0.0923112423497552,1.77702860514066e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,-0.0774201931134217,0.00613992536878541,-0.0894544468362411,-0.0653859393906023,2.7913535630792e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,40008,-0.0745087524579608,0.00591112328379263,-0.0860945540941944,-0.0629229508217272,2.94223901610064e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,-0.0646454367527396,0.00512997891184203,-0.0747001954199499,-0.0545906780855292,3.309358383395e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,-0.0975408800802281,0.00775122889488184,-0.112733288714196,-0.0823484714462597,4.11656395776245e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,-0.0731697403651436,0.00581737035010119,-0.0845717862513419,-0.0617676944789453,4.15651856443141e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,-0.0492533558359251,0.003923542479732,-0.0569434990961998,-0.0415632125756503,6.11150431409528e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,0.0302102316623721,0.00240797476628745,0.0254906011204487,0.0349298622042955,6.17121588111305e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,39795,-0.057716104379883,0.0046032248415974,-0.0667384250694139,-0.0486937836903521,6.81567416968685e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,-0.0275518519426555,0.00219664458498774,-0.0318572753292315,-0.0232464285560796,6.96517527013736e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,-0.110662214435805,0.00883614302427755,-0.127981054763389,-0.0933433741082206,8.73455920789666e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,-0.134362770205433,0.0107738098408877,-0.155479437493573,-0.113246102917293,1.56711486808253e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASPN,Asporin,37437,0.0341728428233724,0.00273922079777641,0.0288039700597306,0.0395417155870142,1.59244188867331e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,-0.0242455540686667,0.00194951925486149,-0.0280666118081952,-0.0204244963291382,2.40974673615693e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,39866,-0.120270104973719,0.00967192802542453,-0.139227083903551,-0.101313126043887,2.45828728343745e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,37056,-0.116830792007684,0.00939510649718811,-0.135245200742173,-0.0984163832731954,2.65115433695412e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,37208,-0.0347075991068369,0.00280374784124619,-0.0402029448756794,-0.0292122533379943,5.28348278637497e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,37437,-0.100040242446283,0.00808752402778151,-0.115891789540735,-0.0841886953518315,5.88107878127883e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,-0.0685965236983772,0.00554873651273655,-0.0794720472633408,-0.0577210001334135,6.01667149055013e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,-0.0871280896730082,0.00704686676561783,-0.100939948533619,-0.0733162308123972,6.31133919789368e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,40058,-0.118381150594929,0.00959185478206191,-0.13718118596777,-0.0995811152220874,7.73099368133468e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,0.029963440568149,0.00243200381607869,0.0251967130886347,0.0347301680476632,1.01147432711378e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,40058,-0.053514847055113,0.0043465835259208,-0.0620341507659178,-0.0449955433443082,1.11658060740082e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,39858,-0.0559789537870548,0.00455084163469837,-0.0648986033910636,-0.047059304183046,1.28585544009388e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,39866,-0.101055306665492,0.00823065818841875,-0.117187396714793,-0.0849232166161911,1.70164661497013e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,39476,-0.0866954001530163,0.00707129969954675,-0.100555147564128,-0.0728356527419047,2.13268656968023e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,-0.123591607236631,0.0100903306077004,-0.143368655227723,-0.103814559245538,2.4275440013375e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,-0.134965975595143,0.0110193097838699,-0.156563822771528,-0.113368128418757,2.61203403939692e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,39866,-0.114133757303791,0.00933987621892023,-0.132439914692875,-0.0958275999147078,3.45007005693227e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,39587,-0.058965049248666,0.00482565622672307,-0.0684233354530432,-0.0495067630442888,3.51302549194594e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,37021,-0.052920680460085,0.00434695076647792,-0.0614407039623818,-0.0444006569577883,6.48974524915316e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,39749,-0.0645082073262047,0.00530334517728716,-0.0749027638736876,-0.0541136507787219,6.86434257266153e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,40058,-0.0416562703069047,0.00342487935546896,-0.0483690338436238,-0.0349435067701855,6.88914904274069e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,-0.0921311092688591,0.00758154757291244,-0.106990942511768,-0.0772712760259508,8.48411244685761e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,-0.0514949396807464,0.004239725522492,-0.0598048017048307,-0.0431850776566621,8.5024405860677e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,39913,-0.0496439111943691,0.00409227980450338,-0.0576647796111958,-0.0416230427775425,1.01499005372461e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,-0.0932085657815707,0.00768719536356599,-0.10827546869416,-0.0781416628689813,1.15970718161942e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,39788,-0.057376759324678,0.0047366007773139,-0.0666604968482132,-0.0480930218011427,1.25942276149662e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,37437,-0.0922713508319862,0.00762591032996081,-0.107218135078709,-0.077324566585263,1.57657430362245e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNST,Consortin,39868,-0.132316568230282,0.0109404707817037,-0.153759890962421,-0.110873245498143,1.5864658016637e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,-0.0492526976907733,0.00407375300830127,-0.0572372535870438,-0.0412681417945029,1.65815658240379e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,37373,-0.073082724162479,0.00604389884366365,-0.0849287658960598,-0.0612366824288983,1.73373804633246e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,39846,-0.0456276985710702,0.00377765452507435,-0.0530319014402159,-0.0382234957019245,1.92297756462489e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,-0.108227304794082,0.0089574641093586,-0.125783934448425,-0.090670675139739,1.94584553859063e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,-0.0548898386808231,0.00454852243778395,-0.0638049426588796,-0.0459747347027665,2.34627855092067e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,39666,-0.0441934756890369,0.00366494348602529,-0.0513767649216465,-0.0370101864564273,2.45229476337174e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,-0.047352091133167,0.0039291597617608,-0.0550532442662182,-0.0396509380001159,2.66232873663556e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,-0.0936704342298863,0.00777461639645532,-0.108908682366939,-0.0784321860928339,2.76502893886445e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,-0.0530408239434397,0.00440343771699205,-0.0616715618687441,-0.0444100860181352,2.85907522040423e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,-0.167765287737452,0.0139421764203259,-0.19509195352129,-0.140438621953613,3.32314000923773e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,-0.115233915611929,0.00957893372316698,-0.134008625709336,-0.0964592055145216,3.43627977370387e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,-0.105187341490925,0.00875076139507117,-0.122338833825264,-0.0880358491565854,3.85796645477192e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,37368,-0.0535554330140155,0.00445503393458713,-0.0622872995258063,-0.0448235665022247,4.05082195076584e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,40011,-0.0327134584790036,0.00272255744403293,-0.0380496710693082,-0.0273772458886991,4.06753790028101e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,-0.0605311095022546,0.00503833416899873,-0.0704062444734921,-0.0506559745310171,4.15834929946786e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,-0.049917784074094,0.00415830457080029,-0.0580680610328626,-0.0417675071153255,4.66769478707737e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,-0.0818011027490905,0.00681536299402939,-0.0951592142173881,-0.0684429912807929,4.82039322021755e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,40030,-0.066570870005697,0.00555233558507222,-0.0774534477524385,-0.0556882922589554,5.55185138955058e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,-0.117341771523767,0.00980152620981599,-0.136552762895007,-0.098130780152528,6.9407168562737e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,-0.114590633928298,0.00957956845853918,-0.133366588107034,-0.0958146797495609,7.77637668529635e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,39866,-0.0989613456049293,0.00827671199468641,-0.115183701114515,-0.0827389900953439,8.2726971829074e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,-0.0742567517169521,0.00621345701974949,-0.0864351274756611,-0.0620783759582431,8.86287375478653e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,37437,-0.0319269999784768,0.00267484833386595,-0.0371697027128541,-0.0266842972440995,1.11932775911534e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,39866,-0.101614922680079,0.00852595870808405,-0.118325801747924,-0.0849040436122343,1.30566557412088e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,-0.0699111650676236,0.00587787854124124,-0.0814318070084564,-0.0583905231267908,1.74792659251589e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,37386,-0.0333852906232259,0.00280793944064909,-0.0388888519268982,-0.0278817293195537,1.94437539149481e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,37411,-0.127252035813414,0.0107180994716863,-0.148259510777919,-0.106244560848909,2.37559621170217e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,-0.102774739625354,0.00867118906855827,-0.119770270199728,-0.0857792090509793,2.84851810749621e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,-0.103553082023857,0.00873726084252502,-0.120678113275206,-0.0864280507725081,3.03800329332731e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,-0.0930861205463121,0.00785888173435335,-0.108489528745645,-0.0776827123469796,3.30668564100802e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,-0.137406433656509,0.0116230585674037,-0.160187628448621,-0.114625238864398,4.33030536174781e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,-0.103998354585272,0.0088007461220827,-0.121247816984554,-0.0867488921859899,4.33201527920811e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,39866,-0.110061503785261,0.0093206386845551,-0.128329955606989,-0.0917930519635331,4.7998458089979e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,39489,-0.0776426708225048,0.00658056950060019,-0.0905405870436811,-0.0647447546013284,5.41350424610751e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,39477,-0.0745479503205853,0.00632307623694722,-0.0869411797450018,-0.0621547208961687,6.01675241998297e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COCH,Cochlin,37437,-0.0547060292975364,0.00464612415629245,-0.0638124326438696,-0.0455996259512032,7.54185149422888e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,-0.0701348577095568,0.00597276977581463,-0.0818414864701535,-0.0584282289489601,1.0499434186635e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,39913,-0.0658657280298901,0.0056247564815594,-0.0768902507337465,-0.0548412053260337,1.52264914764173e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,37382,-0.123910569750436,0.0105841658649345,-0.144655534845708,-0.103165604655165,1.66217267831535e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,-0.0834304011691333,0.00713085202311902,-0.0974068711344466,-0.0694539312038201,1.72286647670835e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,-0.123111015269486,0.0105357113709718,-0.143761009556591,-0.102461020982381,2.03734517052875e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,-0.092180196761791,0.0078897105959608,-0.107644029529874,-0.0767163639937078,2.0737246754845e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,40009,0.043425359561447,0.003717448530855,0.0361391604409712,0.0507115586819228,2.11977668617294e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,-0.0349933311763818,0.00299647803867311,-0.0408664281321811,-0.0291202342205825,2.35187938641635e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,39749,-0.0615433903305626,0.00527291264306188,-0.0718782991109639,-0.0512084815501613,2.39001091769522e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,37445,-0.0859951605047523,0.00736526520741568,-0.100431080311287,-0.0715592406982176,2.39287507333252e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,39868,0.0365175187031521,0.00313109602575601,0.0303805704926703,0.0426544669136339,2.64101410870245e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,0.0614438504061616,0.00526982139355221,0.0511150004747993,0.071772700337524,2.74451701237838e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,39866,-0.0742337981874573,0.00636696142415647,-0.086713042578804,-0.0617545537961106,2.75534972227417e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,-0.0328914134906167,0.00282072832187345,-0.0384200410014886,-0.0273627859797447,2.87820614409423e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,39713,-0.0719166855776779,0.00617428610718418,-0.0840182863477589,-0.0598150848075969,3.15676619976646e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,-0.0472972055710895,0.00406178582185756,-0.0552583057819304,-0.0393361053602487,3.27306959971854e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,-0.0523651622759701,0.00450023623189039,-0.0611856252904753,-0.0435446992614649,3.61363560849828e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,37420,0.0399954075163011,0.00344720743701823,0.0332388809397454,0.0467519340928568,5.62040811001495e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,40009,-0.071807166473995,0.00619513623802757,-0.083949633500529,-0.0596646994474609,6.0764324487382e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,-0.085638679729248,0.0073900181499921,-0.100123115303233,-0.0711542441552635,6.60428750633572e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,37388,-0.0742910964856612,0.00641094805964767,-0.0868565546825707,-0.0617256382887518,6.62130878693441e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,-0.147860211588173,0.0127859386365239,-0.17292065131576,-0.122799771860586,8.27771892091641e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,37124,-0.0342592860240698,0.00296332907011638,-0.0400674110014979,-0.0284511610466417,9.11140370865508e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,37437,-0.0346442415116334,0.00299727988778589,-0.0405189100916937,-0.028769572931573,9.3073956422366e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,39585,0.0273381381691853,0.00236708217849957,0.0226986570993261,0.0319776192390445,9.90157526108464e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,39486,-0.0336653621928657,0.00291519229511183,-0.0393791390912849,-0.0279515852944465,1.00403675348552e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,0.0302940356144022,0.00262433661048409,0.0251503358578534,0.035437735370951,1.10710000906384e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,-0.0602580968152505,0.00522478186209748,-0.0704986692649615,-0.0500175243655394,1.18729248875036e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,0.0613046820405096,0.00531757699553204,0.0508822311292668,0.0717271329517524,1.24949418422552e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,-0.0455399678813746,0.00395636054887004,-0.0532944345571599,-0.0377855012055893,1.6292143180572e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,40009,-0.0754247473269751,0.00658214258664658,-0.0883257467968024,-0.0625237478571478,2.77521683644739e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,-0.065350480226185,0.00570543005258466,-0.076533123129251,-0.0541678373231191,3.11941635217803e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,-0.0893096095999931,0.00780028342422244,-0.104598165111469,-0.0740210540885171,3.25731471797673e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,39972,-0.0789463804657351,0.00690659941952578,-0.0924833153280056,-0.0654094456034646,3.84379533353372e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,39803,-0.0346170995404011,0.00303793505918676,-0.0405714522564071,-0.028662746824395,5.78719761990106e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,39314,-0.106116056839902,0.00931314374652273,-0.124369818583087,-0.0878622950967177,5.88397425949931e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,-0.0294328843319289,0.00258471771036606,-0.0344989310442463,-0.0243668376196114,6.3039345667794e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,0.0513975439785477,0.00451541975671957,0.0425473212553773,0.060247766701718,6.63233632435593e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,-0.0925364028651803,0.00812595497025695,-0.108463274606884,-0.0766095311234767,6.64109947240188e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,-0.0740219971415404,0.00650337400697253,-0.0867686101952065,-0.0612753840878742,7.01442665173201e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,39788,-0.0375890356188006,0.00331254157771385,-0.0440816171111198,-0.0310964541264815,9.9266976633434e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,39794,-0.0969445064042507,0.00855466810428982,-0.113711655888659,-0.0801773569198427,1.17839569879561e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,-0.0340965287021906,0.00301039004113365,-0.0399968931828126,-0.0281961642215687,1.3219622297762e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,39489,-0.0397008129287731,0.00350987136170189,-0.0465801607977088,-0.0328214650598374,1.50488859092082e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,39931,-0.0554970110029838,0.00491431732629297,-0.065129072962518,-0.0458649490434495,1.83648093692907e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,39866,-0.0984007407499114,0.00872156592266559,-0.115495009958336,-0.0813064715414869,2.06874064474009e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,-0.0223823791359683,0.0019844735298513,-0.0262719472544769,-0.0184928110174598,2.15845586970095e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,-0.0390317005434358,0.00346779153600715,-0.0458285719540098,-0.0322348291328618,2.82099442956418e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,37043,-0.0358874456073902,0.00318750701756157,-0.0421349593618108,-0.0296399318529695,2.85122085770868e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,37124,-0.0790013339285486,0.00701927742913369,-0.0927591176896507,-0.0652435501674466,2.97245978675365e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,-0.0530289234813139,0.00471480393631847,-0.0622699391964981,-0.0437879077661297,3.07357356298306e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,37430,-0.0643100580588288,0.00572135219685774,-0.0755239083646699,-0.0530962077529876,3.47623517665304e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,37453,0.0311891364578232,0.00277519001255945,0.0257497640332067,0.0366285088824397,3.54544294221525e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,0.0340628909721127,0.00303780821497634,0.0281087868707591,0.0400169950734663,4.51467042676693e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,-0.029716891826561,0.00265265909978108,-0.034916103662132,-0.0245176799909901,5.06727057996661e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,39749,-0.0566037958249129,0.00505463336374008,-0.0665108772178435,-0.0466967144319824,5.33125323524959e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,39749,-0.0736986038445785,0.00658263537059637,-0.0866005691709474,-0.0607966385182096,5.48175293869959e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,-0.058804472167754,0.00525350194820242,-0.0691013359862308,-0.0485076083492773,5.93179161686796e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,-0.0952839012922631,0.00851576710610394,-0.111974804820227,-0.0785929977642994,6.17711985359078e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,-0.0317109609690738,0.00283906739016707,-0.0372755330538013,-0.0261463888843463,7.36091967671043e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,39489,-0.0689648081076005,0.00617915199205738,-0.081075946012033,-0.0568536702031681,8.14211059409127e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,40052,0.0181305812684065,0.00162493265388397,0.0149457132667939,0.021315449270019,8.35989271259029e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,-0.0879848129568536,0.00788360761586228,-0.103436683883944,-0.0725329420297636,8.4981482031606e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,-0.0718580152656395,0.00644095043037264,-0.0844822781091698,-0.0592337524221091,8.50675496153139e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,-0.0728176121868517,0.00652813645100895,-0.0856127596308292,-0.0600224647428742,9.09085661693231e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,-0.0956090173889243,0.00858050967160467,-0.112426816345269,-0.0787912184325791,9.93955977629993e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,39730,0.0318272795822857,0.00285663083215646,0.0262282831512591,0.0374262760133124,1.00638831304312e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,-0.0825772822930775,0.00741152231404356,-0.0971038660286029,-0.0680506985575521,1.00641954920458e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,39866,-0.0657951147437282,0.00591278091980448,-0.077384165346545,-0.0542060641409115,1.17291103992323e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,-0.0881847815206989,0.0079307313232322,-0.103729014914234,-0.0726405481271638,1.35078441585178e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,-0.0807997646897011,0.00727874094621216,-0.095066096944277,-0.0665334324351253,1.57603217642119e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,-0.0319008279534534,0.0028737518598593,-0.0375333815987776,-0.0262682743081292,1.58333881802989e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,-0.125935459922637,0.0113501514717137,-0.148181756807196,-0.103689163038078,1.68001498383239e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,-0.0757456213034904,0.00682666364349297,-0.0891258820447366,-0.0623653605622442,1.68454595438418e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,40030,-0.0450244996496024,0.00405839820724835,-0.0529789601358092,-0.0370700391633956,1.69701833649339e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,-0.0345349462144535,0.00311406697590306,-0.0406385174872234,-0.0284313749416835,1.86094511147713e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,-0.102207366049477,0.00922112648434358,-0.120280773958791,-0.084133958140164,1.987452623558e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,-0.070550653690668,0.00636784370311015,-0.0830316273487639,-0.0580696800325721,2.09677558032384e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,-0.0465456891153997,0.00420558756978029,-0.054788640752169,-0.0383027374786303,2.2816028253661e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,37124,-0.0594466304987059,0.00537504942856971,-0.0699817273787025,-0.0489115336187093,2.61490229516694e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,-0.0771517740868754,0.00698518689195455,-0.0908427403951063,-0.0634608077786445,3.08059470788538e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,0.0344935268150975,0.00312475893118121,0.0283689993099824,0.0406180543202127,3.23714484627299e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,-0.0300226713193043,0.00272143437793183,-0.0353566827000507,-0.024688659938558,3.38388421580617e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,37445,-0.0251466652018696,0.00228048266036723,-0.0296164112161894,-0.0206769191875498,3.73139079635201e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,39866,-0.0739585835009681,0.00670967814335546,-0.0871095526619448,-0.0608076143399914,3.75126887615494e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,39871,0.0303577376987527,0.00276085686872997,0.024946458236042,0.0357690171614635,5.04498219516263e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,39805,-0.126849566422254,0.0115460305255965,-0.149479786252423,-0.104219346592084,5.59631082478848e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,39931,-0.118158673360035,0.0107567589583072,-0.139241920918317,-0.0970754258017534,5.69938169944395e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,39908,-0.0286923856512155,0.00261301078301436,-0.0338138867859236,-0.0235708845165073,5.95833885717916e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,37388,-0.0422243496327561,0.00384633841813179,-0.0497631729322944,-0.0346855263332178,6.40908816368608e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,-0.08322910413301,0.00758654098730023,-0.0980987244681185,-0.0683594837979016,6.66124368196474e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,39897,0.03995765566564,0.00364549448092359,0.0328124864830298,0.0471028248482502,7.40223189359633e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,37415,-0.0497106313412532,0.00454163502274868,-0.0586122359858406,-0.0408090266966658,9.12165155202025e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,37368,-0.0921095322389441,0.00842783556532889,-0.108628089946989,-0.0755909745308994,1.09145875150685e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,40058,-0.0422605347690568,0.00386986918933171,-0.049845478380147,-0.0346755911579667,1.1498445827731e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,-0.0345852631519941,0.00316818423837274,-0.0407949042592047,-0.0283756220447835,1.20097100726253e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,37437,-0.0909389249692637,0.00834053791944467,-0.107286379291375,-0.0745914706471522,1.44686082102858e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,39788,-0.0813820562626698,0.00746664908724267,-0.0960166884736654,-0.0667474240516741,1.45152470786699e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,36543,-0.0270899368856579,0.00248841465629461,-0.0319672296119954,-0.0222126441593205,1.76983844238313e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREH,Trehalase,37437,-0.0833021538695057,0.00765326734361605,-0.0983025578629932,-0.0683017498760183,1.77405994241186e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,-0.0799696684546856,0.00734851498362098,-0.0943727578225827,-0.0655665790867885,1.81497530966101e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,-0.0804465718310825,0.0074038235240167,-0.0949580659381553,-0.0659350777240098,2.19758735674294e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,39858,0.0309900963184743,0.00285380894290113,0.0253966307903881,0.0365835618465605,2.24659969294359e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,39788,-0.0607597843484986,0.00560263293923071,-0.0717409449093908,-0.0497786237876064,2.62786525514031e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,39790,-0.0477698481150398,0.00440493300968563,-0.0564035168140237,-0.039136179416056,2.63456955948454e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,39885,-0.0516200307245451,0.00476075282821217,-0.060951106267841,-0.0422889551812493,2.68295395017123e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,40011,-0.0634329889151445,0.00585048744252679,-0.074899944302497,-0.051966033527792,2.69260352958803e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,-0.0590936765100303,0.00546231734524317,-0.069799818506707,-0.0483875345133537,3.65239439719384e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,39866,-0.0356072524953529,0.00329367871619616,-0.0420628627790974,-0.0291516422116085,3.79802811571123e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,39843,0.0344228396886278,0.00318581292727507,0.0281786463511687,0.0406670330260869,4.04280658156938e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,37249,-0.12108562384341,0.0112086253467304,-0.143054529523001,-0.099116718163818,4.31313990146425e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,-0.0246949675075218,0.00228723743151673,-0.0291779528732946,-0.020211982141749,4.61503630110358e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,37424,0.0410607851365078,0.00380635336719541,0.0336003325368048,0.0485212377362108,5.07977992756793e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,-0.0612610120298642,0.00568125041471546,-0.0723962628427065,-0.0501257612170219,5.11474104525781e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,40030,-0.121851762480835,0.0113012654690423,-0.144002242800158,-0.0997012821615119,5.16551793788332e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,-0.0706674717760201,0.00655778493216551,-0.0835207302430645,-0.0578142133089757,5.52680516755163e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,37411,-0.085164440405977,0.00790713815715459,-0.100662431194,-0.069666449617954,6.09329370629419e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,-0.0429148196981645,0.00398618018170146,-0.0507277328542994,-0.0351019065420296,6.16649837386716e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,37306,-0.10289718483788,0.00956164911954144,-0.121638017112181,-0.084156352563579,6.73564626838591e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,37371,-0.0929019149530217,0.00863672295777592,-0.109829891950263,-0.0759739379557809,7.08643448362809e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,39829,-0.0724883980064698,0.00674381077654564,-0.0857062671284993,-0.0592705288844403,7.41210519470891e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,-0.0614365704816786,0.00571984754454311,-0.0726474716689831,-0.0502256692943741,8.10939038958926e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,37377,-0.082469355490818,0.00767582958750059,-0.0975139814823191,-0.0674247294993168,8.11209308509828e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,-0.0305706257902614,0.0028464421108276,-0.0361496523274835,-0.0249915992530393,8.15577368372831e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BGN,Biglycan,39448,0.129754178079841,0.012103483119646,0.106031351165335,0.153477004994347,1.01179140431749e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,39749,-0.0673310968435559,0.00628569602525089,-0.0796510610530476,-0.0550111326340642,1.10516530457219e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,37388,-0.082572412391176,0.0077078851529961,-0.0976798672910484,-0.0674649574913037,1.13485767412002e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,39868,-0.132962029772085,0.0124380088083261,-0.157340527036404,-0.108583532507766,1.39411805063094e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,-0.112169146450739,0.0104926784877193,-0.132734796286669,-0.0916034966148093,1.45289990984715e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,37368,-0.0232099948216251,0.00217216823453807,-0.0274674445613198,-0.0189525450819305,1.52442262871682e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,37388,-0.0665634084866698,0.00623412471470663,-0.0787822929274948,-0.0543445240458448,1.6582032890209e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,37445,0.0517202154283931,0.00484444824226539,0.042225096873553,0.0612153339832333,1.67579629899243e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,37437,-0.0435331714324946,0.00407815640610699,-0.0515263579884643,-0.0355399848765249,1.70244820629709e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,39810,-0.0438539048853697,0.00411148607061415,-0.0519124175837734,-0.035795392186966,1.79920960833067e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,39913,-0.0321651905980872,0.00301805000006438,-0.0380805685982134,-0.0262498125979611,1.96939036552067e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,-0.0764859421914492,0.00717522967720369,-0.0905493923587684,-0.06242249202413,2.01174483457547e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,-0.0519365520709907,0.00487707329348357,-0.0614956157262185,-0.0423774884157629,2.16509249568077e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,-0.052272723857073,0.00491759443439617,-0.0619112089484895,-0.0426342387656565,2.75274564090341e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_E,,39866,-0.0294951183678321,0.00277889467298717,-0.034941751926887,-0.0240484848087773,3.13656135601548e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,-0.110476785678293,0.0104168179189084,-0.130893748799353,-0.0900598225572324,3.55557940896651e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,-0.0343912602537943,0.00324490775239489,-0.0407512794484882,-0.0280312410591003,3.68735161432272e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,37348,-0.0473224791841192,0.00446744615520086,-0.0560786736483129,-0.0385662847199255,4.07836978771262e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,-0.0781804514524309,0.00738410538017033,-0.0926532979975647,-0.063707604907297,4.2986998961777e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,-0.0340869579379024,0.00322178763797633,-0.040401661708336,-0.0277722541674688,4.49103221629272e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,-0.0341563836164728,0.00323201340793512,-0.0404911298960256,-0.0278216373369199,5.09221673126813e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,-0.0633113935609302,0.00599253692972833,-0.0750567659431977,-0.0515660211786627,5.45923234263431e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,-0.100086031234475,0.00948593016343681,-0.118678454354811,-0.0814936081141384,6.11536489151976e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,-0.0862046911145287,0.00818208076325024,-0.102241569410499,-0.0701678128185582,7.43748437155163e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,-0.062577243827628,0.00593962042086784,-0.074218899852529,-0.0509355878027271,7.49239408272888e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,0.0822764871833711,0.00781807093858279,0.0669530681437489,0.0975999062229934,8.13751516535709e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,-0.070405564841717,0.00669584848367808,-0.083529427869726,-0.0572817018137079,9.27691571677825e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,39477,-0.105098116463745,0.00999964195945612,-0.124697414704279,-0.0854988182232106,9.45103334727626e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0270326501733631,0.00257227886482659,0.021990983598303,0.0320743167484232,9.50717980095973e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,0.0458544709314571,0.00436756285383476,0.037294047737941,0.0544148941249732,1.05877460939149e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,-0.110688307247017,0.0105438922432348,-0.131354336043758,-0.0900222784502773,1.07007176454241e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,37385,-0.102889181836752,0.00981262929277404,-0.122121935250589,-0.0836564284229153,1.26437585692778e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,40024,-0.0731221381213719,0.00697826147036605,-0.0867995306032894,-0.0594447456394545,1.30927244094914e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,39749,-0.0356013131213453,0.003401229606128,-0.0422677231493562,-0.0289349030933344,1.48003786516347e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,-0.109104833666691,0.0104223911509674,-0.129532720322587,-0.0886769470107949,1.51231429157973e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,-0.0726839441475253,0.00694645660833369,-0.0862989990998593,-0.0590688891951912,1.53441592802499e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,37382,-0.0757428641992765,0.00724208242463905,-0.089937345751569,-0.0615483826469839,1.67222513404212e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,37043,-0.0820682091474749,0.00784696363953689,-0.0974482578809672,-0.0666881604139826,1.68393092268091e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,39868,-0.041109539193694,0.00393237550094616,-0.0488169951755485,-0.0334020832118395,1.69488584957532e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,39858,-0.0565755579232657,0.00541483256177626,-0.0671886297443472,-0.0459624861021843,1.80251934573352e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,40058,-0.0552884386093241,0.00530809948321058,-0.0656923135964168,-0.0448845636222313,2.52329142726752e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,37124,-0.0535799901995656,0.00515237356145142,-0.0636786423800104,-0.0434813380191209,3.12933561298588e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,37411,-0.0586711286401015,0.00564572554391145,-0.0697367507061679,-0.047605506574035,3.34849315008133e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,-0.0810316814770684,0.00780200458284328,-0.0963236104594412,-0.0657397524946956,3.56873780860903e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,39846,-0.0402819811660593,0.00387995071414935,-0.047886684565792,-0.0326772777663265,3.59684105353602e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,-0.0821587926142506,0.00794066542959104,-0.0977224968562491,-0.0665950883722522,5.22329645653369e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,-0.0475571807155666,0.00459936951485962,-0.0565719449646915,-0.0385424164664417,5.59628357296733e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,39477,-0.0577616020310236,0.00559045762469077,-0.0687188989754175,-0.0468043050866297,6.06458751358499e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,-0.0459741421246884,0.00444948007947181,-0.0546951230804531,-0.0372531611689237,6.24242143993834e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,39984,-0.0246842241370007,0.00239073999508783,-0.0293700745273728,-0.0199983737466285,6.49947825234258e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,39866,-0.0806548901935344,0.00783487838951515,-0.0960112518369841,-0.0652985285500847,8.92841748659409e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,39669,-0.0482513580536242,0.00468846278925316,-0.0574407451205604,-0.039061970986688,9.21324531680141e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,-0.0496356918347531,0.00482441681348985,-0.0590915487891932,-0.040179834880313,9.80224579183575e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,0.0343123493858709,0.00333760225936118,0.027770648957523,0.0408540498142188,1.06236163604883e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,39713,-0.0670779151086718,0.00652954672944808,-0.07987582669839,-0.0542800035189536,1.11466966071477e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,39931,-0.0407325785385954,0.00396536449912046,-0.0485046929568715,-0.0329604641203193,1.12226036678795e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,37039,-0.0513161888782445,0.00500078779505517,-0.0611177329565526,-0.0415146447999364,1.2986355989994e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,37043,-0.0558720413725068,0.00544624283602883,-0.0665466773311233,-0.0451974054138903,1.33642152380403e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,37043,-0.0779308174876571,0.00759871360826828,-0.0928242961598629,-0.0630373388154513,1.37869731615229e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,40052,-0.0579298996827679,0.00565347327180511,-0.0690107072955059,-0.0468490920700298,1.45414989019111e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,37043,-0.049206971776203,0.00480095151805073,-0.0586168367515824,-0.0397971068008236,1.47187687700909e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,39776,-0.0404061103452205,0.00394515433154123,-0.0481386128350413,-0.0326736078553996,1.53254248655632e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,-0.049691973146243,0.00485821324850438,-0.0592140711133116,-0.0401698751791744,1.81468097004979e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,39843,-0.0402969372111392,0.00394329919141737,-0.0480258036263173,-0.0325680707959612,1.93633935219182e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0331284519466892,0.00324693117861539,0.0267644668366031,0.0394924370567754,2.36714644644842e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,39749,0.0262298174118822,0.00257345592073649,0.0211858438072387,0.0312737910165257,2.54596353009645e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,-0.0674328784207784,0.00663894618599439,-0.0804452129453274,-0.0544205438962294,3.77295445831509e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,-0.0284919844934349,0.00280830891690716,-0.033996269970573,-0.0229876990162969,4.09758597383507e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,-0.0612655808950245,0.00604039118574617,-0.073104747619087,-0.049426414170962,4.23788192798846e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,-0.0383212715152613,0.00377906896885066,-0.0457282466942086,-0.030914296336314,4.33613066863234e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,37388,-0.0682695343872077,0.0067316545286082,-0.0814635772632798,-0.0550754915111357,4.40474683491338e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,-0.0562506706934053,0.00555196836287106,-0.0671325286846326,-0.045368812702178,4.74448017326247e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,-0.0349027016297719,0.00344620393081362,-0.0416572613341666,-0.0281481419253772,4.90817770805411e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,39477,-0.0603785853541273,0.00597438809999407,-0.0720883860301157,-0.0486687846781389,6.14126735338199e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,40040,-0.0537234999007208,0.00531800707797961,-0.0641467937735608,-0.0433002060278807,6.36123850902456e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,39489,-0.0732395580976286,0.00725107204957144,-0.0874516593147886,-0.0590274568804686,6.50714649410909e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,-0.0560235839963564,0.00554930211980013,-0.0669002161511646,-0.0451469518415481,6.81711803477405e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,-0.105160649893155,0.0104515942748527,-0.125645774671866,-0.0846755251144432,9.58836820281058e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,-0.0458446420345374,0.00455726701375069,-0.0547768853814888,-0.0369123986875861,9.80321279611226e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,37056,-0.046739500814877,0.00464999217082019,-0.0558534854696846,-0.0376255161600694,1.10067787073182e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,-0.0337259143459653,0.0033553117721684,-0.0403023254194154,-0.0271495032725153,1.10441404288541e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,-0.0804700341259081,0.00801294866197548,-0.09617541350338,-0.0647646547484361,1.20534371385847e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDK,Midkine,39843,-0.0514599425078875,0.00512925651276088,-0.0615132852728988,-0.0414065997428762,1.28685584240626e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,-0.0816007119092305,0.00813907725844459,-0.0975533033357819,-0.0656481204826791,1.42616990811642e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,40058,-0.0503754607352687,0.00503421566078855,-0.0602425234304142,-0.0405083980401231,1.66808147485074e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,37453,-0.0222238633874008,0.00222077761725354,-0.0265765875172178,-0.0178711392575839,1.70804068553135e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,39749,-0.0370307980756738,0.00370275134559173,-0.0442881907130336,-0.029773405438314,1.77220395009025e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,-0.0783373337713755,0.00783770707598213,-0.0936992396403005,-0.0629754279024505,1.9436425165168e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,-0.110050409803437,0.0110162326417697,-0.131642225781306,-0.0884585938255683,2.03551589086294e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,39477,-0.0295389199909804,0.00296027801878981,-0.0353410649078085,-0.0237367750741524,2.2258192904478e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.0268111545018714,0.00268771589200735,0.021543231353537,0.0320790776502058,2.28618135338988e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,39843,-0.0840707649634884,0.00843008545456841,-0.100593732454442,-0.0675477974725343,2.34838998416041e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,0.0203609310597518,0.00204217912603016,0.0163582599727327,0.024363602146771,2.40601067448992e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPARC,SPARC,39913,-0.0712321840011691,0.00714704301892539,-0.0852403883182628,-0.0572239796840753,2.49302046301239e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,40009,-0.0786434179398183,0.00789089103815748,-0.094109564374607,-0.0631772715050297,2.49846574555517e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,-0.0469767346591879,0.00471850530045885,-0.0562250050480872,-0.0377284642702885,2.78162728465214e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,-0.0406167818043987,0.00408518854310621,-0.0486237513488869,-0.0326098122599105,3.26820284610474e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,37437,-0.102480778896706,0.0103081001206573,-0.122684655133194,-0.0822769026602173,3.28793236280572e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,39788,-0.0903589248685077,0.00910312719017704,-0.108201054161255,-0.0725167955757607,3.74067255249381e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,-0.0854377474057301,0.00861033161363948,-0.102313997368463,-0.0685614974429967,3.97697630020467e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,39817,0.0638255135456251,0.00644500179833143,0.0511933100208955,0.0764577170703547,4.70332579349616e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,39882,-0.062503709698781,0.00631167411795316,-0.0748745909699692,-0.0501328284275928,4.71113541997965e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,39686,-0.0505167960705892,0.00510230137399739,-0.060517306763624,-0.0405162853775543,4.8189348092848e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,39973,-0.053770429431954,0.00543614009889121,-0.0644252640257807,-0.0431155948381272,5.28132427604309e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,-0.0916743179939988,0.00926924091132308,-0.109842030180192,-0.0735066058078056,5.52079276926393e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.0655717763065086,0.00663863570366241,-0.0785835022856869,-0.0525600503273302,6.07537278577032e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,-0.0326337185423266,0.00330572267817167,-0.039112934991543,-0.0261545020931101,6.41340834216488e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,0.0428361251074742,0.00434353254470269,0.0343228013198569,0.0513494488950915,7.06527984293535e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,37437,-0.0229386445847748,0.00232898281856299,-0.0275034509091583,-0.0183738382603914,8.2378024086313e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,40009,-0.0220909823581134,0.00224468017875341,-0.02649055550847,-0.0176914092077567,8.64700615249698e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,-0.0975235886676329,0.00990789421903503,-0.116943061336942,-0.0781041159983243,8.80315736093885e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,-0.0635977370280952,0.00647342262070834,-0.0762856453646835,-0.0509098286915068,1.02829501608817e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,39984,-0.0591193403067986,0.00601901778801744,-0.0709166151713128,-0.0473220654422844,1.04739092217427e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,-0.0753633042154309,0.00768249723285805,-0.0904209987918326,-0.0603056096390291,1.18735503183161e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,39619,-0.0420516498549938,0.00430210613594359,-0.0504837778814433,-0.0336195218285444,1.67577675068149e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,37409,0.0716016727288033,0.00732493935828592,0.0572447915865629,0.0859585538710437,1.70981016094013e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,-0.0559738233365501,0.00573503829284983,-0.0672144983905357,-0.0447331482825644,1.93809592252971e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,-0.0778037088939317,0.00797510642220809,-0.0934349174814596,-0.0621725003064039,2.01352194590741e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,-0.0706078652076497,0.00723877895421436,-0.0847958719579098,-0.0564198584573895,2.04464854867631e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,-0.0598303941174573,0.00614941593678804,-0.0718832493535619,-0.0477775388813527,2.67141254188769e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,37388,-0.0548187185166904,0.00563477105660163,-0.0658628697876296,-0.0437745672457512,2.69293271798073e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,39720,-0.0508991357433036,0.005239182005606,-0.0611679324742914,-0.0406303390123158,2.99930555950272e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,-0.0363384891669021,0.0037402762570091,-0.04366943063064,-0.0290075477031643,3.07709017738029e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,36879,-0.0690374178793915,0.00710849525106324,-0.0829700685714754,-0.0551047671873076,3.18968001044795e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,37388,-0.0813736734245738,0.00838018723936194,-0.0977988404137232,-0.0649485064354244,3.22238544667437e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,-0.0408070730522437,0.00420999852545661,-0.0490586701621387,-0.0325554759423488,3.71925353807484e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,-0.0587357214166758,0.00606012719447274,-0.0706135707178424,-0.0468578721155093,3.75499521079476e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,37056,-0.0539340935548634,0.00557411398730973,-0.0648593569699904,-0.0430088301397363,4.52282390726078e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REN,Renin,39868,-0.0646531536643491,0.00668706685388734,-0.0777598046979683,-0.0515465026307299,4.71980345981627e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,39749,-0.095099913232369,0.00985660977835374,-0.114418868397942,-0.0757809580667957,5.73925375818562e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,37437,-0.0633951507557018,0.00657267140595544,-0.0762775867113745,-0.0505127148000292,6.05339113760302e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,-0.0958093173108531,0.00993611364226654,-0.115284100049696,-0.0763345345720107,6.24443343029027e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,39496,-0.036803161820551,0.00381793784625435,-0.0442863199992095,-0.0293200036418924,6.26398372793245e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,39477,-0.0398578207587684,0.00413635284436469,-0.0479650723337232,-0.0317505691838136,6.48459431205319e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,37388,-0.105712891718417,0.010988555792074,-0.127250461070882,-0.0841753223659522,7.71241904609438e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,37043,-0.0607681495685735,0.00631854694801085,-0.0731525015866747,-0.0483837975504722,7.9606133279213e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,-0.0915268592259748,0.00952951137355654,-0.110204701518146,-0.072849016933804,8.77642890567511e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,37382,-0.0662443657135894,0.00689814270987875,-0.0797647254249517,-0.052724006002227,9.0923667197299e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,-0.0610496501380264,0.00636163299910902,-0.0735184508162801,-0.0485808494597728,9.739207290524e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,-0.110147942641423,0.0114976900218182,-0.132683415084187,-0.087612470198659,1.10942926538874e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,-0.117750009248756,0.0123013072200315,-0.141860571400018,-0.0936394470974945,1.23084316626509e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,39453,-0.0435743167308649,0.00456948797556325,-0.0525305131629689,-0.0346181202987609,1.70011307454342e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,39931,-0.0285606443558634,0.0029985603560302,-0.0344378226536826,-0.0226834660580442,1.88409252061739e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,-0.0908763455760593,0.0095442939733312,-0.109583161763788,-0.0721695293883301,1.99101642399213e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,39858,0.0275606807412988,0.00289946279967307,0.0218777336539395,0.033243627828658,2.26827746796125e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,-0.0706078654139231,0.00743700995826074,-0.0851844049321141,-0.0560313258957321,2.52713541437304e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NBN,Nibrin,39587,-0.0496026947076927,0.00522582373729795,-0.0598453092327966,-0.0393600801825887,2.58856430967989e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,0.0202517941893146,0.00213397465501054,0.0160692038654939,0.0244343845131353,2.69722833014839e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,-0.0517742112895753,0.00545736586927432,-0.0624706483933529,-0.0410777741857976,2.78481578627444e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0353560238734495,0.00372903153185914,0.0280471220710056,0.0426649256758935,2.92386103096169e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,-0.0388602981276728,0.00410381890120014,-0.046903783174025,-0.0308168130813205,3.20887280293221e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0365406303750845,0.00386139861429769,-0.044108971659108,-0.028972289091061,3.39857747439372e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,37124,-0.0553090981447644,0.0058612635586528,-0.0667971747197239,-0.0438210215698049,4.49285082368093e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,37382,-0.0571859109300003,0.00606185713755046,-0.0690671509195992,-0.0453046709404014,4.59381288571641e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,37368,-0.0380140345063311,0.00403057817709548,-0.0459139677334382,-0.0301141012792239,4.69653911959321e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,-0.0599189360619211,0.00635518979911099,-0.0723751080681786,-0.0474627640556635,4.83249125924987e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,0.0389764071961654,0.00414042812773672,0.0308611680658014,0.0470916463265293,5.42947584534704e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,-0.103063747547011,0.0109617644628245,-0.124548805894147,-0.0815786891998746,6.19156163687741e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,39585,-0.0550216995680944,0.00585627909390687,-0.0665000065921519,-0.0435433925440369,6.47084703409459e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,-0.0238428770263644,0.00254189849182918,-0.0288249980703496,-0.0188607559823792,7.46316484828751e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,37124,-0.0514957615928226,0.00549130188502663,-0.0622587132874748,-0.0407328098981704,7.82177915547901e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,-0.0964881828908404,0.0103055264122102,-0.116687014658772,-0.0762893511229084,8.77856546730919e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,37056,-0.039935602838006,0.00426617664717946,-0.0482973090664778,-0.0315738966095343,9.16117512013738e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,39489,0.069932456043991,0.00747334707956455,0.0552846957680444,0.0845802163199375,9.24424506896388e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,-0.0475460362357665,0.00508012968620704,-0.0575030904207323,-0.0375889820508007,9.31447074006547e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,-0.0648931084577639,0.00693547294834508,-0.0784866354365203,-0.0512995814790076,9.53069032136036e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,-0.0661103738411342,0.00707032805297362,-0.0799682168249625,-0.0522525308573059,1.01117611158996e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.0588968849692798,0.00630492220251416,-0.0712545324862075,-0.046539237452352,1.07305525633424e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,39836,-0.0853123804984793,0.00913921478363601,-0.103225241474406,-0.0673995195225528,1.14250014655303e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",37453,-0.0154658320784153,0.00165744416565757,-0.0187144226431041,-0.0122172415137264,1.20728533014006e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,40058,-0.0471382845384155,0.0050588552790338,-0.0570536408853218,-0.0372229281915093,1.33513408818867e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,-0.0324291089956831,0.00348310282801231,-0.0392559905385872,-0.025602227452779,1.43830292076765e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,-0.0666554965365267,0.00716052135317455,-0.0806901183887488,-0.0526208746843046,1.45899321639741e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,37056,-0.0303273172842232,0.00325778053212058,-0.0367125671271796,-0.0239420674412669,1.48889756349915e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,39881,-0.100862237413567,0.0108533960126644,-0.122134893598389,-0.0795895812287448,1.68656890721456e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,37453,-0.039155180796039,0.00421903200166711,-0.0474244835193065,-0.0308858780727714,1.93645104255872e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,-0.0293693023814187,0.00317019025234762,-0.03558287527602,-0.0231557294868173,2.25769263328197e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.0326609874388038,0.00352949754653665,-0.0395788026300156,-0.025743172247592,2.43679657263648e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,-0.0636031607792956,0.00688006891992196,-0.0770880958623426,-0.0501182256962485,2.65002142173152e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,39913,-0.0364390227673554,0.00394425445996961,-0.0441697615088958,-0.0287082840258149,2.80615464866869e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,37411,-0.0628337784868534,0.00680082765532511,-0.0761634006912906,-0.0495041562824162,2.84976351029261e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,37124,-0.0390433228672583,0.0042306400938922,-0.047335377451287,-0.0307512682832296,3.14877159895371e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,37368,-0.0601786150982505,0.00652270225009085,-0.0729631115084286,-0.0473941186880725,3.2198896295978e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,-0.0492598416027817,0.00534032341675174,-0.0597268754996151,-0.0387928077059483,3.27553601457956e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,-0.0279624964589289,0.00304427448026813,-0.0339292744402544,-0.0219957184776034,4.59797993155931e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,-0.0847571686683686,0.00922676392823846,-0.102841625967716,-0.0666727113690212,4.6596959695542e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,-0.0367493053950912,0.00400337886932271,-0.0445959279789638,-0.0289026828112187,4.86009412674755e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,-0.0377033465066135,0.00411799936869413,-0.045774625269254,-0.029632067743973,6.16270061833127e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,37039,-0.122957007079045,0.0134352976943404,-0.149290190559952,-0.0966238235981373,6.41346019423394e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,37411,-0.0511712452427735,0.00559444696440687,-0.0621363612930109,-0.040206129192536,6.69026127625836e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,39808,-0.0961287544808947,0.0105182898074771,-0.11674460250355,-0.0755129064582395,7.03427510055833e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,39858,0.0220962492026654,0.00241929653549466,0.0173544279930958,0.0268380704122349,7.42137459133203e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,-0.0279224980508004,0.0030606109447834,-0.0339212955025758,-0.0219237005990249,8.13959679503418e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,-0.0349692661743654,0.00383453853928044,-0.042484961711355,-0.0274535706373757,8.59559295442753e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,-0.0669954424967958,0.00735398822911941,-0.0814092594258699,-0.0525816255677218,9.39712536674634e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,40030,-0.0346137849573263,0.00380189159726036,-0.0420654924879566,-0.027162077426696,9.67135918247716e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,-0.136644968409319,0.0150206918492236,-0.166085524433797,-0.107204412384841,1.05550302440175e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,37368,-0.0333782383998859,0.00367059795752438,-0.0405726103966337,-0.0261838664031382,1.09207320972107e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,-0.0987763196253353,0.0108726743325343,-0.120086761317103,-0.0774658779335679,1.18072695001592e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,37453,-0.0226458648372837,0.0024930621812387,-0.0275322667125115,-0.0177594629620558,1.19402302696244e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,37411,-0.0472698431993111,0.00520581730364326,-0.0574732451144518,-0.0370664412841703,1.23169414353459e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,37039,-0.0387846641641204,0.00427818494443967,-0.0471699066552222,-0.0303994216730187,1.41115723307985e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,-0.0551010270993769,0.00608563141071211,-0.0670288646643726,-0.0431731895343812,1.52878314174127e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,37411,-0.0698663331949906,0.00772091210388527,-0.0849993209186057,-0.0547333454713754,1.63729666958599e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,-0.0339706573991744,0.00377101489649594,-0.0413618465963065,-0.0265794682020424,2.36769630483136e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,39749,-0.0742712348104887,0.00824891201791118,-0.0904391023655946,-0.0581033672553828,2.42403204808321e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,-0.0516097827806301,0.00574765492464057,-0.0628751864329256,-0.0403443791283346,3.02364034793131e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,-0.0454504256132199,0.00506118010477218,-0.0553703386185734,-0.0355305126078665,3.07348772900044e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,37453,-0.0275127124579715,0.00306689750339749,-0.0335238315646306,-0.0215015933513124,3.32239203736944e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,37124,-0.0612515014162176,0.00683244874878072,-0.0746431009638278,-0.0478599018686074,3.51985949899822e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,0.0319971483389239,0.0035700566262286,0.0249998373515159,0.038994459326332,3.59151033606114e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,39785,-0.0798472720781827,0.00891421234889609,-0.0973191282820191,-0.0623754158743464,3.68904580615915e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,-0.117538025874963,0.013139745048091,-0.143291926169221,-0.0917841255807042,4.10931995631319e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,40009,-0.0578974282328333,0.00647619320126161,-0.0705907669073061,-0.0452040895583605,4.30381412693507e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,-0.0838998313848543,0.00940346582884515,-0.102330624409391,-0.0654690383603178,5.0691709269873e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,-0.0590493602251021,0.00662935694412924,-0.0720428998355954,-0.0460558206146088,5.89134855848998e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,37021,-0.0608393087956816,0.00684060246082266,-0.074246889618894,-0.0474317279724692,6.66421467160696e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,37411,-0.0614478233256605,0.00690936831817384,-0.0749901852292812,-0.0479054614220398,6.66761042472234e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,39858,0.0231550191240289,0.00260757453896419,0.0180441730276591,0.0282658652203987,7.39015653573812e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,39866,-0.076004347042871,0.00856043455246746,-0.0927827987657073,-0.0592258953200348,7.47924320045553e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,37388,-0.0416195006148687,0.00468783494791687,-0.0508076571127857,-0.0324313441169516,7.64101437657078e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,39843,-0.0544424189467951,0.0061425716530334,-0.0664818593867405,-0.0424029785068496,8.58635372055504e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,-0.103337217208122,0.011680014353255,-0.126230045340502,-0.0804443890757424,1.00588236372129e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,39866,-0.0638265287539569,0.00721771899358671,-0.0779732579813869,-0.0496797995265269,1.02707523868954e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,39855,-0.0700784740113541,0.00792541828550664,-0.0856122938509471,-0.0545446541717611,1.03440131187947e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,40024,0.0318476140616105,0.00360632467849808,0.0247792176917543,0.0389160104314667,1.14169708564281e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,37437,-0.0320756257042547,0.00363216648408119,-0.0391946720130539,-0.0249565793954556,1.16329279020358e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,39868,-0.0478115236476417,0.00541852119894401,-0.0584318251975719,-0.0371912220977114,1.21967367646571e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,-0.0478612737295428,0.00542992209079472,-0.0585039210275005,-0.0372186264315852,1.34927680105084e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,40052,-0.0382521504114868,0.00434105926332519,-0.0467606265676041,-0.0297436742553694,1.35558136107177e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,-0.0790298641677797,0.00900682274834112,-0.0966832367545283,-0.0613764915810311,1.88891894948398e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,-0.0371257317352404,0.00423085944845895,-0.04541821625422,-0.0288332472162609,1.91602811990908e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,-0.0503266915568022,0.00573719786944309,-0.0615715993809106,-0.0390817837326937,1.9325713896432e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,-0.0329141687942027,0.00375518942272223,-0.0402743400627383,-0.0255539975256671,2.05273259162166e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,39862,0.0193198420766179,0.00220435799707839,0.0149993004023442,0.0236403837508915,2.06364108152621e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,39788,-0.0843583755596285,0.00962714197166607,-0.103227573824094,-0.065489177295163,2.09815360848721e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,39489,-0.0602329999774894,0.0068792709665991,-0.0737163710720236,-0.0467496288829551,2.23260979626306e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,-0.076432168348762,0.00872750866235829,-0.0935380853269842,-0.0593262513705397,2.23562690941623e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,39931,-0.0578238593190437,0.00660872697296799,-0.070776964186061,-0.0448707544520265,2.34990550633339e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,39489,-0.0552882600156946,0.0063197653493833,-0.0676750001004858,-0.0429015199309033,2.38019131022492e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,-0.0513507836691154,0.00586935945240586,-0.0628547281958309,-0.0398468391423999,2.41260774966326e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RETN,Resistin,39790,-0.0361669223522933,0.00413738866978053,-0.0442762041450632,-0.0280576405595235,2.5267041914297e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,-0.026144793263344,0.0029941085773946,-0.0320132460750374,-0.0202763404516506,2.74366527007672e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,0.0219030711986599,0.00251198078494191,0.0169795888601737,0.026826553537146,3.0630158835888e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,-0.0513438708744649,0.00588998091067383,-0.0628882334593856,-0.0397995082895442,3.13548867895655e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,-0.0714088348557798,0.00819623569505843,-0.0874734568180943,-0.0553442128934652,3.26210252281265e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,37124,0.0251050553122975,0.00288160063562503,0.0194571180664724,0.0307529925581225,3.33050363604456e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,-0.0501850317892206,0.00576304342706611,-0.0614805969062702,-0.038889466672171,3.38809863140422e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,39866,-0.0431555544197678,0.00495606027330897,-0.0528694325554534,-0.0334416762840823,3.40139638863236e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,-0.0176074605741238,0.00202189073985544,-0.0215703664242405,-0.0136445547240071,3.43527890227285e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,-0.0317557117349818,0.00364747334108301,-0.0389047594835045,-0.0246066639864591,3.50253871642813e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,37388,-0.0822962613925668,0.00946129938230017,-0.100840408181875,-0.0637521146032585,3.75711742293717e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,-0.0212560920817395,0.00244379083047274,-0.0260459221094661,-0.0164662620540129,3.76220579918389e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,-0.0542269210195996,0.00623767408826401,-0.0664527622325971,-0.0420010798066021,3.8508840661835e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,-0.0508158930506768,0.00584684516972693,-0.0622757095833416,-0.039356076518012,3.9300865671616e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,-0.0851084005423852,0.00979844844586273,-0.104313359496276,-0.0659034415884942,4.11516426530974e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.0572314391174121,0.00659008265807544,0.0443148771075842,0.0701480011272399,4.16872385801385e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,-0.0445347166288544,0.00513528255053441,-0.0545998704279018,-0.0344695628298069,4.64549158883922e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,-0.0593864362754766,0.00684961397530722,-0.0728116796670787,-0.0459611928838744,4.81488520706617e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,0.0264296923645008,0.00305155594395487,0.0204486427143493,0.0324107420146524,5.11271248731107e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,37021,-0.0345691663326256,0.0039950876924805,-0.0423995382098874,-0.0267387944553638,5.59748241321789e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,39858,-0.0315969070897082,0.00365403034738435,-0.0387588065705815,-0.0244350076088349,5.77461227705803e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,-0.0920337556287065,0.0106481922140529,-0.11290421236825,-0.0711632988891627,5.97947699842748e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,40058,0.0345484897637613,0.00399976552012049,0.0267089493443251,0.0423880301831974,6.26669388798951e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,37043,-0.0806979702655323,0.00934197412107358,-0.0990082395428365,-0.0623877009882281,6.36105059730939e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,-0.0596334300106045,0.00691125715265318,-0.0731794940298047,-0.0460873659914042,6.90475012616319e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,39477,-0.0855326680812925,0.00992063383553209,-0.104977110398935,-0.0660882257636496,7.22221229423694e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,-0.0410098387457173,0.00475692929117222,-0.0503334201564148,-0.0316862573350198,7.3603045138854e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,0.0354801935154454,0.00412445961653818,0.0273962526670305,0.0435641343638602,8.52568879784875e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,-0.0295952763465444,0.0034411247683548,-0.0363398808925198,-0.022850671800569,8.68401707203562e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,-0.0774374668130503,0.00900807733171635,-0.0950932983832144,-0.0597816352428863,9.14020037828693e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,-0.0694128564402988,0.00808311005539381,-0.0852557521488706,-0.0535699607317269,9.71084168573428e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,0.0186628901133914,0.00217365148858399,0.0144025331957668,0.022923247031016,9.84098862476077e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,-0.0671327906225817,0.00781856532565428,-0.0824571786608641,-0.0518084025842993,9.95152339831317e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,-0.0486661238765433,0.00566986001810668,-0.0597790495120324,-0.0375531982410542,1.00701294515087e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,39913,-0.0590944256831808,0.00688644616727621,-0.0725918601710422,-0.0455969911953194,1.02309193898513e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,-0.0328144079345773,0.00382517056656905,-0.0403117422450526,-0.0253170736241019,1.04773115768511e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,-0.0731829674146169,0.00852971202994931,-0.0899012029933175,-0.0564647318359162,1.05337187710741e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,-0.0778367483032241,0.00907770318461979,-0.0956290465450789,-0.0600444500613693,1.10236694500426e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,-0.057045339527019,0.00665446360308483,-0.0700880881890653,-0.0440025908649728,1.10320107246226e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,37039,-0.0707192335858954,0.00825585457634719,-0.0869007085555359,-0.0545377586162549,1.18997804747899e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.01893067519752,0.00221260518784692,0.0145939690293401,0.0232673813657,1.29458380266434e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,37187,-0.0217707463986073,0.00254638146759584,-0.0267616540750952,-0.0167798387221195,1.36764757085938e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,37124,-0.048175636481751,0.00563609866708547,-0.0592223898692386,-0.0371288830942635,1.39194500931227e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,-0.0409256123777204,0.00479141883124354,-0.0503167932869578,-0.0315344314684831,1.4423288321497e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,-0.0464080509451739,0.00543396236973136,-0.0570586171898474,-0.0357574847005004,1.48252699502659e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,39931,-0.0805542720585259,0.00943796652955991,-0.0990526864564634,-0.0620558576605885,1.52349845943489e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,37445,-0.0194709413345472,0.00228137709473663,-0.023942440440231,-0.0149994422288634,1.55248199470911e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,37056,-0.0389649173318917,0.00456867709904599,-0.0479195244460219,-0.0300103102177616,1.63980390069356e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,39788,-0.0779011823144607,0.00914098141468283,-0.0958175058872391,-0.0599848587416824,1.70419941980426e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,-0.0663482296693037,0.00778747387455796,-0.0816116784634373,-0.0510847808751701,1.73750094365705e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,-0.104012266446876,0.0122080255288098,-0.127939996483343,-0.0800845364104086,1.76263277866156e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,-0.0387389838408401,0.00454953584928521,-0.0476560741054391,-0.0298218935762411,1.81694627953508e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,37124,0.0437544629036506,0.00513818384579265,0.033683622565897,0.0538253032414042,1.83506090171121e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,39715,-0.062755992927175,0.00737971314204287,-0.077220230685579,-0.0482917551687709,1.9956528918566e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,39403,-0.0733684943075602,0.00863354475691426,-0.0902902420311122,-0.0564467465840083,2.10060413193353e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,40003,-0.0519942299850271,0.00612499811157934,-0.0639992262837226,-0.0399892336863316,2.26602056583328e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,-0.0947480171703806,0.0111645681708657,-0.116630570785277,-0.0728654635554838,2.31322773765305e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,39866,-0.0282933857143457,0.00333400386602909,-0.0348280332917628,-0.0217587381369287,2.31763638663569e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,-0.0510774443128134,0.00601999791437118,-0.0628766402249809,-0.0392782484006459,2.35606813893547e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,-0.0431926696948164,0.00509483449811545,-0.0531785453111227,-0.0332067940785101,2.49182609266437e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,39587,-0.0796481460085693,0.0094026273445678,-0.0980772956039222,-0.0612189964132164,2.64943042473739e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,39858,-0.0206864480146432,0.00244384548398034,-0.0254763851632447,-0.0158965108660418,2.7878877316448e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,-0.0217734167751283,0.00257398235558744,-0.0268184221920797,-0.0167284113581769,2.92625952007567e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,39585,-0.0416572800297841,0.0049249598100643,-0.0513102012575101,-0.0320043588020581,2.94643777571618e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,-0.0322592962129429,0.00381490928545491,-0.0397365184124345,-0.0247820740134512,3.00030308306583e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,-0.0516087801810794,0.00610762268278612,-0.0635797206393401,-0.0396378397228186,3.21907356475754e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,37388,-0.0324633041409592,0.00384648305879888,-0.040002410936205,-0.0249241973457134,3.50114927809183e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,37382,-0.0678970623366611,0.00804683613824642,-0.0836688611676241,-0.0521252635056981,3.56147812621061e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C3,Complement C3,36816,-0.0396401072332934,0.00470411117288564,-0.0488601651321492,-0.0304200493344375,3.9282791003496e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,37021,-0.0576018955552956,0.00683972320384532,-0.0710077530348324,-0.0441960380757587,4.09319874605476e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,-0.0832792712959203,0.00989209597869046,-0.102667779414154,-0.063890763177687,4.12374946168617e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPTC,Opticin,39788,0.0376735904942874,0.0044785908953809,0.0288955523393409,0.046451628649234,4.37156348368912e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,37056,0.0254421064326338,0.00302482220702515,0.0195134549068645,0.031370757958403,4.47589665488531e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,37388,-0.0613911221587886,0.00730169609321632,-0.0757024465014926,-0.0470797978160846,4.59274083028938e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,-0.0377365386995946,0.00448960697732505,-0.0465361683751517,-0.0289369090240375,4.62308243492953e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,40058,0.00768338428958328,0.000914406166816588,0.00589114820262276,0.00947562037654379,4.72561366551924e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,37445,-0.0589221459172628,0.0070132272020472,-0.0726680712332753,-0.0451762206012502,4.83928205123268e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,-0.0323190106823387,0.00384969918101271,-0.0398644210771236,-0.0247736002875537,5.03428474000746e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,39477,-0.0376717937441451,0.00448717730001097,-0.0464666612521666,-0.0288769262361236,5.03610951696409e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,37368,-0.0277385369672811,0.00330631669949205,-0.0342189176982855,-0.0212581562362767,5.36039911570482e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,37388,-0.0182117894805726,0.00217198259576711,-0.0224688753682761,-0.0139547035928691,5.57654233572017e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,37162,-0.019319531501527,0.00230577360877846,-0.0238388477747328,-0.0148002152283212,5.8812303055318e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,-0.0409130540860926,0.00488586941025278,-0.050489358130188,-0.0313367500419971,6.12619771997344e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,-0.0498722849519266,0.00596605071754872,-0.0615657443583221,-0.0381788255455311,6.93384874067855e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,-0.0722354739905269,0.00865066045144292,-0.089190768475355,-0.0552801795056988,7.36249849352562e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,-0.0281312354993803,0.00336941349020608,-0.0347352859401842,-0.0215271850585763,7.43960324305047e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,-0.0734938265131383,0.00881102995798118,-0.0907634452307814,-0.0562242077954952,8.08270569215002e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,-0.0301824529728294,0.00362869345418649,-0.0372946921430349,-0.0230702138026239,9.68353633092678e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,-0.0664810967626891,0.00799321480314991,-0.0821477977768629,-0.0508143957485153,9.74209302499596e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,-0.0723492700755223,0.00869761054463435,-0.0893965867430056,-0.055301953408039,9.77262569450301e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,39858,-0.0755692339217921,0.00910026631584084,-0.0934057559008401,-0.057732711942744,1.08574961665861e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,-0.0368464424631091,0.00443777120116191,-0.0455444740173864,-0.0281484109088317,1.11420839103417e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,39826,-0.0574068131031585,0.00691689099591328,-0.0709639194551485,-0.0438497067511685,1.12820335559287e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,-0.0768475930076392,0.00926178289665036,-0.0950006874850739,-0.0586944985302045,1.16538130286538e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,39858,-0.0208584363335655,0.00251531022404729,-0.0257884443726982,-0.0159284282944328,1.1953678137707e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,-0.0782539282483095,0.00945154246009312,-0.096778951470092,-0.059728905026527,1.33561632638599e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,40052,0.0255965216675986,0.00309491582321473,0.0195304866540978,0.0316625566810995,1.43654957408642e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,37382,-0.0572340341589033,0.00691972037648335,-0.0707966860968107,-0.043671382220996,1.44987271495518e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,39587,-0.0673268346012896,0.00814304097992649,-0.0832871949219455,-0.0513664742806337,1.46988590609505e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,39866,0.0216053728023163,0.00261425217530893,0.0164814385387108,0.0267293070659218,1.51228212906129e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,39788,-0.0453643491666932,0.00549653681089104,-0.0561375613160397,-0.0345911370173468,1.66091600570835e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,37437,-0.0709264753888477,0.00860345654707513,-0.087789250221115,-0.0540637005565805,1.81805083495772e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASN,Vasorin,39642,0.0228738053041358,0.00277716912408992,0.0174305538209195,0.028317056787352,1.91298357862602e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,-0.0230681574344514,0.00280127727617422,-0.0285586608957529,-0.0175776539731499,1.93540241836344e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,36991,-0.0331677999793385,0.00402679345949533,-0.0410603151599494,-0.0252752847987277,1.93551484142123e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,-0.0402225304232366,0.00488356384081353,-0.0497943155512311,-0.0306507452952421,1.94223657100192e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,-0.0299433454188273,0.00363890234926236,-0.0370755940233815,-0.0228110968142731,2.04571907960085e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,40052,0.0239098808040819,0.00291566394163306,0.0181951794784811,0.0296245821296827,2.57196568796298e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,-0.0709240053616435,0.00866825939095311,-0.0879137937679116,-0.0539342169553754,3.00424103818173e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,-0.101945752460994,0.0124652144897506,-0.126377572860905,-0.0775139320610826,3.09687332502874e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,37043,-0.0425218231783699,0.00520083585785583,-0.0527154614597673,-0.0323281848969725,3.20189536290181e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,40030,0.0277960097726038,0.00340114511928955,0.0211297653387963,0.0344622542064113,3.24114487802777e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,37445,-0.0395296159440258,0.00483841948001361,-0.0490129181248524,-0.0300463137631991,3.35621466535976e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,-0.0415735457718019,0.00509266727695778,-0.0515551736346391,-0.0315919179089646,3.50258105941301e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.0213330260697499,0.00261696665763716,0.0162037714207811,0.0264622807187187,3.89776547485612e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,39788,-0.0240181632618349,0.00294963831108056,-0.0297994543515528,-0.018236872172117,4.14783962181463e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,-0.0445253035476226,0.00547531351245193,-0.0552569180320284,-0.0337936890632168,4.58759738535066e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,39858,-0.0598695610596543,0.00737299292610645,-0.0743206271948229,-0.0454184949244856,4.99404532803707e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,-0.087981588718446,0.0108444259794268,-0.109236663638123,-0.0667265137987694,5.36583253288222e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,39913,-0.0455001823076457,0.00560949241096615,-0.0564947874331393,-0.034505577182152,5.36799702390053e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,-0.0550748611694841,0.00679872813554018,-0.0684003683151429,-0.0417493540238254,5.94031440403354e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,-0.0618460228952653,0.00763661857861442,-0.0768137953093495,-0.046878250481181,5.95623274022831e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0403741557816292,0.00498715940651072,-0.0501489882183902,-0.0305993233448682,6.10276968189952e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,39856,-0.0350984413833112,0.00433669546250291,-0.0435983644898169,-0.0265985182768054,6.21808020987536e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,39789,-0.0617485909811085,0.00762991347389651,-0.0767032213899457,-0.0467939605722713,6.2402630141404e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,-0.0381859191826609,0.00472131038047844,-0.0474396875283987,-0.0289321508369232,6.50798357578068e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,39555,-0.0311197776507331,0.00384824028331982,-0.0386623286060399,-0.0235772266954262,6.57178944557192e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,37357,-0.0262469599927445,0.00324662688318002,-0.0326103486837773,-0.0198835713017117,6.77717127359424e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,37388,-0.112920109412356,0.0139802255482919,-0.140321351487008,-0.0855188673377037,7.18881138672753e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,-0.0861631025931525,0.0106718888354633,-0.10708000471066,-0.0652462004756445,7.396318483054e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,-0.0451753721732204,0.00559936031324808,-0.0561501183871866,-0.0342006259592541,7.76371290491985e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,-0.0371611330602584,0.00461161608457447,-0.0461999005860244,-0.0281223655344925,8.40759327856702e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,39477,-0.038203599981047,0.00474304533792369,-0.0474999688433775,-0.0289072311187166,8.54176583951139e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,39858,-0.0631128488319798,0.00783991127998108,-0.0784790749407427,-0.0477466227232169,8.84279013782558e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,37422,-0.0380427388500862,0.00472726391134968,-0.0473081761163316,-0.0287773015838408,9.14756069379178e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,39858,-0.0213826430467449,0.00265939757758507,-0.0265950622988116,-0.0161702237946781,9.57573350388207e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,-0.0497411338510765,0.0061889156420003,-0.0618714085093971,-0.0376108591927559,9.83378588005012e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,37124,-0.0894744227467837,0.0111345276584446,-0.111298096957335,-0.0676507485362322,1.00819544553367e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,-0.0535104505654124,0.00666959889749391,-0.0665828644045005,-0.0404380367263243,1.10440564546716e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,39812,-0.0387827079596044,0.0048386812824122,-0.0482665232731323,-0.0292988926460765,1.17576409526314e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.0532414112947532,0.00665073572093433,-0.0662768533077845,-0.0402059692817219,1.29103870192296e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,-0.049919615631706,0.00624224290938409,-0.0621544117340988,-0.0376848195293132,1.3767012733407e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,39858,-0.0425286130692952,0.00532347573856664,-0.0529626255168858,-0.0320946006217045,1.45381278709602e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,39866,0.0375534792057029,0.00470299603072892,0.0283356069854742,0.0467713514259315,1.4999074667771e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,-0.0339701905196308,0.00425619099464431,-0.0423123248691337,-0.0256280561701279,1.54419078684222e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,37453,-0.0250219653125898,0.00313535665587935,-0.0311672643581133,-0.0188766662670663,1.57256575073769e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,-0.0548398616304659,0.0068742711109593,-0.0683134330079461,-0.0413662902529857,1.59546991510659e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,-0.0528170808114246,0.00662004579896084,-0.0657923705773878,-0.0398417910454614,1.60166830101934e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,0.0365750086373687,0.00458833231750593,0.0275818772950571,0.0455681399796803,1.67497148398435e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,0.023792238640608,0.00298593398075357,0.017939808038331,0.029644669242885,1.73955417460101e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,-0.0277965431119855,0.00349312235452151,-0.0346430629268476,-0.0209500232971233,1.87281260664743e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,-0.0297804425511312,0.00374307819171635,-0.0371168758068952,-0.0224440092953671,1.89512569860504e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,37411,-0.0389516701138159,0.0049001971381934,-0.0485560565046749,-0.0293472837229568,2.02815929483495e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,37021,-0.038111994328343,0.00479635858864625,-0.0475128571620897,-0.0287111314945964,2.08183182918844e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,37043,-0.0562077164961381,0.00707685616387481,-0.0700783545773327,-0.0423370784149435,2.14186028030278e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,-0.0514539295225938,0.00647882901467757,-0.0641524343913618,-0.0387554246538257,2.15243164024889e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,37124,-0.0562145456772696,0.00707998821486298,-0.070091322578401,-0.0423377687761382,2.18509405384386e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,-0.0504166723049312,0.00635043706659525,-0.0628635289554579,-0.0379698156544045,2.19587243805917e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAX,Protein max,39489,-0.0850350653585773,0.0107127652802869,-0.10603208530794,-0.064038045409215,2.19812165763674e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,39868,-0.0346047958251513,0.00436061957583625,-0.0431516101937904,-0.0260579814565123,2.22990368810854e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BSG,Basigin,40040,-0.0156457441874667,0.00197518221933696,-0.0195171013373671,-0.0117743870375662,2.50494501630827e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,39985,-0.0576195529694561,0.00727522330863781,-0.0718789906543862,-0.0433601152845259,2.52957361810353e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,37043,-0.0326991785351422,0.00412781614012249,-0.0407896981697823,-0.0246086589005021,2.53057217686529e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,40009,-0.0427779859574077,0.00540285078659637,-0.0533675734991366,-0.0321883984156788,2.57639088686611e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,39866,-0.0301003059268683,0.00380171299523137,-0.0375516633975218,-0.0226489484562148,2.58000418622285e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,-0.0939985203365973,0.0118810395349798,-0.117285357825158,-0.0707116828480368,2.70612227448325e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPART,Spartin,37124,-0.0629684501384414,0.007961204114849,-0.0785724102035455,-0.0473644900733374,2.78989143138573e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,-0.0154662555524527,0.00195869297400582,-0.0193052937815041,-0.0116272173234013,3.09486059571539e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,-0.035105673541899,0.00444578526457349,-0.043819412660463,-0.0263919344233349,3.09714255228165e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,-0.0188704960940825,0.00239076607283168,-0.0235563975968326,-0.0141845945913324,3.14000749343112e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,-0.069171807936573,0.00878059615261928,-0.0863817763957068,-0.0519618394774392,3.59023331120903e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,39908,-0.0697485252535794,0.0088651599674147,-0.0871242387897122,-0.0523728117174466,3.84076795336511e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,-0.0322927710452555,0.00410378952102104,-0.0403361985064568,-0.0242493435840543,3.84468000721964e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,-0.0548059297603597,0.00696769633706756,-0.0684626145810121,-0.0411492449397073,3.90315779046275e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,37039,-0.0394729863526263,0.00502237413527222,-0.0493168396577599,-0.0296291330474928,4.15729658185771e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,39858,0.036592140293685,0.0046610147011739,0.0274565514793842,0.0457277291079859,4.39862171429397e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,-0.045751550395265,0.00584692584944722,-0.0572115250601815,-0.0342915757303484,5.46637406004837e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,-0.0616425955427272,0.00788061703502951,-0.077088604931385,-0.0461965861540694,5.51963510833808e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,37021,-0.0474875737948506,0.00607302171048059,-0.0593906963473926,-0.0355844512423087,5.70866583967044e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,37124,-0.0592082264741766,0.00757385561442824,-0.074052983478456,-0.0443634694698973,5.79556097171257e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,37043,-0.0936588078842956,0.0119958027971208,-0.117170581366652,-0.0701470344019388,6.26570558843961e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,39858,0.024975744989847,0.00319977141016079,0.0187041930259319,0.0312472969537622,6.29259528598956e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,-0.0428207783487547,0.00548659734242942,-0.0535745091399164,-0.032067047557593,6.33163373651002e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,-0.0184600625968588,0.00236590255289051,-0.0230972316005242,-0.0138228935931934,6.50869933188283e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,-0.0751680173168349,0.00963605079766694,-0.0940546768802621,-0.0562813577534077,6.53682494817715e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,-0.0417228754350934,0.00535771017446228,-0.0522239873770394,-0.0312217634931473,7.34365549748876e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,40009,-0.0914103381712815,0.0117415878299052,-0.114423850317896,-0.0683968260246673,7.38160527276545e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,37345,-0.0700427693361092,0.00899585061292257,-0.0876746365374374,-0.052410902134781,7.41204554848568e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,39575,0.0236975967420124,0.00304624367574422,0.0177269591375538,0.0296682343464711,7.7447450082465e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,39793,-0.0630374302612647,0.00811282854280236,-0.0789385742051573,-0.0471362863173721,8.31890993312066e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,-0.0406695870280709,0.005239954204709,-0.0509398972693005,-0.0303992767868412,8.90222511541241e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,37437,-0.065175601234686,0.00839892094259373,-0.0816374862821697,-0.0487137161872023,9.09776387794802e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,-0.0657029484752259,0.00847421459875564,-0.082312409088787,-0.0490934878616649,9.49117727041189e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,40052,0.0236907814842207,0.00305601675111971,0.0177009886520261,0.0296805743164153,9.56733212688118e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,37039,-0.0358273656409625,0.00462398278398761,-0.0448903718975782,-0.0267643593843467,1.00034271988079e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,37043,0.0336095974839537,0.00433946536720194,0.0251042453642379,0.0421149496036695,1.02460190669244e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,-0.0210261785212787,0.00271594831614243,-0.0263494372209179,-0.0157029198216395,1.0394006477018e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,-0.0308010564338383,0.00398097556928071,-0.0386037685496285,-0.0229983443180481,1.07710289970632e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,-0.0392853808149496,0.00508356192340005,-0.0492491621848137,-0.0293215994450855,1.1712556808049e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,-0.0419371630182801,0.00542702118820031,-0.0525741245471527,-0.0313002014894075,1.17411507455471e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,-0.0772385880806044,0.00999785554819697,-0.0968343849550705,-0.0576427912061384,1.18145038638449e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,-0.0708970285132931,0.00918532429754707,-0.0889002641364854,-0.0528937928901008,1.26138715268354e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,39821,-0.0531339616590154,0.00688727728829287,-0.0666330251440694,-0.0396348981739613,1.28305316421966e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,39788,-0.0463845866353751,0.00601982290847163,-0.0581834395359795,-0.0345857337347707,1.38189906305798e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,-0.0532408535558524,0.00691491863094663,-0.0667940940725078,-0.039687613039197,1.44643623426624e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,-0.0378938212597914,0.00492311492019707,-0.0475431265033777,-0.0282445160162051,1.47457849874575e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,37382,-0.081146898529693,0.0105502395160359,-0.101825367981123,-0.0604684290782627,1.5547859174969e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,39858,-0.025838587728412,0.0033626258740897,-0.0324293344416278,-0.0192478410151962,1.63041880324005e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,40052,-0.0423722142682201,0.00551612732955957,-0.0531838238341568,-0.0315606047022833,1.66178999463842e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,37453,-0.0276580427380433,0.00360509505315263,-0.0347240290422224,-0.0205920564338641,1.80925993038992e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,40034,-0.0180904682072267,0.00235848045200471,-0.022713089893156,-0.0134678465212975,1.81199550454261e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,-0.0529883852161239,0.00690874950759335,-0.0665295342510069,-0.0394472361812409,1.84411181023342e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,39777,-0.0220351688942883,0.00287784733695581,-0.0276757496747217,-0.0163945881138549,2.01500805070148e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,-0.0469298865711027,0.00613635987483747,-0.0589571519257841,-0.0349026212164212,2.16262983885124e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,0.0294704023396831,0.00386192080782077,0.0219010375563544,0.0370397671230118,2.46148373440556e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,39868,-0.0994942835908182,0.0130457888735249,-0.125064029782927,-0.0739245373987093,2.54638430575373e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,0.0302594532696911,0.00396781915918839,0.0224825277176818,0.0380363788217003,2.55280949151234e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,-0.0607271642244572,0.00796345078682122,-0.0763355277666268,-0.0451188006822876,2.58771763545251e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,-0.022176958335706,0.00290997708530566,-0.027880513422905,-0.0164734032485069,2.68352953651809e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,-0.0691932624562756,0.0090827147793059,-0.0869953834237152,-0.051391141488836,2.71792597744135e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,37411,-0.059520728225813,0.00781462095884632,-0.0748373853051518,-0.0442040711464742,2.77698288609965e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,0.0853612019278059,0.0112212559250088,0.0633675403147887,0.107354863540823,2.95978508326229e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,39771,-0.0432604995570683,0.00569771951736441,-0.0544280298111026,-0.0320929693030341,3.30910902550912e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,-0.0430937097844895,0.00568137345507514,-0.0542292017564368,-0.0319582178125423,3.50310293373629e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,-0.0191308979577208,0.00253355097663147,-0.0240966578719185,-0.0141651380435232,4.55004165062667e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,-0.0759653591830594,0.0100645103073239,-0.0956917993854143,-0.0562389189807045,4.70671519678832e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,37382,-0.0753265906760827,0.0099844663712163,-0.0948961447636666,-0.0557570365884988,4.83427167487369e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,40058,-0.034986437448448,0.0046407146509551,-0.04408223816432,-0.025890636732576,4.98533849279496e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,39477,-0.0404189272079261,0.0053623986303607,-0.050929228523433,-0.0299086258924191,5.05427759425579e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,39477,-0.0288754464431819,0.00383663937965992,-0.0363952596273154,-0.0213556332590485,5.50691750900621e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.0256291750283799,0.00341290302941521,-0.0323184649660337,-0.0189398850907261,6.24822920753654e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,-0.0421860150470752,0.00562553354837197,-0.0532120608018843,-0.0311599692922662,6.83309928246094e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,37124,-0.0221193335626328,0.00295010118371365,-0.0279015318827116,-0.0163371352425541,6.90025647394559e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,-0.028440862888016,0.00379646802029182,-0.035881940207788,-0.0209997855682441,7.24768430354579e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,39862,-0.0188560104549275,0.00252044309807741,-0.0237960789271593,-0.0139159419826958,7.74494035688698e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,37340,-0.035994554411772,0.00481814193746112,-0.0454381126091958,-0.0265509962143482,8.47182195419596e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,39985,-0.0529038744435327,0.00709138532931614,-0.0668029896889924,-0.0390047591980731,9.07163723207463e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,39749,-0.0765510016383539,0.010291013572427,-0.0967213882403109,-0.0563806150363969,1.06931314989693e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,39857,0.0443071594956242,0.0059604358044783,0.0326247053188467,0.0559896136724016,1.11071373300505e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,-0.043155058857675,0.00580642448588378,-0.0545356508500073,-0.0317744668653428,1.12255915612182e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,37056,-0.0373561897084878,0.00502988679214124,-0.0472147678210846,-0.027497611595891,1.18042513366392e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,-0.0847000826022482,0.0114092934800379,-0.107062297823122,-0.062337867381374,1.19521130132498e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,0.0131112963623845,0.0017663592253611,0.00964923228067674,0.0165733604440923,1.20459463823602e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,37388,-0.0756577147769467,0.0101996385873803,-0.0956490064082121,-0.0556664231456814,1.26277433001783e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,-0.0490998961712985,0.00661923438490068,-0.0620735955657038,-0.0361261967768932,1.2640952963184e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,-0.0370662646637453,0.00499943020570073,-0.0468651478669187,-0.0272673814605719,1.29702050992883e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.0315091379882231,0.00425208478443865,-0.0398432241657229,-0.0231750518107234,1.32245275011948e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,-0.0688073090764035,0.0092884680450059,-0.0870127064446151,-0.0506019117081919,1.3618777072151e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,-0.0269742473772795,0.00364212866116535,-0.0341128195531636,-0.0198356752013954,1.37680806774773e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,0.0585365075100299,0.0079052236373485,0.0430422691808269,0.074030745839233,1.37893490467553e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,-0.0698299124294219,0.0094403549234277,-0.0883330080793402,-0.0513268167795036,1.4775885679644e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,-0.0274803541344609,0.00371674261098474,-0.034765169651991,-0.0201955386169309,1.51441389546144e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,37388,-0.0634905069282169,0.00859730916641601,-0.0803412328943923,-0.0466397809620415,1.61453300958078e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,39749,0.0314528750700031,0.00426014747855211,0.023102986012041,0.0398027641279652,1.62368330848299e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,37376,-0.047715656694145,0.00647621226597213,-0.0604090327354504,-0.0350222806528397,1.83475416258053e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,-0.0722392261419413,0.00980881660785702,-0.0914645066933411,-0.0530139455905415,1.86238940263628e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0179567232372101,0.00243965689483713,0.0131749957233294,0.0227384507510909,1.92293579678304e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,39747,-0.0170508487062116,0.00231716956339323,-0.0215925010504624,-0.0125091963619609,1.95106264959965e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,-0.0542710603790507,0.0073763790620173,-0.0687287633406046,-0.0398133574174968,1.96572657627788e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,-0.0314238861649879,0.00427042070219196,-0.0397939107412842,-0.0230538615886917,1.96725001632933e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,39913,-0.0542175134522422,0.00738842293010212,-0.0686988223952423,-0.039736204509242,2.26887844904233e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,-0.0298871002092449,0.00407280554731993,-0.037869799081992,-0.0219044013364978,2.28759180486694e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0291170431220781,0.00396945057084564,0.0213369200032206,0.0368971662409356,2.32042376526001e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,-0.0199234665102051,0.00271789859431123,-0.0252505477550551,-0.0145963852653551,2.42308866568065e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,-0.0208763441735905,0.00284868653717819,-0.0264597697864598,-0.0152929185607212,2.439273592075e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,37088,-0.0775943074942674,0.0105903503109393,-0.0983513941037084,-0.0568372208848263,2.49208299045587e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.027099615147166,0.00369935923554035,-0.0343503592488251,-0.0198488710455069,2.49737497200569e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,-0.0473320008079507,0.00646228087606548,-0.059998071325039,-0.0346659302908623,2.51371624487727e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,-0.0540995272579923,0.00738654562788302,-0.068577156688643,-0.0396218978273416,2.52023228443887e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),37186,0.131138543370253,0.0179194773408411,0.0960163677822046,0.166260718958302,2.65678068431231e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,-0.0210991770505561,0.0028868639078276,-0.0267574303098982,-0.015440923791214,2.82539816056435e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0192735239825687,0.00263920663071076,0.0141006789863757,0.0244463689787618,2.95001050015043e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,39713,0.0350658175406542,0.00481034483743559,0.0256375416592804,0.0444940934220279,3.2537593862292e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,-0.0476891029324302,0.00654457701106671,-0.0605164738741209,-0.0348617319907394,3.32540764131525e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,37437,-0.0226197558746399,0.00310420710839436,-0.0287040018070929,-0.016535509942187,3.34903376717201e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,39882,-0.0681352587998988,0.00935596925220364,-0.086472958534218,-0.0497975590655797,3.42808488497218e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,-0.0219738982503136,0.0030190381937387,-0.0278912131100414,-0.0160565833905857,3.53208139268806e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,-0.0225513279590998,0.00309923705738005,-0.0286258325915647,-0.0164768233266349,3.61810659466931e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,37287,-0.0740062869015899,0.0101729003214295,-0.0939451715315918,-0.054067402271588,3.66044772639268e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,39892,-0.0277461735167478,0.00381853574170464,-0.0352305035704889,-0.0202618434630067,3.86814085339887e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,37437,-0.0414267102078696,0.00570845944445272,-0.052615290718997,-0.0302381296967423,4.17026077753771e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,-0.043901994109939,0.00605228807180652,-0.0557644787306798,-0.0320395094891983,4.2728711313115e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,37445,0.0449116767704158,0.00620926111536775,0.032741524984295,0.0570818285565366,4.97674707193059e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,-0.0429977055043264,0.00594651796360672,-0.0546528807129956,-0.0313425302956572,5.06185152204344e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,37368,-0.0524108269744189,0.00725760732736868,-0.0666357373360616,-0.0381859166127763,5.41670313654949e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,-0.0354491415155714,0.00491019198077012,-0.0450731177978808,-0.0258251652332619,5.49534795389688e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,0.0174524254794838,0.00241897019426996,0.0127112438987147,0.0221936070602529,5.64242279054185e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,-0.0512643777004889,0.00710670511221387,-0.0651935197204281,-0.0373352356805497,5.69765430843382e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,40058,-0.0568531603993066,0.00790436958047014,-0.0723457247770281,-0.0413605960215851,6.63370457784556e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,37039,-0.0499275318235774,0.00694716809224224,-0.0635439812843722,-0.0363110823627826,6.99241913802595e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,-0.062645176771127,0.00872292538027651,-0.079742110516469,-0.045548243025785,7.24559567631246e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,37073,-0.0481213441727176,0.00670184101906398,-0.061256952570083,-0.0349857357753522,7.3269042748396e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,40058,-0.0401421700347924,0.00559445215034578,-0.0511072962494702,-0.0291770438201147,7.52443565250769e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,39931,0.046798864121438,0.0065318392005434,0.0339964592883729,0.0596012689545031,8.13227143887426e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,37342,-0.0702169892255748,0.00981750370199502,-0.0894592964814851,-0.0509746819696646,8.97855233691288e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,-0.0260816979366012,0.00365240276937917,-0.0332404073645844,-0.0189229885086181,9.66164954688902e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,37453,-0.0193795019535172,0.00271372533685591,-0.0246984036137548,-0.0140606002932797,9.71571899132997e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,39908,-0.0413289410957823,0.00579153084264446,-0.0526803415473655,-0.0299775406441992,1.00123353563573e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,0.0326884483860886,0.00458466652502427,0.0237025019970411,0.0416743947751362,1.05490677292723e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,-0.0784303505623138,0.011004894640158,-0.0999999440570235,-0.0568607570676041,1.07893393718979e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,40058,-0.0465998653951241,0.00653995738799167,-0.0594181818755878,-0.0337815489146605,1.08143247621065e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,37124,0.0237138172809974,0.00332770228265012,0.0171915208070032,0.0302361137549917,1.08521668800025e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,-0.0711452352344572,0.0099891920485288,-0.0907240516495737,-0.0515664188193408,1.11567130061403e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,40009,-0.0240398282270338,0.00337683684735821,-0.0306584284478559,-0.0174212280062117,1.1325837590126e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,39585,-0.0611986911632535,0.0085980142270834,-0.078050799048337,-0.04434658327817,1.14427690202598e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,-0.0342598664041021,0.00481629640922437,-0.0436998073661819,-0.0248199254420223,1.19129910515172e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,-0.036975438949089,0.00519843859794113,-0.0471643786010536,-0.0267864992971244,1.19437843271329e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,-0.0416132390544417,0.00586138665728672,-0.0531015569027237,-0.0301249212061598,1.30456911233976e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,-0.0226537621762755,0.00319309807617822,-0.0289122344055848,-0.0163952899469662,1.36348925776647e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,37056,-0.024302940781879,0.00342753123232287,-0.0310209019972318,-0.0175849795665261,1.40421314986342e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,-0.0407227750448712,0.00574819933284673,-0.0519892457372508,-0.0294563043524916,1.4545218213146e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,37056,-0.032621032845482,0.00460835774985624,-0.0416534140352002,-0.0235886516557637,1.52906156222883e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,39715,-0.0507092489615759,0.00716873027775748,-0.0647599603059806,-0.0366585376171713,1.57194474031247e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,39901,-0.0211557409996429,0.00299091997949117,-0.0270179441594456,-0.0152935378398402,1.57515755330537e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,39866,-0.0478975864149206,0.00677864034962591,-0.0611837215001874,-0.0346114513296538,1.66087842082646e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,37056,-0.0407023818460133,0.00576095308238296,-0.0519938498874839,-0.0294109138045427,1.68412271953491e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,-0.0326809519576902,0.00462898543836994,-0.0417537634168953,-0.0236081404984851,1.73230891902143e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,0.0182785959375732,0.0025894996116784,0.0132031766986836,0.0233540151764629,1.76172466135735e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,-0.0354924870078498,0.00503207150819355,-0.0453553471639091,-0.0256296268517904,1.83256670878523e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,-0.0390896221125963,0.00554527540306104,-0.0499583619025959,-0.0282208823225966,1.87366578985165e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,-0.0680001826626096,0.00964770670699968,-0.0869096878083289,-0.0490906775168902,1.89869958043413e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,37453,-0.0394309125035775,0.00560750663752415,-0.0504216255131249,-0.0284401994940302,2.1361128635717e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,-0.0161380744570726,0.00229599731493657,-0.0206382291943483,-0.0116379197197969,2.16893664524351e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,39970,-0.0429276783561231,0.00611048137659009,-0.0549042218542397,-0.0309511348580065,2.22229751473923e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,-0.0530798352078586,0.00756408291003917,-0.0679054377115354,-0.0382542327041818,2.35402320770634e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,-0.0181728893817538,0.00259082028505184,-0.0232508971404554,-0.0130948816230522,2.40262075729309e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,-0.0361295005888638,0.00515089925167183,-0.0462252631221406,-0.026033738055587,2.4048299952945e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0231582731075428,0.00330244038767782,0.0166854899476942,0.0296310562673913,2.45216485563259e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,-0.0309352416064705,0.00441566113760768,-0.0395899374361815,-0.0222805457767594,2.57385854251203e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,39913,-0.0448891672690798,0.0064093421082987,-0.0574514778013453,-0.0323268567368144,2.59163155238535e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.0254127770244648,0.00363541951837274,-0.0325381992804754,-0.0182873547684543,2.85072878832999e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,-0.0440324001213334,0.00630997752367545,-0.0563999560677373,-0.0316648441749295,3.13258658988265e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,37347,-0.0198741439494776,0.00284949596368721,-0.0254591560383046,-0.0142891318606507,3.20995634594916e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,39868,-0.0237466976851161,0.0034056004855123,-0.0304216746367202,-0.017071720733512,3.22754277179853e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,-0.0588308958566611,0.00844863049991689,-0.0753902116364982,-0.042271580076824,3.47885244358789e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,36991,-0.045625490663325,0.00655259444479595,-0.058468575775125,-0.0327824055515249,3.49030984122845e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,-0.0477709316956344,0.00686421238938095,-0.061224787978821,-0.0343170754124477,3.57384543998948e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,-0.0601207069605126,0.00865243020668002,-0.0770794701656054,-0.0431619437554197,3.84005876185691e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,39868,-0.0469018555460512,0.00676790766167184,-0.060166954562928,-0.0336367565291744,4.36775814818366e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,-0.0629060055378663,0.00908394617613644,-0.0807105400430938,-0.0451014710326389,4.55697593079606e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,-0.0188315070347605,0.00272106218533771,-0.0241647889180225,-0.0134982251514986,4.6671422995943e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,39344,-0.05383708431567,0.00777953019450906,-0.0690849634969077,-0.0385892051344322,4.68200588387196e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,39908,-0.0409575433331531,0.00593146126621835,-0.0525832074149411,-0.0293318792513652,5.20365327025692e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,40031,0.0286427375979778,0.00414831160827959,0.0205120468457498,0.0367734283502058,5.21910101322018e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,36942,0.0438197619877062,0.00634724651941512,0.0313791588096525,0.0562603651657598,5.29867511395342e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,37220,-0.0232323958561112,0.00336558077633495,-0.0298289341777277,-0.0166358575344947,5.32371992097459e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,36961,-0.0389938908340875,0.00566734372684881,-0.0501018845387112,-0.0278858971294638,6.23745113409594e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,0.0763272551380004,0.0110974025026453,0.0545763462328157,0.0980781640431852,6.3562167799702e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCN,Decorin,39585,0.0151399759334143,0.00220169678072408,0.0108246502431951,0.0194553016236335,6.36492051437786e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,-0.041832619492387,0.00608592657969061,-0.0537610355885806,-0.0299042033961934,6.48950792570219e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,-0.0536876165757979,0.00781764012653983,-0.069010191223816,-0.0383650419277798,6.78031371214936e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,39405,-0.0825205915790947,0.0120242211375056,-0.106088065008606,-0.0589531181495837,7.00448077928599e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,-0.0454753624885062,0.00663568500480567,-0.0584813050979253,-0.032469419879087,7.53677018690628e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,-0.0247298587424195,0.00360928338907463,-0.0318040541850057,-0.0176556632998332,7.56239284309918e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,40052,-0.0618218292328441,0.00903661451173128,-0.0795335936758374,-0.0441100647898508,8.13108794167955e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,39788,-0.0492068424003406,0.00719499515534117,-0.0633090329048093,-0.0351046518958719,8.26264741349764e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,39829,-0.0464544963668674,0.00679875977428941,-0.0597800655244746,-0.0331289272092601,8.62887559727203e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,37124,-0.060236400195416,0.00882330302045408,-0.077530074115506,-0.042942726275326,9.05016102247516e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,-0.0818237488166053,0.0119952208664986,-0.105334381714942,-0.0583131159182681,9.34513664016376e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,37382,-0.0231231030166308,0.00338941641202934,-0.0297663591842083,-0.0164798468490532,9.35039572018786e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,-0.0613976417417563,0.00900314610867125,-0.079043808114752,-0.0437514753687607,9.51877541329404e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,-0.0557399174069176,0.00818740856579559,-0.0717872381958769,-0.0396925966179582,1.03241542154395e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,39868,0.0481207899574544,0.00707903603009119,0.0342458793384756,0.0619957005764331,1.10097272245509e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,40009,-0.0239092987140186,0.00351767092819766,-0.030803933733286,-0.0170146636947512,1.10625543982117e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,-0.0828135379170443,0.0121897813499885,-0.106705509363022,-0.0589215664710669,1.13967979401028e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,37437,-0.0370798116723284,0.00545879178096598,-0.0477790435630217,-0.026380579781635,1.14654337785732e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,39563,-0.0340071878802146,0.00501178014520605,-0.0438302769648185,-0.0241840987956108,1.19862720867508e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,-0.0362774629315182,0.0053492317966802,-0.0467619572530114,-0.025792968610025,1.22909965328165e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,39788,-0.0521196762088233,0.00768716718921361,-0.067186523899682,-0.0370528285179646,1.24321838317792e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,36962,-0.0389785047284828,0.00575155535431147,-0.0502515532229332,-0.0277054562340323,1.27912786705379e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,39585,-0.0253654207840638,0.00374620800553607,-0.0327079884749145,-0.0180228530932131,1.32460990001623e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,37411,0.0310336319565266,0.00458431381092482,0.022048376887114,0.0400188870259393,1.34522111052717e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,39839,-0.0651068452114272,0.00962393487429632,-0.083969757565048,-0.0462439328578064,1.37845272356914e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,40009,0.0202855089454112,0.00300230556842341,0.0144009900313013,0.0261700278595211,1.46050946118502e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,39859,-0.0648972098816954,0.00961123302481519,-0.0837352266103332,-0.0460591931530576,1.50604279926433e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,37043,-0.062199096955687,0.00921319086036792,-0.0802569510420082,-0.0441412428693659,1.52879859885645e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,-0.0685435634218285,0.0101680478000763,-0.0884729371099781,-0.0486141897336789,1.63789483886485e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,39729,0.0228977858013537,0.00340093404916536,0.0162319550649896,0.0295636165377178,1.72145022698544e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,-0.0299946356437134,0.00445752748696545,-0.0387313895181657,-0.0212578817692612,1.77737380521574e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,39587,-0.0451589555099579,0.00671428290925393,-0.0583189500120956,-0.0319989610078202,1.80644008479496e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,39750,-0.0450987227910125,0.00671265463051345,-0.0582555258668189,-0.0319419197152061,1.89888588094669e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,-0.022566599623448,0.00335929727706755,-0.0291508222865004,-0.0159823769603956,1.90831446235565e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,-0.0288767574418914,0.00430196951840234,-0.03730861769796,-0.0204448971858228,1.99164758434232e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,39913,0.0183328909079302,0.00273328925232159,0.0129756439733799,0.0236901378424805,2.0492988476891e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,39868,-0.0162397783584818,0.00242687350429394,-0.020996450426898,-0.0114831062900657,2.27995581875341e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,39866,-0.0530176424649801,0.00792529459693675,-0.0685512198749761,-0.037484065054984,2.31080226563614e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,37043,-0.0353186494868489,0.00528844433576382,-0.045684000384946,-0.0249532985887518,2.51152605252022e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,39615,-0.0507349395359236,0.0076005406263384,-0.0656319991635468,-0.0358378799083003,2.55182177794084e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,37445,-0.0423334934137816,0.00634357998078835,-0.0547669101761268,-0.0299000766514364,2.59566125995634e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,39931,-0.0517988221865103,0.00776764122820021,-0.0670233989937827,-0.0365742453792378,2.66782625813903e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,39248,-0.0198998101607927,0.00298578815829169,-0.0257519549510444,-0.014047665370541,2.73952796508018e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,-0.0677148000351786,0.0101610257071092,-0.0876304104211126,-0.0477991896492446,2.76454898158853e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,39489,-0.04173120386587,0.00626427907330849,-0.0540091908495546,-0.0294532168821853,2.79578715297957e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,39856,0.0417714934929107,0.00627374345545517,0.0294749563202186,0.0540680306656028,2.86330540524886e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,-0.0415928073147168,0.00626050738714848,-0.0538634017935278,-0.0293222128359057,3.17606586750055e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,-0.0246492388017192,0.00371587228628388,-0.0319323484828356,-0.0173661291206028,3.40629751177281e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,-0.0226634620183028,0.00342086258334334,-0.0293683526816558,-0.0159585713549499,3.60158840479663e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,39749,0.0222855947532332,0.00336977714361995,0.0156808315517381,0.0288903579547283,3.87643457630457e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,39456,-0.0614197379117632,0.00930639944399234,-0.0796602808219882,-0.0431791950015382,4.25184566480872e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,-0.0495556980787474,0.00750844310071755,-0.0642722465561538,-0.034839149601341,4.26895108258784e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,37445,-0.0616470680591216,0.00935428492363922,-0.0799814665094545,-0.0433126696087887,4.55284160651137e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,39587,-0.0325514957768754,0.00494142403077238,-0.0422366868771893,-0.0228663046765615,4.61574621348482e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,-0.0559674830490396,0.00849957217068577,-0.0726266445035837,-0.0393083215944955,4.69819262383293e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,-0.0642830916127258,0.00976714641126005,-0.0834266985787955,-0.0451394846466561,4.80015820625689e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,37056,-0.0387581132424664,0.00589306070398727,-0.0503085122222814,-0.0272077142626513,4.98434916791293e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,-0.0422963686123715,0.00644171579964537,-0.0549221315796764,-0.0296706056450666,5.32743524292053e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,40030,-0.0286519255492828,0.00436426242341131,-0.037205879899169,-0.0200979711993967,5.35721347735054e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,-0.0189105084882821,0.00288577011060361,-0.0245666179050652,-0.013254399071499,5.84726806963689e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,-0.0193803981141679,0.00296328648885878,-0.0251884396323311,-0.0135723565960047,6.33244589022256e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,-0.0453227152521512,0.00693879055238792,-0.0589227447348315,-0.0317226857694709,6.69971391099357e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,-0.0336581766185842,0.0051525513860581,-0.0437571773352581,-0.0235591759019103,6.71307173425061e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,37382,-0.0223297913417616,0.00342523883013256,-0.0290432594488214,-0.0156163232347018,7.31958094837148e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,0.0289282538236441,0.00444617758553564,0.0202137457559942,0.0376427618912939,7.92998938626198e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,-0.0580256702078029,0.0089208764491383,-0.075510588048114,-0.0405407523674918,8.07761716230167e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNC,Tenascin,39931,0.0311084540790023,0.00478454573655099,0.0217307444353623,0.0404861637226422,8.16706454799137e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,0.0436143941161048,0.00671028702504098,0.0304622315470245,0.0567665566851852,8.33395179740465e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,37021,-0.0260233266372285,0.00400398935071569,-0.0338711457646313,-0.0181755075098258,8.3575503154062e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,39866,-0.04509908853669,0.00695076240077581,-0.0587225828422106,-0.0314755942311694,8.93197774605746e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,-0.0216301890328377,0.00333660478435998,-0.0281699344101832,-0.0150904436554921,9.27347386147565e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,39713,-0.0501200895039695,0.0077570692000319,-0.065323945136032,-0.034916233871907,1.06894025184089e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,37411,-0.0384582352800361,0.00595304552344116,-0.0501262045059807,-0.0267902660540914,1.08092263524822e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,39617,-0.0456642157096804,0.00707504785576014,-0.0595313095069703,-0.0317971219123905,1.11923698315935e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,39866,-0.0427968290025669,0.00663297259394543,-0.0557974552866999,-0.0297962027184338,1.13452434545394e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,-0.0302878458639587,0.00469701209350004,-0.0394939895672188,-0.0210817021606987,1.17039233745234e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELL,L-selectin,37453,0.0148668784818902,0.00230624030045665,0.0103466474929952,0.0193871094707853,1.18428768478101e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,-0.0631887646785692,0.00983185869266876,-0.0824592077162,-0.0439183216409384,1.34565084350368e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,39858,-0.0796427851241403,0.0123984116382134,-0.103943671935039,-0.0553418983132421,1.36820122259658e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,39788,-0.0541854022963029,0.0084368166200894,-0.0707215628716782,-0.0376492417209277,1.378580454089e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,-0.043196751921809,0.00672885608884558,-0.0563853098559463,-0.0300081939876717,1.40555618816079e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,39809,-0.0178455389079133,0.00278368448731686,-0.0233015605030543,-0.0123895173127723,1.4886145544001e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,39489,-0.0308004681316815,0.00480686560592524,-0.040221924719295,-0.0213790115440681,1.52059408299804e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,-0.0534091603366014,0.00833906779899593,-0.0697537332226335,-0.0370645874505694,1.54874831713214e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.0185696073056775,0.0029061402545709,0.0128735724067185,0.0242656422046364,1.70657090379815e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,37257,0.070019546143838,0.0109580734740233,0.0485417221347524,0.0914973701529236,1.71634642129406e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,37388,-0.0460792184486548,0.00721832867485987,-0.0602271426513801,-0.0319312942459295,1.78570099739223e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGMN,Legumain,39931,-0.023270534947883,0.00364592732993784,-0.0304165525145611,-0.0161245173812048,1.78863151270038e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,-0.0726943788874317,0.0113905129023497,-0.0950197841760372,-0.0503689735988262,1.79670019401156e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,-0.0448645487080292,0.00703082429536275,-0.0586449643269402,-0.0310841330891182,1.8151360225995e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,37437,-0.0468741469846353,0.00734684430755081,-0.0612739618274349,-0.0324743321418357,1.82626134935174e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,39739,-0.0376560912225758,0.00590314878554791,-0.0492262628422497,-0.0260859196029019,1.83198810874037e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,0.0233165405507453,0.00365917497158144,0.0161445576064456,0.0304885234950449,1.91620715048527e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,-0.0476907647142138,0.00750066230985394,-0.0623920628415275,-0.0329894665869001,2.10788804177487e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFP,Properdin,37453,-0.0149950534620283,0.00235961662154836,-0.0196199020402631,-0.0103702048837935,2.15259865124857e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,37169,-0.0350114279249352,0.00551225843122438,-0.045815454450135,-0.0242074013997354,2.20077914992916e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,-0.0231606810351916,0.00364938560533058,-0.0303134768216395,-0.0160078852487437,2.27550108227311e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,39826,-0.0169649761302966,0.00267456741898501,-0.0222071282715072,-0.0117228239890859,2.31286825004551e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,39858,-0.0414790928122813,0.00654592019987459,-0.0543090964040355,-0.0286490892205271,2.41121388258267e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,-0.0302966439907625,0.00478476008613822,-0.0396747737595934,-0.0209185142219316,2.4854940151819e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,39858,-0.0177868882341431,0.00281358924473996,-0.0233015231538334,-0.0122722533144527,2.65421080694855e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,37388,-0.0292535725992765,0.00463692056957263,-0.0383419369156389,-0.0201652082829141,2.8989805145749e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,-0.0722996610572596,0.011462853523427,-0.0947668539631765,-0.0498324681513427,2.91578242957774e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,-0.0246263233388572,0.00391478881999792,-0.0322993094260531,-0.0169533372516612,3.2454072651203e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,40058,-0.0221471809178636,0.00353382733602106,-0.0290734824964648,-0.0152208793392623,3.76907417091086e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,-0.0486534398649638,0.00776688697311697,-0.063876538332273,-0.0334303413976545,3.86248029233545e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,-0.0484445032806574,0.00774007818163759,-0.0636150565166671,-0.0332739500446477,3.99366987310947e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,37368,-0.0310067330614463,0.00496054744146775,-0.0407294060467231,-0.0212840600761695,4.20991613955004e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,-0.0559662668119672,0.0089601889024299,-0.0735282370607298,-0.0384042965632046,4.33371050141285e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,39836,-0.0562302300210243,0.00900477543636107,-0.073879589876292,-0.0385808701657567,4.35931726326926e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,37021,-0.0381981137359105,0.00611774840780532,-0.0501889006152089,-0.026207326856612,4.40140370953333e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,-0.0390935193586638,0.00626729003668984,-0.0513774078305759,-0.0268096308867517,4.57237274646707e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,-0.0389495558387977,0.00624696391356033,-0.0511936051093759,-0.0267055065682194,4.65398640687595e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,-0.0305025715214976,0.00490817767036105,-0.0401225997554053,-0.02088254328759,5.27459508708104e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,-0.0283288294151307,0.00455851427670796,-0.0372635173974783,-0.0193941414327831,5.27733163464029e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,-0.0454062322169134,0.00734988969111906,-0.0598120160115068,-0.0310004484223201,6.65961011912753e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,-0.0228120780102312,0.00369398438047012,-0.0300522873959526,-0.0155718686245097,6.79044430132033e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,39477,-0.0363320756820338,0.00588516478875005,-0.0478669986679839,-0.0247971526960837,6.84449668732925e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,-0.0276077522255331,0.0044738010479674,-0.0363764022795492,-0.018839102171517,6.95004129317938e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,39947,0.0159807813893529,0.00259091734828747,0.0109025833867095,0.0210589793919963,7.08119740398142e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,39477,-0.0364032819324217,0.00592657051713439,-0.0480193601460051,-0.0247872037188383,8.32610899180207e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,-0.0384279145140345,0.00625881039247458,-0.0506951828832847,-0.0261606461447844,8.49927019876582e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,-0.0173000477394306,0.00281863338683145,-0.0228245691776202,-0.0117755263012409,8.6106384748231e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,-0.0318584617790939,0.00519255126816789,-0.042035862264703,-0.0216810612934849,8.69857292322101e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,39788,0.0476413803351642,0.00776625770502947,0.0324195152333064,0.0628632454370219,8.74979227169337e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,-0.0628536305220618,0.0102463166020294,-0.0829364110620395,-0.0427708499820842,8.75650998023786e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,37169,-0.0209716165781557,0.0034204488014154,-0.0276756962289299,-0.0142675369273815,8.96589625755463e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,36991,-0.0344184362834373,0.0056155163465405,-0.0454248483226567,-0.0234120242442179,9.08699024542623e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,39991,-0.0239193713878131,0.00390553320142444,-0.031574216462605,-0.0162645263130212,9.30878636910707e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,37021,-0.0499244544500292,0.00815409024204846,-0.0659064713244442,-0.0339424375756142,9.46632378310512e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,-0.0502919263992423,0.00821618054459951,-0.0663956402666574,-0.0341882125318273,9.55779756819179e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,39868,-0.0431231934345661,0.00704717857260415,-0.0569356634368703,-0.029310723432262,9.62277763389774e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,39489,-0.018135743628158,0.00296601621412424,-0.0239491354078415,-0.0123223518484745,9.91559881101993e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,40052,0.0145416289995776,0.0023793901091657,0.00987802438561283,0.0192052336135424,1.00963215447926e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,40011,-0.0330225369863694,0.00541891544897503,-0.0436436112663605,-0.0224014627063784,1.12667232367159e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,40009,-0.0185082020059575,0.00304196070187274,-0.0244704449816281,-0.0125459590302869,1.19641396121391e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,-0.0245643955017624,0.00403780309013625,-0.0324784895584294,-0.0166503014450953,1.20744301184689e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,-0.0479316647054142,0.00788023346293385,-0.0633769222927646,-0.0324864071180639,1.21583014147781e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,-0.0347027048339459,0.00570660290251688,-0.045887646522879,-0.0235177631450129,1.22591256181803e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,-0.0476520141839633,0.00783854384981373,-0.0630155601295982,-0.0322884682383284,1.24137998351879e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,-0.0428803472486516,0.00708336741933963,-0.0567637473905573,-0.0289969471067459,1.45436551988348e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,0.0433773094474515,0.00717897023264873,0.02930652779146,0.0574480911034431,1.55948660508415e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,39749,-0.0205075219323339,0.00339716422264043,-0.0271659638087092,-0.0138490800559587,1.6083672303456e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,39858,-0.0277664168642561,0.0046020114957148,-0.0367863593958571,-0.0187464743326551,1.63942544312056e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,-0.0324011604096907,0.0053715548009156,-0.0429294078194853,-0.0218729129998962,1.65582122483894e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,-0.0383839534745699,0.0063652207475007,-0.0508597861396712,-0.0259081208094685,1.67291299708931e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,37388,-0.0167926523122752,0.00278837148207515,-0.0222578604171425,-0.0113274442074079,1.76318041001506e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,-0.0289115827224855,0.00480182836651146,-0.038323166320848,-0.0194999991241231,1.77875619674712e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,-0.0529663714979632,0.00880584708094661,-0.0702258317766185,-0.0357069112193078,1.84748085902145e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,-0.0454157242728317,0.00755782697901981,-0.0602290651517105,-0.0306023833939529,1.91334343951553e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,37169,-0.045391031455415,0.00755749386068102,-0.0602037194223498,-0.0305783434884802,1.9499877208302e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,37437,-0.0407128816976758,0.00678981264294254,-0.0540209144778432,-0.0274048489175085,2.0715196706628e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,-0.0371354116297041,0.00619365993805981,-0.0492749851083013,-0.0249958381511069,2.07857712658211e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,40012,0.0273720935056034,0.004571065603391,0.0184128049229571,0.0363313820882498,2.16777257715087e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,-0.0409378491899998,0.00683826727812178,-0.0543408530551185,-0.0275348453248811,2.19812104979268e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,39913,0.0240961860861725,0.00402678427940418,0.0162036888985403,0.0319886832738047,2.22383653237386e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,-0.0577032648059034,0.00964911494165777,-0.0766155300915527,-0.0387909995202542,2.27682067681881e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,37437,0.020514835870753,0.00343261023425494,0.0137869198116133,0.0272427519298927,2.33761802144201e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,37380,-0.0155318894058273,0.00260025808405052,-0.0206283952505663,-0.0104353835610883,2.38470641967444e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,-0.0284094300108626,0.00475967475611763,-0.0377383925328532,-0.0190804674888721,2.44087799956557e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,36962,-0.0299946998377123,0.00504738183465269,-0.0398875682336316,-0.0201018314417931,2.87617770939269e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,37453,-0.0199746281494243,0.00336390658911871,-0.026567885064097,-0.0133813712347516,2.9569298705483e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,0.0338027996821029,0.00569415597202354,0.0226422539769368,0.0449633453872691,2.97304274468882e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,-0.0285255468920844,0.00480569334922707,-0.0379447058565694,-0.0191063879275993,2.99596051711281e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,-0.0159549558509449,0.00268888857037481,-0.0212251774488795,-0.0106847342530103,3.02364492317802e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,-0.0197883513124164,0.00333595541376336,-0.0263268239233925,-0.0132498787014402,3.07060440268353e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,39866,0.025480470006725,0.00429759801490551,0.0170571778975102,0.0339037621159398,3.11048222457178e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,-0.0717057353788055,0.0120947945275069,-0.0954115326527189,-0.047999938104892,3.12891707105392e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWC2,Brorin,39684,-0.0231390071202594,0.00391327566508247,-0.030809027423821,-0.0154689868166977,3.42949088156362e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,-0.0545038987088646,0.00922951041934615,-0.0725937391307831,-0.0364140582869462,3.60230241800583e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0271512972370707,0.00460911414489896,0.0181174335130687,0.0361851609610726,3.92050672239161e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,37437,-0.0158896712976082,0.00269727299489695,-0.0211763263676063,-0.0106030162276102,3.92922279565508e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,0.0170925223830078,0.00290257006771078,0.0114034850502946,0.0227815597157209,3.96885216007718e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,-0.0257434840408658,0.00437553239728368,-0.0343195275395418,-0.0171674405421898,4.09815867610683e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,-0.0272688662976798,0.00464081621252555,-0.0363648660742298,-0.0181728665211297,4.28884990891599e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,-0.0302971452270344,0.00515904658206348,-0.0404088765278788,-0.02018541392619,4.39021371617935e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,-0.0761346998865378,0.012979490217622,-0.101574500713077,-0.0506948990599986,4.57481496267909e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00864929795396185,0.0014747620931195,0.00575876425144762,0.0115398316564761,4.59946903146811e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,-0.024717715287771,0.00421952580837469,-0.0329879858721854,-0.0164474447033566,4.77913529531713e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,39858,0.0113840253276775,0.00194376599748706,0.00757424397260292,0.0151938066827522,4.81455906362573e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,39718,-0.0269505724808918,0.00460460542937482,-0.0359755991224665,-0.0179255458393172,4.92428530619254e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,-0.0209249806823967,0.00357940044281718,-0.0279406055503184,-0.0139093558144751,5.15638529714205e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,-0.0197287820839465,0.00337652632523141,-0.0263467736814001,-0.013110790486493,5.22888185980971e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F3,Tissue factor,39931,0.0161275890666552,0.00276083482384561,0.0107163528119178,0.0215388253213926,5.27126166432117e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,39587,-0.0678664228354058,0.0116177429817802,-0.090637199079695,-0.0450956465911166,5.27169385324925e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,39453,0.0259292320364004,0.00444381627341529,0.0172193521405065,0.0346391119322944,5.48894537679715e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,39456,-0.0417025916509193,0.00714837848230571,-0.0557134134762385,-0.0276917698256001,5.52347310810658e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,-0.0402899424515999,0.00691014107920817,-0.053833818966848,-0.0267460659363519,5.65401089729937e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,39585,-0.027496973926453,0.00471893308149345,-0.0367460827661802,-0.0182478650867259,5.75544034651368e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0151238444691332,0.00259663086115692,0.0100344479812656,0.0202132409570007,5.84134707074698e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,37388,-0.0388920138476099,0.00667989382777357,-0.0519846057500461,-0.0257994219451737,5.93779269302378e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,-0.0228035304349662,0.00392126788581086,-0.0304892154911555,-0.0151178453787769,6.18750893361572e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,-0.0172783372444122,0.00297589072104638,-0.0231110830576631,-0.0114455914311613,6.51729209354727e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,-0.070956061174233,0.012220707314769,-0.0949086475111802,-0.0470034748372858,6.53753663921431e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,-0.0606174959476159,0.0104593511267541,-0.081117824156054,-0.0401171677391778,6.96630119759849e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,39858,-0.0226246702089484,0.00390771355617023,-0.0302837887790421,-0.0149655516388548,7.181401597571e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,-0.041481925977073,0.00717648781355376,-0.0555478420916384,-0.0274160098625076,7.62789749650548e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0235321778619409,0.00407334246955817,0.0155484266216069,0.0315159291022749,7.74030025802883e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,-0.0244893060742928,0.00425682023719079,-0.0328326737391867,-0.0161459384093988,8.95906783329887e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,39931,-0.0243898805798382,0.00424187820766132,-0.0327039618668543,-0.016075799292822,9.09803375744136e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,37124,-0.0559089444282029,0.00977787926061382,-0.075073587779006,-0.0367443010773998,1.10173109197075e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,40042,-0.0188015619385845,0.00328890172474795,-0.0252478093190905,-0.0123553145580785,1.10547473368526e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,39568,-0.0242047073626564,0.00423700397591772,-0.0325092351554551,-0.0159001795698577,1.13215825663317e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,-0.018959182486565,0.00331944780783213,-0.0254653001899159,-0.012453064783214,1.13941796825278e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,-0.0167890585026382,0.00294219634392961,-0.0225557633367402,-0.0110223536685361,1.17477179068855e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,39477,-0.0469217419095459,0.00824707162562769,-0.0630860022957762,-0.0307574815233156,1.2969411832113e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,-0.0188396155461656,0.00331320015613668,-0.0253334878521935,-0.0123457432401378,1.32148892202969e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,-0.019254936946639,0.00338659155183989,-0.0258926563882452,-0.0126172175050328,1.32571050303707e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,39477,-0.027991203609294,0.00492505871396937,-0.0376443186886739,-0.018338088529914,1.34380954359541e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,40052,-0.0135479218788161,0.00238704341099337,-0.0182265269643631,-0.0088693167932691,1.40563974237304e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,36874,-0.0467205840040076,0.0082319135444475,-0.0628551345511247,-0.0305860334568905,1.41199850688517e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,37368,-0.02219753126738,0.00391413208071443,-0.0298692301455803,-0.0145258323891797,1.44770514257695e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,-0.0165944270204221,0.00292664794084024,-0.022330656984469,-0.0108581970563753,1.45620922415081e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,39931,0.0173064190889658,0.00305525595385418,0.0113181174194116,0.02329472075852,1.50001243417929e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,-0.0478675821669375,0.00846125263776304,-0.0644516373369531,-0.031283526996922,1.56431902529041e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,-0.0202063228729992,0.00357938701349829,-0.0272219214194558,-0.0131907243265425,1.6836955910488e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,39720,0.0179443159528507,0.00318250617207272,0.0117066038555881,0.0241820280501132,1.74539356442903e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,39489,-0.0213068768100475,0.00377924889277115,-0.0287142046398789,-0.013899548980216,1.75153132204209e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,-0.0219680962651007,0.00389746388463265,-0.0296071254789807,-0.0143290670512207,1.76527932415846e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,39480,-0.0636458642448947,0.0112990466080349,-0.0857919955966432,-0.0414997328931462,1.80308748210025e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,37021,-0.0696867143593003,0.0123710553528047,-0.0939339828507974,-0.0454394458678032,1.8068309226748e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,-0.0408219836795364,0.00725164606391495,-0.0550352099648097,-0.0266087573942631,1.84503323570208e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,39238,0.0176108074294379,0.00313397919237865,0.0114682082123757,0.0237534066465,1.95045296332741e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAT,Catalase,37252,-0.0302724747766858,0.00539010161031271,-0.0408370739328987,-0.0197078756204729,1.98962340080111e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,39788,0.0161675815842641,0.00287992508318997,0.0105229284212118,0.0218122347473164,2.01128690506671e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,0.0159914964300051,0.0028521077338906,0.0104013652715796,0.0215816275884307,2.09379236275392e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,-0.0287266727384145,0.00513300193428659,-0.0387873565296162,-0.0186659889472128,2.23016892969106e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,-0.0192410535604166,0.00344720772351462,-0.0259975806985052,-0.0124845264223279,2.42856861904313e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,-0.0276476849038519,0.00496088368262417,-0.0373710169217953,-0.0179243528859085,2.54981644060057e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,-0.0297552085314156,0.00534022278799809,-0.0402220451958918,-0.0192883718669393,2.56134021404396e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,-0.0147588807051961,0.00264952490811334,-0.0199519495250982,-0.00956581188529396,2.58249566235021e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,-0.0718224699202245,0.0129254728527457,-0.0971563967116061,-0.0464885431288429,2.80283705895363e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,-0.0273087295522964,0.00491694097544969,-0.0369459338641778,-0.017671525240415,2.84476902851943e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,-0.0229958081533998,0.00414054046770637,-0.0311112674701043,-0.0148803488366953,2.84776681666524e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,39866,-0.0298869674261754,0.00539839040881346,-0.0404678126274497,-0.019306122224901,3.13831824050063e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,-0.0381052897391327,0.00688793857520147,-0.0516056493465276,-0.0246049301317378,3.22311858661241e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,39866,-0.0175132682695995,0.00316964279672835,-0.0237257681511871,-0.011300768388012,3.34029645939478e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,-0.0673036048918886,0.012187968852069,-0.0911920238419438,-0.0434151859418335,3.40111558808738e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,-0.00758939658956609,0.00137589438503162,-0.0102861495842281,-0.00489264359490411,3.53301160180346e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,-0.0344468769919304,0.00627386917662586,-0.0467436605781171,-0.0221500934057437,4.08143028239615e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,-0.0491730766775092,0.00895906263133407,-0.066732839434924,-0.0316133139200944,4.11169559379863e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,40030,-0.0212396859696917,0.00387010707944209,-0.0288250958453982,-0.0136542760939852,4.12298755259561e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,-0.0399417363530209,0.00728402868106731,-0.0542184325679128,-0.025665040138129,4.24522485515193e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,0.0184038950685044,0.00336380861243291,0.0118108301881359,0.024996959948873,4.53874387589717e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,-0.0594013516486316,0.0108774324666679,-0.0807211192833007,-0.0380815840139624,4.81894186175511e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,-0.0291512135816494,0.00534359351320085,-0.0396246568675231,-0.0186777702957757,4.97563050329577e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,39822,-0.0225395727480988,0.00413251517986995,-0.0306393025006439,-0.0144398429955537,4.99248172180503e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,-0.0491176012961897,0.0090096142571002,-0.0667764452401061,-0.0314587573522733,5.078651648909e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,-0.0235379709716723,0.00432811577171842,-0.0320210778842404,-0.0150548640591041,5.47224034150168e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,39738,-0.0265672430013955,0.00488988555208715,-0.0361514186834863,-0.0169830673193047,5.61985573843087e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,-0.0583060436387629,0.0107337288733359,-0.0793441522305012,-0.0372679350470246,5.65306866321399e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,39900,-0.0276933551945361,0.00510518065949535,-0.037699509287147,-0.0176872011019252,5.89393812371135e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,-0.0209337091365796,0.0038681175277087,-0.0285152194908887,-0.0133521987822706,6.34345931655475e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,-0.0176695934032059,0.00326504456795005,-0.024069080756388,-0.0112701060500238,6.34725728746016e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,-0.0403248616851459,0.00745889344469855,-0.0549442928367551,-0.0257054305335368,6.52783512448391e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,40058,-0.0146765270735058,0.00271546765586151,-0.0199988436789944,-0.00935421046801725,6.58027045925113e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,-0.0154138548921363,0.00285339365470582,-0.0210065064553597,-0.0098212033289129,6.7070609035435e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,39885,0.0177617187657777,0.0032927284315999,0.0113079710398418,0.0242154664917135,6.97962148688625e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,39818,-0.0219792983513613,0.00407997264558123,-0.0299760447367006,-0.0139825519660221,7.26108241262579e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,37437,-0.0292680395278994,0.0054338688007783,-0.0399184223774249,-0.0186176566783739,7.31520908467354e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,40009,-0.0137165586561345,0.00254768517350709,-0.0187100215962084,-0.00872309571606065,7.38951742091569e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,39788,-0.0228217408320345,0.00424552574148928,-0.0311429712853535,-0.0145005103787155,7.74542625368673e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,-0.0658581247051739,0.012253372612986,-0.0898747350266265,-0.0418415143837213,7.77829448777652e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,0.0134327562666761,0.00249923105199693,0.0085342634047621,0.0183312491285901,7.79841965003758e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,-0.0264815697365937,0.00493198832034843,-0.0361482668444767,-0.0168148726287108,8.03267755100051e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.0268382648009538,0.00500830345206698,0.0170219900349026,0.0366545395670051,8.52028193747846e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,40009,0.0123532246657497,0.00231018602447053,0.00782526005778746,0.0168811892737119,9.04978330525846e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,-0.0299882706246067,0.00560980580305132,-0.0409834899985873,-0.0189930512506261,9.15394143335485e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,40009,0.015278303556365,0.00285894209840086,0.00967477704349927,0.0208818300692307,9.21308756397131e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,39788,-0.046855192797032,0.00877762741668972,-0.0640593425337438,-0.0296510430603201,9.52522253949562e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2,Complement C2,39908,-0.01281308403647,0.00240400956997516,-0.0175249427936213,-0.00810122527931872,9.96060018750372e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,-0.0353930824962949,0.00664851064750775,-0.0484241633654101,-0.0223620016271797,1.03209796178062e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,-0.0179014859716858,0.00336346881759722,-0.0244938848541763,-0.0113090870891952,1.03826744795652e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,39434,0.0489930540913851,0.0092245628089207,0.0309129109859005,0.0670731971968697,1.10431645303577e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,37043,-0.0224655190394882,0.0042331707406613,-0.0307625336911843,-0.014168504387792,1.13237959821249e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,39858,0.0256831429848385,0.00484178408483257,0.0161932461785667,0.0351730397911104,1.14499314529799e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,-0.0287915671741782,0.00542817699921061,-0.039430794092631,-0.0181523402557254,1.15064107304427e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,36991,-0.0234599011530715,0.00442975335897491,-0.0321422177366624,-0.0147775845694807,1.20287686392805e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,39489,-0.0359983277177634,0.00679977563779664,-0.0493258879678448,-0.0226707674676819,1.21257053123961e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,-0.0182736802910465,0.00345405388707457,-0.0250436259097126,-0.0115037346723803,1.23595154173167e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,-0.0258492039987205,0.0048859046663201,-0.0354255771447078,-0.0162728308527331,1.23840827909216e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,-0.0510172849856256,0.00964690905357485,-0.0699252267306323,-0.0321093432406189,1.24986976920959e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,-0.0161293888853128,0.00305387096885937,-0.0221149759842772,-0.0101438017863484,1.30022808325647e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,39489,-0.0381346375930875,0.00722264752225553,-0.0522910267367083,-0.0239782484494667,1.31005974232125e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0158796140470103,0.00300811227462598,-0.0217755141052772,-0.00998371398874333,1.31950815884849e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,39687,-0.0308288807348999,0.00584616870775296,-0.0422873714020957,-0.0193703900677041,1.35719148541305e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,36654,-0.0662932957041941,0.0125719848073386,-0.0909343859265778,-0.0416522054818104,1.36325395302304e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,39788,-0.0157131175043427,0.0029804154197403,-0.0215547317270337,-0.00987150328165167,1.3661512076606e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,39868,-0.0355058398160141,0.00675246993111449,-0.0487406808809985,-0.0222709987510297,1.47342389893968e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,37037,-0.0229394406134124,0.00436225653255799,-0.031489463417226,-0.0143894178095987,1.47412431332904e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,37056,-0.0208985718716666,0.00398938189582393,-0.0287177603874815,-0.0130793833558517,1.64334750717103e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,-0.0380308338834413,0.00727332043645487,-0.0522865419388929,-0.0237751258279898,1.73185780950435e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,39490,-0.0224512732984507,0.00429663735192333,-0.0308726825082204,-0.0140298640886809,1.7609569540129e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,-0.0119173080497826,0.00228181701661121,-0.0163896694023406,-0.00744494669722463,1.78520733792633e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,-0.0527620459554066,0.0101036901516496,-0.0725652786526398,-0.0329588132581734,1.79571011532813e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,-0.030387742982594,0.00582524638282457,-0.0418052258929301,-0.0189702600722578,1.85039484106138e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,37437,-0.0524991223266724,0.0100751579134295,-0.0722464318369943,-0.0327518128163505,1.9083438801075e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,39585,-0.0273536628344253,0.00525855382472118,-0.0376604283308788,-0.0170468973379718,1.99902692587483e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,39419,-0.0362988832769977,0.00698016218306889,-0.0499800011558127,-0.0226177653981827,2.01496994905268e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,39585,-0.0212475772402875,0.00409285972257069,-0.029269582296526,-0.0132255721840489,2.11344543947225e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,39477,-0.0360028669303727,0.00693884720500388,-0.0496030074521803,-0.0224027264085651,2.14538683870235e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,-0.0271548783244424,0.00524427133514432,-0.0374336501413253,-0.0168761065075596,2.27052378898723e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,-0.0203837616814927,0.00393792193043292,-0.0281020886651413,-0.0126654346978442,2.29598732419691e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,40030,0.0239136739690929,0.00462249837723302,0.0148535771497162,0.0329737707884696,2.32715408474863e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,-0.014302313348024,0.00276534712165885,-0.0197223937064754,-0.00888223298957266,2.34938556442792e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,-0.0232826448099482,0.00451110530434599,-0.0321244112064663,-0.01444087841343,2.48966157201435e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,-0.0267988522051663,0.00519855789889064,-0.036988025686992,-0.0166096787233407,2.57136723138141e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,-0.0305740273943814,0.0059403248031074,-0.0422170640084719,-0.0189309907802909,2.68111715241306e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,37056,-0.0274756926427481,0.00534581525949049,-0.0379534905513495,-0.0169978947341467,2.79163413357612e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,-0.0312223882876259,0.00608562738700967,-0.0431502179661648,-0.0192945586090869,2.92959289092166e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,-0.0343697347675989,0.00670005564584078,-0.0475018438334468,-0.0212376257017509,2.93486793612601e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,-0.0337075816884139,0.00657993883329564,-0.0466042618016734,-0.0208109015751545,3.04645789975523e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,-0.0290844307434189,0.0056838054693368,-0.0402246894633191,-0.0179441720235188,3.14623470847388e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,39866,-0.020503696767863,0.0040180143725705,-0.0283790049381012,-0.0126283885976248,3.38239942666059e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,-0.0321956373043788,0.00631207260792248,-0.0445672996159069,-0.0198239749928508,3.43078982386727e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,37382,-0.0297931205659191,0.00584124299843669,-0.0412419568428551,-0.0183442842889832,3.43385442630675e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,37382,-0.0434208331536287,0.00851384644575525,-0.0601079721873089,-0.0267336941199484,3.4420261310858e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,-0.0455317090944741,0.00893673846896683,-0.0630477164936491,-0.0280157016952991,3.53644380600114e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,-0.0321927000099309,0.00631968735696554,-0.0445792872295833,-0.0198061127902784,3.55367403452903e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,39489,-0.0267290131597761,0.00524833203996659,-0.0370157439581106,-0.0164422823614416,3.56807775851416e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,-0.0381693969825425,0.00749719037235407,-0.0528638901123565,-0.0234749038527286,3.60013916191047e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,37445,0.0745124751466069,0.0146390581183087,0.0458199212347219,0.103205029058492,3.62891772113893e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,37388,0.0216801650046445,0.00427198673057757,0.0133070710127124,0.0300532589965765,3.92718020770512e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,37453,-0.0375112892316014,0.0073943368553922,-0.0520041894681701,-0.0230183889950326,3.96806238513394e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,37056,-0.0607003897332634,0.0119832555279406,-0.084187570568027,-0.0372132088984998,4.12973435270627e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,-0.0196647491400828,0.00388630568707037,-0.0272819082867407,-0.0120475899934249,4.24822171036397e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,-0.0355924902270992,0.00704231964136763,-0.0493954367241797,-0.0217895437300186,4.38111174090338e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,-0.0382267982244234,0.00756669296305384,-0.0530575164320089,-0.0233960800168379,4.43042484999712e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,37056,-0.0332777828012318,0.00659474041555656,-0.0462034740157227,-0.020352091586741,4.56896063649207e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,39455,-0.0445620253314579,0.00884983248102059,-0.0619076969942583,-0.0272163536686576,4.82291754884411e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,37056,-0.021941997874799,0.0043601930557,-0.030487976263971,-0.013396019485627,4.90893588487626e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,39858,0.0120190966972068,0.00239128741931448,0.00733217335535047,0.0167060200390632,5.05687486636914e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,-0.0235992974869282,0.00469653774979816,-0.0328045114765326,-0.0143940834973238,5.10314638966026e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,-0.0451617347561211,0.00899185851215152,-0.0627857774399381,-0.0275376920723042,5.15581811718325e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.0200070472108861,0.00398872405822835,-0.0278249463650137,-0.0121891480567586,5.3355308063911e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,37056,0.0136079991916216,0.00271311395829213,0.00829029583336902,0.0189257025498742,5.35445323804734e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,-0.0196618735639163,0.00392214779927699,-0.0273492832504992,-0.0119744638773334,5.41440272228099e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGN,Mimecan,39858,-0.0200875859666687,0.00401022244639396,-0.0279476219616009,-0.0122275499717366,5.52692606881694e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,-0.0122545945870187,0.00244726129485772,-0.0170512267249398,-0.00745796244909759,5.57400691939395e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,-0.0176171779035508,0.00352085651506495,-0.0245180566730781,-0.0107162991340235,5.68521989388964e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PI3,Elafin,39594,-0.0269293981287794,0.0053842008509555,-0.0374824317966522,-0.0163763644609067,5.74811809666794e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,-0.0214334892861996,0.0042944516412165,-0.0298506145029839,-0.0130163640694152,6.08204702067357e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAYN,Layilin,39713,-0.0163518612825613,0.00327844861000961,-0.0227776205581802,-0.0099261020069425,6.17541650698198e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,40058,-0.0227029722273666,0.00456013521214336,-0.0316408372431676,-0.0137651072115656,6.47126639854394e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,37124,0.0106982717261667,0.0021530820532686,0.00647823090176027,0.0149183125505732,6.82022730130078e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,-0.023799834005539,0.00479925480116123,-0.033206373415815,-0.014393294595263,7.15629449781616e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,39731,0.0144341276593466,0.00292106465412089,0.00870884093726966,0.0201594143814235,7.83569083725578e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,-0.0290029140343902,0.00587501203276601,-0.0405179376186116,-0.0174878904501688,8.02934580628723e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,39477,-0.0371773309948527,0.00753182235603068,-0.0519397028126728,-0.0224149591770326,8.05494758330412e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,39455,-0.0383420918368104,0.00777903975851241,-0.0535890097634947,-0.0230951739101261,8.35441164945224e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,39754,-0.0300478695678923,0.0061179234561784,-0.0420389995420019,-0.0180567395937826,9.1304301960181e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,39858,0.0441168348719253,0.00898613273823484,0.026504014704985,0.0617296550388656,9.22396136002622e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,37124,-0.0566188280574553,0.0115474324484567,-0.0792517956564305,-0.0339858604584801,9.54272234335975e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,-0.0145246953206561,0.00296282306729468,-0.0203318285325537,-0.00871756210875857,9.58136965553426e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,0.0170495582291325,0.00348190456992055,0.0102250252720882,0.0238740911861768,9.86218544086629e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,-0.0130456237027605,0.00266949391375439,-0.0182778317737191,-0.00781341563180194,1.0340910603805e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.0211600856774466,0.00433243872175216,0.0126685057828124,0.0296516655720808,1.04899119813551e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,37056,-0.0204813910541101,0.00420356726327603,-0.0287203828901312,-0.0122423992180891,1.11540763757897e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,37333,-0.0240360389904638,0.00493524484658786,-0.033709118889776,-0.0143629590911516,1.12704171886921e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,39477,-0.021877856256867,0.00449672288315321,-0.0306914331078473,-0.0130642794058867,1.15404394784404e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,-0.0211982038076261,0.00435782768929846,-0.0297395460786511,-0.0126568615366011,1.16132770932449e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,-0.0328617440580864,0.00676197800079626,-0.0461152209396471,-0.0196082671765258,1.18830533151741e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,37021,-0.0375814671980954,0.00773309776868669,-0.0527383388247213,-0.0224245955714695,1.1884707340511e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,37364,-0.0278930725323785,0.00574664551036534,-0.0391564977326945,-0.0166296473320624,1.22471920129548e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,-0.0266156881227949,0.00548746829298021,-0.0373711259770361,-0.0158602502685537,1.24460151810876e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,-0.0487483074510986,0.0100621021927767,-0.068470027748941,-0.0290265871532562,1.28219582201444e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,39585,-0.0186930411060286,0.00386675432893356,-0.0262718795907384,-0.0111142026213188,1.3487923268609e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,-0.0155117695241799,0.00320933032711128,-0.021802056965318,-0.00922148208304176,1.35515949989408e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,-0.0234565031782354,0.00485313340462169,-0.0329686446512939,-0.0139443617051769,1.35554985256023e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,0.0139900219440845,0.00289655059411745,0.00831278277961427,0.0196672611085547,1.38134322213757e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,-0.0539114831685178,0.0111633143920144,-0.0757915793768661,-0.0320313869601695,1.38254176783314e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,-0.0249106917585138,0.0051605065270601,-0.0350252845515516,-0.0147960989654759,1.40036039403794e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,37368,-0.0201645270771211,0.00417814256316865,-0.0283536865009317,-0.0119753676533106,1.40688843723919e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,-0.0124436958973529,0.00258164653001015,-0.0175037230961728,-0.007383668698533,1.4482068424344e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,37039,-0.0337575901807707,0.00700355138999121,-0.0474845509051535,-0.0200306294563879,1.45110629187229e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,-0.0163883430968531,0.00340918960377369,-0.0230703547202495,-0.00970633147345662,1.5481923301419e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,39868,-0.0425265476838775,0.00886995972568548,-0.059911668746221,-0.025141426621534,1.6459107702187e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,-0.0355464971003518,0.00741738219526623,-0.0500845662030737,-0.02100842799763,1.66347607343182e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,39891,0.013598036596683,0.00284074104381169,0.00803018415081208,0.0191658890425539,1.70980281806687e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,-0.0430080267534775,0.00901171932792138,-0.0606709966362034,-0.0253450568707516,1.83899978980182e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,39531,-0.0288045544897272,0.0060418468631171,-0.0406465743414367,-0.0169625346380177,1.88194580669758e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,39520,-0.0433112168689491,0.00908517149321714,-0.0611181529956547,-0.0255042807422435,1.88443552264513e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,39587,-0.0403545050043384,0.00847020102333807,-0.056956099010081,-0.0237529109985958,1.91211199105509e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,-0.0389458879733609,0.00820236919621748,-0.0550225315979472,-0.0228692443487747,2.07080693253932e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,-0.0128164292988258,0.00269950458387153,-0.018107458283214,-0.00752540031443765,2.07508884984447e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,37056,-0.0256917673200071,0.0054314873043903,-0.0363374824366121,-0.0150460522034021,2.26674667081307e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,39868,-0.016803870745424,0.0035552087148199,-0.023772079826471,-0.00983566166437698,2.30310062978482e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,37039,-0.021080280629009,0.00446057985346902,-0.0298230171418083,-0.0123375441162097,2.31459953244022e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,36962,-0.0173519883267213,0.00367317282802857,-0.0245514070696573,-0.0101525695837853,2.3367635187558e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPL,Periplakin,37056,-0.0154577274767704,0.0032736761319257,-0.0218741326953448,-0.00904132225819602,2.36142264700489e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,40009,-0.0129248081708482,0.00274445727995947,-0.0183039444395688,-0.00754567190212766,2.50486126215893e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,39587,-0.0378722955095252,0.00804425857565948,-0.0536390423178178,-0.0221055487012327,2.52304612757157e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,37124,-0.0173698278397006,0.00369577896864106,-0.024613554618237,-0.0101261010611641,2.62893426770648e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,37368,-0.0187969587107417,0.00400191468619777,-0.0266407114956893,-0.0109532059257941,2.66621915260658e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,-0.0225301963919983,0.00479798798526771,-0.0319342528431231,-0.0131261399408736,2.67877549663238e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,39868,-0.0366907014430526,0.00781822118635224,-0.052014414968303,-0.0213669879178022,2.71492019531273e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,-0.0240979086248221,0.0051365632642118,-0.0341655726226773,-0.014030244626967,2.74006504573408e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,39477,-0.0347334762890421,0.00740455480001261,-0.0492464036970668,-0.0202205488810174,2.74409749337277e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,37043,-0.0145649315874973,0.00310696646230176,-0.0206545858536087,-0.00847527732138583,2.78882637170706e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,37318,0.0135560051703999,0.00289177650323978,0.00788812322404997,0.0192238871167499,2.78897580750571e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,-0.0250970240043941,0.00535741151044125,-0.035597550564859,-0.0145964974439293,2.82933826499831e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,-0.025527390526078,0.00547277183859405,-0.0362540233297223,-0.0148007577224336,3.11980587392637e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,-0.0193254453521038,0.00414819861664869,-0.0274559146407353,-0.0111949760634724,3.21234023297743e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,-0.0103985380895527,0.00223603435204974,-0.0147811654195702,-0.00601591075953525,3.34366301983254e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,37453,0.0143769390619493,0.00309227630827542,0.00831607749772948,0.0204378006261691,3.36187568937681e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,37382,-0.0332657628899198,0.00716074111480558,-0.0473008154749387,-0.0192307103049008,3.4232786902982e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,-0.0167326897554561,0.00360217227052443,-0.023792947405684,-0.00967243210522821,3.42998775804206e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,37039,0.0147426816562045,0.00317667803071984,0.00851639271599361,0.0209689705964154,3.50219199882409e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,0.0127257588613811,0.0027436681150059,0.00734816935596956,0.0181033483667927,3.54716311503112e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,39489,-0.0344874290818003,0.00744160977196113,-0.0490729842348442,-0.0199018739287565,3.60858816682512e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,37453,-0.00873353271425553,0.00189166867507313,-0.0124412033173989,-0.00502586211111221,3.93195009384343e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,40014,-0.0439106249155188,0.00953782156965911,-0.0626047551920506,-0.0252164946389869,4.17927317411789e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,37149,0.0144730938020898,0.00314470969642934,0.00830946279708826,0.0206367248070913,4.21592306402566e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,39587,-0.0224071980270075,0.00487796533009942,-0.0319680100740024,-0.0128463859800127,4.39141412248647e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,37043,-0.0142800138637611,0.00311252299399842,-0.020380558931998,-0.00817946879552421,4.5180641918762e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,39489,-0.0239512459071818,0.00522337020266353,-0.0341890515044023,-0.0137134403099613,4.56630689293874e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,40030,-0.0277741020736845,0.00606712208239199,-0.0396656613551728,-0.0158825427921962,4.73379980034708e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,39489,-0.0204673037966871,0.0044734440267562,-0.0292352540891293,-0.011699353504245,4.79217969860602e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,37388,-0.0275487404509699,0.00602726359641497,-0.0393621770999432,-0.0157353038019965,4.90430338687526e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,36991,0.0418568005294228,0.00918246282794014,0.0238591733866601,0.0598544276721855,5.20246898651944e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,39868,-0.0259669112405262,0.00572644305034488,-0.0371907396192021,-0.0147430828618502,5.81418737902734e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,39585,-0.0231537907248527,0.00510867542803928,-0.0331667945638097,-0.0131407868858957,5.87890595482648e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,0.014043119841926,0.00309972700544422,0.00796765491125537,0.0201185847725967,5.92978238871236e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,39788,0.0133818155110028,0.00295710675726272,0.00758588626676783,0.0191777447552377,6.07441911071997e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,40030,-0.0123761114577356,0.00273839285972276,-0.0177433614627922,-0.00700886145267896,6.24312637259526e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,-0.0168138806109463,0.00373363625001086,-0.0241318076609676,-0.00949595356092503,6.74648541536842e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,-0.0280591418514285,0.00623277733393121,-0.0402753854259336,-0.0158428982769233,6.79361880716171e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,-0.0191519718714919,0.00425649366520367,-0.0274946994552911,-0.0108092442876928,6.86150777651025e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,-0.0267600863288629,0.00596333650292965,-0.038448225874605,-0.0150719467831208,7.25927598867537e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,-0.0338186622422592,0.00754364285876937,-0.0486042022454472,-0.0190331222390713,7.40823987276277e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,39866,0.022640648877274,0.00505905993568298,0.0127248914033354,0.0325564063512127,7.68419471346626e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,39559,-0.0246554589093872,0.00551691255432065,-0.0354686075158557,-0.0138423103029187,7.91106454743589e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,39585,-0.0203267792471264,0.0045582641298231,-0.0292609769415797,-0.0113925815526731,8.27877756827767e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,-0.0171791845637989,0.00386240287340638,-0.0247494941956754,-0.00960887493192241,8.74665857957672e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,-0.0331360086242627,0.00745047997467904,-0.0477389493746336,-0.0185330678738918,8.75652249406129e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,37021,0.0187976124794797,0.00422744685199353,0.0105118166495724,0.0270834083093871,8.79692561431536e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,39866,-0.0254241509797114,0.00572578596305004,-0.0366466914672895,-0.0142016104921333,9.04389924989817e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,37043,-0.0235249636133298,0.00530287966518298,-0.0339186077570885,-0.0131313194695712,9.22761201163592e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,37382,-0.016213805393931,0.00366364943691823,-0.0233945582902907,-0.00903305249757123,9.69323975763982e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,-0.0544077679551298,0.0122996227164308,-0.0785150284793341,-0.0303005074309256,9.77410715234578e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,-0.0346133346337411,0.00782493832866802,-0.0499502137579305,-0.0192764555095518,9.77874763925571e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,39804,-0.0208530911660904,0.00472274004741184,-0.0301096616590176,-0.0115965206731632,1.01456193781069e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,40058,-0.0378126894719259,0.00856679503733719,-0.0546036077451068,-0.021021771198745,1.02196990842448e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,-0.0242882261270216,0.00551205184316898,-0.0350918477396328,-0.0134846045144104,1.05915520422631e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,-0.0216984689832078,0.00493439719747725,-0.0313698874902632,-0.0120270504761523,1.10418940612066e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,40009,-0.0295030072996177,0.00672758942133166,-0.0426890825654278,-0.0163169320338077,1.16518121500181e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,37430,-0.0168632189383137,0.0038471103429531,-0.0244035552105018,-0.00932288266612565,1.17748384561723e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,37043,-0.0125774950128738,0.00286965164692621,-0.0182020122408491,-0.00695297778489841,1.17997174009597e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.0135436522142891,0.00309034840188491,0.00748656934659469,0.0196007350819835,1.18174108184042e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,-0.0407500757323614,0.00932376464040173,-0.0590246544275488,-0.022475497037174,1.24850666749043e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,39868,0.0151042836224775,0.00345741941962117,0.00832774156001996,0.021880825684935,1.25798392859463e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,39788,-0.0583205919308524,0.0133523293704805,-0.0844911574969941,-0.0321500263647107,1.26284507092544e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,-0.0266712277118854,0.00611621294715115,-0.0386590050883017,-0.0146834503354692,1.30451837880358e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,40009,-0.0129298317726904,0.00296661466548723,-0.0187443965170454,-0.00711526702833544,1.31798073766279e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,-0.0543497781920693,0.0124744483226859,-0.0787996969045336,-0.0298998594796049,1.32745726808514e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,37411,-0.0266703809842189,0.00612160458243316,-0.0386687259657879,-0.0146720360026499,1.32970818770493e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,40030,0.0261640166422351,0.0060084494430865,0.0143874557337856,0.0379405775506847,1.34168252159425e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,37072,-0.0193479722527719,0.00446573042046808,-0.0281008038768894,-0.0105951406286545,1.48484869149969e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,39868,-0.029850739081916,0.00689185863489219,-0.0433587820063047,-0.0163426961575273,1.49130464710954e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,39489,-0.0345023539285943,0.00797077012431523,-0.0501250633722521,-0.0188796444849364,1.50986589365928e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,39173,-0.00930103039657123,0.00214906542622699,-0.0135131986319761,-0.00508886216116633,1.51463850670202e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.0131392706387158,0.00303718884556468,0.00718638050140906,0.0190921607760226,1.52868269865407e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,37453,-0.00923667605421784,0.0021356148431625,-0.0134224811468163,-0.00505087096161933,1.53573121610224e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,-0.0177155451409655,0.00409979492054453,-0.0257511431852327,-0.00967994709669816,1.56408076478447e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",40030,-0.0322143185900991,0.00746075850248278,-0.0468374052549653,-0.0175912319252328,1.58505668903148e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,-0.021432814077863,0.00496660830854609,-0.0311673663626134,-0.0116982617931127,1.6028285459308e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,-0.0154528072685495,0.00358334993883848,-0.022476173148673,-0.00842944138842611,1.62488969093322e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,-0.0502294662437652,0.0116564820063116,-0.0730761709761358,-0.0273827615113945,1.65045416633293e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,-0.0151433743793387,0.00352423885294317,-0.0220508825311073,-0.00823586622757005,1.74213297865327e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,0.0261956570125175,0.00610622140507739,0.0142274630585658,0.0381638509664692,1.79918308489788e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,37368,-0.0184734580124294,0.00430695123032708,-0.0269150824238705,-0.0100318336009883,1.80548520493774e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,0.0133050802671439,0.00310360176477549,0.00722202080818392,0.0193881397261038,1.82413518348013e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,37021,0.0137263551316807,0.0032052202043862,0.00744412353108375,0.0200085867322776,1.86115754597546e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,37445,0.0104317179240284,0.00243691410728375,0.0056553662737523,0.0152080695743046,1.87577333150264e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,-0.0122278906025869,0.00285935880376747,-0.0178322338579711,-0.00662354734720264,1.91238621262074e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,37138,0.00924197593342953,0.00216167861466437,0.00500508584868737,0.0134788660181717,1.92152816217474e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,-0.0267779598635258,0.00626512682308985,-0.0390576084367819,-0.0144983112902697,1.92995995348341e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,-0.0399954358147458,0.00935774219944848,-0.0583366105256648,-0.0216542611038268,1.93304740110422e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,-0.0267735350547702,0.00629167995295002,-0.0391052277625522,-0.0144418423469881,2.10087491534062e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,-0.021168298228169,0.0049782615721093,-0.0309256909095033,-0.0114109055468348,2.13153249924907e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,-0.0293914400352497,0.00691689564586727,-0.0429485555011496,-0.0158343245693499,2.15995383502413e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,-0.0175096972364012,0.00412686410447767,-0.0255983508811774,-0.00942104359162494,2.21962739612136e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.0132480654374328,0.00312509654647996,0.0071228762063321,0.0193732546685335,2.25525068971763e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,37169,-0.022874456064178,0.00541503198317133,-0.0334879187511939,-0.0122609933771622,2.41331853640089e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,-0.0261435500807981,0.00621940419684722,-0.0383335823066186,-0.0139535178549775,2.64499235936829e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,37289,-0.0185380314880113,0.00441279503850041,-0.0271871097634721,-0.00988895321255049,2.67486959627848e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.00863637859781846,0.00205805922477445,0.00460258251726053,0.0126701746783764,2.73006522229819e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,-0.0227667409286603,0.00543134285149377,-0.0334121729175881,-0.0121213089397325,2.78355187117117e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,-0.0189340178348299,0.00452514445662087,-0.0278033009698069,-0.010064734699853,2.88007140746528e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,37043,0.0279543270807686,0.00668666897688618,0.0148484558860717,0.0410601982754655,2.92611039409465e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,-0.0251683387238557,0.00602481278758583,-0.0369769717875239,-0.0133597056601875,2.96679062183246e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,0.0147225190452585,0.0035263797543291,0.00781081472677346,0.0216342233637435,2.99605687196393e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,39967,0.0173598940594022,0.00416211722348506,0.00920214430137146,0.0255176438174329,3.04949481407633e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,0.0119313272779024,0.00286075462100662,0.00632424822072947,0.0175384063350754,3.05287498235797e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,37368,-0.0266485820547613,0.00639799575428801,-0.0391886537331658,-0.0141085103763568,3.13087775199498e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,-0.0273188241729859,0.00656423372989165,-0.0401847222835735,-0.0144529260623983,3.17784068231815e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0298936733805736,0.00718437600070177,-0.043975050341949,-0.0158122964191981,3.18599624508484e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,37039,-0.0248588508218843,0.00597488525395712,-0.0365696259196402,-0.0131480757241283,3.19485944059818e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,37437,0.0127954764175643,0.00308456352982791,0.00674973189910157,0.018841220936027,3.37096436060445e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,37453,-0.0109276189002449,0.00263727486382653,-0.0160966776333449,-0.00575856016714494,3.4407558789037e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,39397,0.0271846961079759,0.00658130752051492,0.0142853333677667,0.0400840588481852,3.63723442072888e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,-0.0199600260425241,0.00483653463265816,-0.0294396339225341,-0.0104804181625141,3.69553004781846e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,39587,-0.0180639618285794,0.00438057401663967,-0.0266498869011931,-0.00947803675596562,3.74827778226377e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,0.0174503192761616,0.00423670597965236,0.00914637555604303,0.0257542629962803,3.83109823474743e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,39908,-0.0121136771017561,0.002941412278042,-0.0178788451667184,-0.00634850903679374,3.8355582946422e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,39587,0.0138595015851907,0.00336585770139358,0.00726242049045928,0.0204565826799221,3.84671890975095e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,0.0117290649514227,0.00286075158494965,0.00612199184492134,0.017336138057924,4.1519197245141e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,37382,-0.0189172673618317,0.00461442849403041,-0.0279615472101313,-0.00987298751353215,4.16300329734715e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,0.00842488112975686,0.00205539798614968,0.00439630107690348,0.0124534611826102,4.17146066233303e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,-0.0185589586163807,0.00453043257759671,-0.0274386064684703,-0.00967931076429119,4.21869773460953e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRN,Progranulin,39787,-0.0102609592417816,0.00250812309834376,-0.0151768805145354,-0.00534503796902783,4.31461740986571e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,0.0120406604989146,0.00294458431091609,0.00626927524951904,0.0178120457483101,4.35655955060028e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,-0.0220214103063442,0.00538912233517222,-0.0325840900832818,-0.0114587305294067,4.4094259071695e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,0.0109249407054409,0.00267574967458137,0.00568047134326138,0.0161694100676203,4.47324992227821e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,0.0116025284420046,0.00284240891707891,0.00603140696452991,0.0171736499194793,4.49260892424326e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,39866,-0.0355479607079217,0.0087098667752444,-0.0526192995874007,-0.0184766218284427,4.49933275955856e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,-0.0150358783460925,0.00368390208701065,-0.0222563264366334,-0.00781543025555162,4.50013040057776e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,-0.0163999602484408,0.00401920210281668,-0.0242775963699615,-0.00852232412692015,4.51778457865051e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,-0.0101176592235789,0.00248851254293467,-0.0149951438077308,-0.00524017463942691,4.81494249108646e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,-0.0218732591058597,0.0053801345546367,-0.0324183228329476,-0.0113281953787718,4.81956451349295e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,-0.0370755868901667,0.00915039368360771,-0.0550103585100378,-0.0191408152702956,5.1114178173315e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,39477,-0.0214248823132468,0.0052942390033975,-0.0318015907599059,-0.0110481738665877,5.21660340626132e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0268977125025377,0.0066541598156817,-0.0399398657412738,-0.0138555592638015,5.3191502364329e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,-0.0189264979080691,0.00468759107228174,-0.0281141764097413,-0.00973881940639688,5.43122183410357e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,37424,-0.00928984277419158,0.00230344800747452,-0.0138046008688416,-0.00477508467954152,5.53669538816905e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0280501062878416,0.00696865683228127,-0.0417086736791129,-0.0143915388965704,5.72405280713865e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,-0.0149900093759382,0.00372517183621595,-0.0222913461749215,-0.00768867257695494,5.75409038597881e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,-0.0127967134868372,0.0031834845370595,-0.0190363431794738,-0.00655708379420061,5.85313652127761e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,-0.0180554305572111,0.00449909545038706,-0.0268736576399697,-0.00923720347445243,6.02520569341605e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,37021,0.014920507023578,0.00372949512072163,0.00761069658696364,0.0222303174601924,6.35070413017277e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,39701,0.0255263612188803,0.00640418760164814,0.01297415351965,0.0380785689181106,6.75301017280576e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LXN,Latexin,39682,0.0270589546485985,0.00679747542647301,0.0137359028127114,0.0403820064844856,6.90089990819792e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,37411,-0.0317751610910642,0.00798959068034745,-0.0474347588245453,-0.0161155633575832,7.01322058398153e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,37169,0.013688413874838,0.00344304612041601,0.00694004347882264,0.0204367842708534,7.05523508382006e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,39984,-0.02492082105742,0.00626945582355603,-0.0372089544715898,-0.0126326876432502,7.06985118998547e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,39703,-0.018309664180831,0.00461869365279504,-0.0273623037403093,-0.00925702462135271,7.39497251610368e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,-0.0175276355901231,0.00442537782152573,-0.0262013761203135,-0.00885389505993263,7.50590773341953e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,39858,-0.0224407287945327,0.0056769600926123,-0.0335675705760528,-0.0113138870130126,7.75261270314427e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,39657,-0.0424158032537621,0.0107407973299135,-0.0634677660203925,-0.0213638404871317,7.8806753501966e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,39866,-0.0264919813731586,0.00671356032971873,-0.0396505596194073,-0.0133334031269099,7.97934051637672e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,-0.00822741516041592,0.00208534855046334,-0.0123146983193241,-0.00414013200150778,8.00275273019673e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,-0.0324809029981518,0.00823653779902387,-0.0486245170842386,-0.016337288912065,8.06468086794125e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,-0.0209478309657858,0.00531747311620892,-0.0313700782735553,-0.0105255836580163,8.20171149678258e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,39489,-0.019552501333304,0.00497299497532477,-0.0292995714849406,-0.00980543118166749,8.46985417936548e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,40030,0.0177036226987676,0.00450360063657346,0.00887656545108366,0.0265306799464516,8.49481216852161e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,0.0131838346660288,0.00335866888990493,0.00660084364181514,0.0197668256902425,8.69772364623145e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,-0.0156463299851515,0.0039900311250296,-0.0234667909902095,-0.00782586898009348,8.84874341977017e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,37411,-0.0277218388045328,0.00707766506423335,-0.0415940623304302,-0.0138496152786354,9.01701003351166e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,37056,-0.0253098467980491,0.00646197984430244,-0.0379753272928819,-0.0126443663032163,9.0209281575731e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,0.0134730014566263,0.0034531151365567,0.00670489578897519,0.0202411071242774,9.59980182982611e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,39881,-0.0252462772395914,0.00649535950698029,-0.0379771818732728,-0.0125153726059101,0.000101976203085601
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.0231307850058321,0.0059533696157927,-0.0347993894527858,-0.0114621805588784,0.000102611216659439
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,39478,-0.0220385431339273,0.00567515069080096,-0.0331618384878972,-0.0109152477799574,0.00010345542987877
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,-0.010035938006791,0.00258641160690781,-0.0151053047563303,-0.00496657125725165,0.000104839474986539
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,0.010966116729256,0.002826848827391,0.00542549302756962,0.0165067404309423,0.00010527385779731
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.0102582374244333,0.00264504236018966,0.00507395439846162,0.0154425204504051,0.00010570566777564
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,-0.0184956659357661,0.00477486407573779,-0.0278543995242121,-0.00913693234732002,0.000107699808011246
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,-0.0265294467697397,0.00685496506507468,-0.0399651782972861,-0.0130937152421933,0.000109226939669082
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,36962,0.0122185822263213,0.0031628536959677,0.0060193889822246,0.018417775470418,0.000112472622646769
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,40030,0.023547529274326,0.00611531438319118,0.0115615130832713,0.0355335454653808,0.00011829067198665
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,37169,0.0129459533923239,0.0033655845430074,0.00634940768802943,0.0195424990966184,0.000120342006896779
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,39421,-0.018063555826318,0.00470112640563829,-0.0272777635813691,-0.008849348071267,0.000122326477242235
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,-0.0183019398536333,0.00477901750674048,-0.0276688141668446,-0.00893506554042193,0.000128830588981949
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,37021,-0.0241580909665521,0.00631765147773735,-0.0365406878629173,-0.0117754940701869,0.000131961055712052
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,-0.0932446969126466,0.0243881540808118,-0.141045478911038,-0.0454439149142556,0.000132235614198056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,39749,-0.0136939968812064,0.00359114523309535,-0.0207326415380733,-0.00665535222433955,0.000137659919613804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,39791,-0.0416496527460891,0.0109275366586507,-0.0630676245970444,-0.0202316808951338,0.000138679297719936
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,37382,-0.0163626655178745,0.00430067315227106,-0.0247919848963258,-0.00793334613942325,0.000142615604268569
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,39788,0.00581330577479901,0.00152946241874696,0.00281555943405498,0.00881105211554304,0.000144719053467732
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,0.0116115012642782,0.00305496001894449,0.00562377962714704,0.0175992229014094,0.000144842784657745
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,39868,-0.0105042125620435,0.00276554910644454,-0.0159246888106748,-0.00508373631341218,0.000146267177101511
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,-0.0104076124447277,0.00274000613910316,-0.0157780244773699,-0.00503720041208552,0.000146273780567002
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCT,Secretin,37039,-0.0171257351339175,0.00451511955498754,-0.0259753694616931,-0.00827610080614193,0.000149518113930368
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,39831,-0.0101844931072766,0.00268915605280498,-0.0154552389707743,-0.00491374724377881,0.000152884950970212
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,-0.0138365534546514,0.00366259712217147,-0.0210152438141075,-0.00665786309519532,0.00015891613888803
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,39856,-0.0150784588584296,0.00400239999974149,-0.0229231628579229,-0.00723375485893627,0.000165578487696161
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,-0.0199804792736971,0.00531931167657071,-0.0304063301597757,-0.00955462838761853,0.000173129063289959
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,-0.00927264314686535,0.00247197367193411,-0.0141177115438562,-0.0044275747498745,0.000176675651860058
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,37453,0.00850017537917657,0.00226696295586681,0.00405692798567762,0.0129434227726755,0.000177860387825712
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,39673,-0.0126676334470144,0.00338321749741768,-0.019298739741953,-0.00603652715207571,0.000181570272091917
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,-0.0195130072814044,0.00521453673105031,-0.029733499274263,-0.00929251528854576,0.000183185878954622
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,-0.0255157571390873,0.00683079919558124,-0.0389041235624266,-0.0121273907157481,0.000188203372158897
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,39868,-0.0172281913782273,0.0046139967818911,-0.0262716250707338,-0.00818475768572075,0.00018919256074684
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,0.0222322546505261,0.00595861916929866,0.0105533610787007,0.0339111482223514,0.000191291267766488
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,37124,-0.032280656752369,0.00866816737151268,-0.0492702648005339,-0.0152910487042042,0.000196866982008819
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,-0.0119698292336549,0.00321517451103332,-0.0182715712752803,-0.00566808719202963,0.000197609804974664
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,0.0188956246555667,0.00507545223126766,0.00894773828228209,0.0288435110288513,0.000197712303155118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,-0.0159445171468184,0.00428831403009854,-0.0243496126458115,-0.00753942164782522,0.000201398258008089
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,39573,-0.0127803032180511,0.00345269698355491,-0.0195475893058188,-0.0060130171302835,0.000215025304584006
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,39489,-0.0160091991887728,0.00434444340563584,-0.024524308263819,-0.00749409011372655,0.000229490666172128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,37056,0.0201730965453271,0.00547694704143546,0.00943828034411361,0.0309079127465406,0.000231177204083259
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,37445,0.00964549164582994,0.00262359893071551,0.00450323774162754,0.0147877455500323,0.000237427119126099
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,-0.0171548182580803,0.00466699777824255,-0.0263021339034357,-0.00800750261272494,0.000238074028027925
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,37039,-0.0186834951541297,0.00508480021952442,-0.0286497035843975,-0.00871728672386181,0.000239371395207656
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,-0.0258567915964477,0.00703981243953634,-0.0396548239779389,-0.0120587592149564,0.00024054997762781
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,39913,0.0100817160158014,0.00274522170916467,0.00470108146583867,0.0154623505657642,0.0002410070268797
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,-0.034611177199148,0.00942873424372541,-0.0530914963168498,-0.0161308580814462,0.000242560441021424
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,-0.0229627539831917,0.006260051534754,-0.0352324549913096,-0.0106930529750739,0.000245287953008756
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,37064,0.0126224835345574,0.00345850993740373,0.00584380405724608,0.0194011630118687,0.000263571335696035
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,-0.0224488184572384,0.00615417833695004,-0.0345110079976605,-0.0103866289168163,0.000265581641395586
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,37021,0.0177336666154835,0.00487665086383987,0.00817543092235739,0.0272919023086097,0.000277483151079122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,-0.013351917184926,0.00367386767313856,-0.0205526978242776,-0.00615113654557443,0.000279612505099744
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,0.0159883541631905,0.00440679816719208,0.00735102975549406,0.024625678570887,0.000286579824847516
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,0.0181290683840229,0.00500702779318916,0.00831529390937212,0.0279428428586736,0.000294685356018028
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,-0.00799300866769302,0.00220805328652453,-0.0123207931092811,-0.00366522422610493,0.000295590917662392
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.00891446643117405,0.00247676166009574,0.0040600135773864,0.0137689192849617,0.000320109284500518
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,39858,0.0149337302218255,0.00415079821996162,0.00679816571070075,0.0230692947329503,0.000321891708829238
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,-0.0202929038744724,0.00565504502852899,-0.0313767921303892,-0.00920901561855561,0.000333841659046877
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,-0.018331915743048,0.00510881259784872,-0.0283451884348315,-0.00831864305126453,0.000334026629749383
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,39858,0.0122855049278973,0.00342784944168386,0.00556692002219692,0.0190040898335977,0.000339343090907994
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,40002,-0.00980091516754973,0.0027362259387739,-0.0151639180075466,-0.00443791232755288,0.000342094159880317
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,-0.00847863819957736,0.00236765440496447,-0.0131192408333077,-0.003838035565847,0.000343249083971279
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,37368,-0.0294380734463762,0.00822302431816157,-0.0455552011099729,-0.0133209457827795,0.000344855978792073
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,0.0133899713896222,0.0037431952799913,0.00605330864083926,0.0207266341384052,0.000348607446871604
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,-0.0145798915974179,0.00407781765124737,-0.0225724141938627,-0.00658736900097306,0.000350727919270445
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,37095,-0.0518493644933186,0.0145047229177954,-0.0802786214121975,-0.0234201075744396,0.000351939837052649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,37368,-0.0238570726277363,0.00667619034018051,-0.0369424056944901,-0.0107717395609825,0.000353527602629692
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,-0.0209024096317893,0.00585271974509482,-0.0323737403321751,-0.00943107893140344,0.000356117847835413
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,37382,-0.0219021367864337,0.00615211738782908,-0.0339602868665787,-0.00984398670628875,0.000371989378557842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,37453,-0.00702011874329313,0.00197319460371092,-0.0108875801665665,-0.00315265732001972,0.000375329029126026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,-0.0214852205300199,0.00604847646091115,-0.0333402343934058,-0.00963020666663409,0.000383361812709656
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,-0.0083782474315288,0.00236007607329622,-0.0130039965351894,-0.00375249832786821,0.000386360097897549
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,-0.0260415562358047,0.0073389072927081,-0.0404258145295126,-0.0116572979420968,0.000388878104021715
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,37437,0.0183139706880105,0.0051685388975088,0.00818363444889325,0.0284443069271278,0.000396396261090784
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,-0.0138427415496145,0.00391350559701706,-0.021513212519768,-0.00617227057946109,0.000405608343889059
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,-0.0303170559767245,0.00858346607986349,-0.0471406494932569,-0.013493462460192,0.000413756973736655
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,37124,-0.0270188113515995,0.00767721989015403,-0.0420661623363014,-0.0119714603668976,0.000434057782218401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,39868,0.0135720850223836,0.00386840420089078,0.00599001278863771,0.0211541572561296,0.000451970451740442
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,0.0135924237294427,0.00387616419110179,0.00599514191488321,0.0211897055440022,0.000455268916845209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,37021,0.0153053039959122,0.00438114909967863,0.00671825176054212,0.0238923562312824,0.000478397381616021
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,-0.0390614592516214,0.0111919195434289,-0.0609976215567419,-0.0171252969465008,0.000484371236249514
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",39489,-0.0191599949430321,0.00549167404255153,-0.0299236760664331,-0.0083963138196311,0.000486316623252372
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,-0.0225945141914812,0.00648047537434362,-0.0352962459251947,-0.00989278245776768,0.000490885849494713
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,-0.0105431754675231,0.00302541871292109,-0.0164729961448484,-0.00461335479019775,0.00049371711362899
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,39709,0.0097559387847235,0.0028109914482758,0.00424639554610294,0.0152654820233441,0.000520601952206223
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,36962,0.0126236948007186,0.00363781179737817,0.00549358367785737,0.0197538059235798,0.000521872797667936
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,37249,-0.021558202939191,0.00621308359709593,-0.033735846789499,-0.00938055908888297,0.000522471585607628
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,-0.0134904394175449,0.00389501853578329,-0.0211246757476801,-0.00585620308740965,0.00053457613185804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,-0.0162815729233938,0.00470290706902631,-0.0254992707786853,-0.00706387506810221,0.000537537918850418
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,-0.0139875441827366,0.00404037154030278,-0.02190667240173,-0.0060684159637431,0.000537711747937711
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,37430,0.0384947322504035,0.0111234910800985,0.0166926897334106,0.0602967747673965,0.000540490209102671
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,0.0108294942517389,0.00313876907554033,0.00467750686367987,0.016981481639798,0.000561853051712483
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,-0.0164405917219356,0.00476854451222733,-0.0257869389659011,-0.00709424447796999,0.000566834872573581
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,-0.0130024179074012,0.00378056430178256,-0.0204123239388951,-0.00559251187590742,0.000585057915837291
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,37437,-0.018786818893134,0.00548066833666997,-0.0295289288330072,-0.00804470895326087,0.000610223512934473
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00803171852936635,0.00235213335322054,0.0034215371570541,0.0126418999016786,0.000640229066343395
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,-0.0212564785065874,0.00622600728622825,-0.0334594527875948,-0.00905350422558003,0.000641444722727455
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,-0.0248374874392101,0.0072784464819136,-0.0391032425437608,-0.0105717323346595,0.000645684041979266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,39862,0.00767197066684626,0.00225372706384816,0.00325466562170388,0.0120892757119886,0.000665389626458724
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,39587,-0.0229308867911087,0.00675321117353768,-0.0361671806912426,-0.00969459289097489,0.000686594399159135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,40058,-0.0210408229489028,0.00619933850086169,-0.0331915264105918,-0.00889011948721393,0.000690338652252757
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,37411,-0.0177177720624794,0.00522153139205085,-0.0279519735908991,-0.00748357053405976,0.000692754508236795
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,-0.0225047337431213,0.00664045729308848,-0.0355200300375747,-0.00948943744866789,0.00070307041982687
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,40009,0.0106609522561468,0.00314756873724225,0.00449171753115197,0.0168301869811416,0.000708187159558908
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,39913,-0.00977251734604591,0.00288730149393696,-0.0154316282741623,-0.00411340641792947,0.00071438532823353
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,36991,-0.0292493180393164,0.00864211786559415,-0.0461878690558809,-0.0123107670227518,0.000715145570935309
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSPN,Persephin,39866,-0.0324535164782575,0.00959313620920006,-0.0512560634482896,-0.0136509695082254,0.000718721572285483
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,37388,-0.0332175384055426,0.00982908947562186,-0.0524825537777615,-0.0139525230333238,0.000728194037473107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,36991,0.00972809835988537,0.00287881152212464,0.00408562777652109,0.0153705689432497,0.000729068805607726
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,39931,0.0199088768347793,0.00589379145553405,0.00835704558193256,0.031460708087626,0.00073204197937163
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,39868,-0.0392153235597197,0.0117161710165778,-0.0621790187522121,-0.0162516283672273,0.000818465813510461
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,0.00858887569315673,0.00257490012214357,0.00354207145375533,0.0136356799325581,0.000853022232321743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.0200332353288617,0.00601146367383965,0.00825076652813597,0.0318157041295874,0.000862651914702705
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,0.0112581711074277,0.003379807619508,0.004633748173192,0.0178825940416633,0.000867275194934874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,36971,-0.0331193058802945,0.0100017549727952,-0.052722745626973,-0.013515866133616,0.000930980754439065
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,-0.0180470734611615,0.00545644812600582,-0.0287417117881329,-0.0073524351341901,0.000943864775453979
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,0.0194436206925166,0.00588157678933824,0.00791573018541367,0.0309715111996196,0.000949415152374931
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,-0.0325868444939196,0.00987388702510398,-0.0519396630631234,-0.0132340259247158,0.000968359625348053
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,37021,-0.0202591415394079,0.00614438608725468,-0.0323021382704271,-0.00821614480838872,0.000979199489364701
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,39783,-0.0243096888706363,0.00737512040366838,-0.0387649248618263,-0.00985445287944628,0.000982252421937682
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,0.00785198672018854,0.00238386572298507,0.00317960990313781,0.0125243635372393,0.000990552140320878
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,-0.00930238999463669,0.00282508542633305,-0.0148395574302495,-0.00376522255902391,0.000994152333045929
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,0.0063148597670909,0.00191961745800215,0.00255240954940669,0.0100773099847751,0.00100569598136838
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,37169,0.0141267422487605,0.00430947418874204,0.0056801728388261,0.0225733116586949,0.00104788846213358
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.0232988269352659,0.00711019453290764,-0.0372348082197649,-0.0093628456507669,0.00105247778623276
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,35640,-0.0337130198756783,0.0103283686368671,-0.0539566224039379,-0.0134694173474187,0.00110118364864858
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.0105524988164613,0.00323648043807726,0.00420899715782982,0.0168960004750927,0.00111458096990913
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,-0.0245562827889691,0.00754451390195549,-0.0393435300368018,-0.00976903554113632,0.00113738967280888
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,-0.0108550798559949,0.00333526466110476,-0.0173921985917602,-0.00431796112022958,0.00113815813393801
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,36962,-0.011990126892898,0.00368997905688666,-0.0192224858443958,-0.00475776794140011,0.00115950392336124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,-0.0134152701288178,0.00413081607992337,-0.0215116696454676,-0.005318870612168,0.00116625271169916
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,0.0105970829977982,0.00327732965272636,0.00417351687845453,0.0170206491171418,0.00122605621506076
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,-0.00799784948205009,0.00247387846166949,-0.0128466512669223,-0.00314904769717788,0.00122833512589369
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,39866,0.0194364862489847,0.00601834071855329,0.00764053844062026,0.0312324340573492,0.00124238667251037
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,-0.0111715248481929,0.00346225503258549,-0.0179575447120604,-0.00438550498432531,0.00125496638709595
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,-0.0185634694517423,0.00575319435738944,-0.0298397303922256,-0.00728720851125898,0.00125560631073701
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,39815,-0.0195486461913183,0.00606764613852576,-0.0314412326228288,-0.00765605975980786,0.00127650635332426
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,37411,0.0115873827719304,0.00359866485631123,0.00453399965356033,0.0186407658903004,0.00128532386061899
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,-0.012006311135797,0.00373273555051012,-0.0193224728147968,-0.00469014945679713,0.00130074163218127
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,-0.0118746219408836,0.00369248018416858,-0.019111883101854,-0.0046373607799132,0.00130345550969734
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENG,Endoglin,40052,0.00553337110189082,0.00172267345942025,0.00215693112142713,0.00890981108235452,0.0013203364279809
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,39587,-0.0185537873595543,0.0057940747493739,-0.0299101738683272,-0.00719740085078149,0.00136653567104715
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00868886342766997,0.00272451782607579,0.00334880848856142,0.0140289183667785,0.00142970119484852
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,-0.0117695996864426,0.00371566715840827,-0.0190523073169228,-0.0044868920559624,0.00154017759494744
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,-0.0133419101597332,0.00421273089798029,-0.0215988627197746,-0.00508495759969186,0.00154347298637441
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,37437,0.0106762777040415,0.0033740927670346,0.00406305588065372,0.0172894995274294,0.00155857176795595
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,39587,-0.00919620529997245,0.0029092695896193,-0.0148983736956263,-0.00349403690431861,0.0015752602864282
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0233878381898028,0.00740385276315718,-0.0378993896055909,-0.00887628677401473,0.00158675016456051
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,39393,0.0222433844828733,0.00706009375365974,0.00840560072570023,0.0360811682400464,0.00163256303358582
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,0.0173744304326739,0.00553777170086989,0.00652039789896896,0.0282284629663789,0.00170739587506873
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,37169,0.00929177298329732,0.00296409558653912,0.00348214563368065,0.015101400332914,0.00172359895597328
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,-0.0268604300239452,0.00857188029923114,-0.0436613154104383,-0.0100595446374522,0.00173079493676546
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,39585,-0.0239364940806149,0.00764008477206165,-0.0389110602338557,-0.00896192792737405,0.00173338806215676
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,-0.0117520446315829,0.00375270894925641,-0.0191073541721254,-0.00439673509104031,0.00174217913274939
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,40058,-0.0127539361141118,0.00408055938556096,-0.0207518325098113,-0.00475603971841234,0.00177794855213635
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,36962,0.0115070410299438,0.00368988273788658,0.00427487086368615,0.0187392111962015,0.00182144318405648
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,36962,0.0148435385413055,0.00477092711376126,0.00549252139833345,0.0241945556842776,0.00186698526239316
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,0.0104798786130241,0.00337055198391948,0.00387359672454187,0.0170861605015062,0.00187899790432971
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,-0.0142172505915894,0.00457752311743629,-0.0231891959017646,-0.00524530528141432,0.00190105570543029
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,39749,-0.0193546705864531,0.00623709747811165,-0.0315793816435519,-0.00712995952935424,0.00191806286020118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,37437,-0.0273085190363011,0.00881601174842217,-0.0445879020632085,-0.0100291360093936,0.00195489507507777
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,37411,-0.00946581479459539,0.00306514046580676,-0.0154734901075766,-0.00345813948161414,0.00201769316318272
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C7,Complement component C7,37149,0.0100950015285227,0.0032745442027791,0.00367689489107565,0.0165131081659697,0.00205433039643765
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,37178,-0.0113304707188962,0.00369006329291344,-0.0185629947730066,-0.00409794666478588,0.00214105536508202
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,39868,-0.013679433177304,0.0044650456279423,-0.0224309226080709,-0.00492794374653709,0.0021900212853545
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,-0.013228275522005,0.00432080143847391,-0.0216970463414139,-0.00475950470259617,0.00220638943620186
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,-0.0914439329296249,0.0298796809665098,-0.150008107623984,-0.0328797582352657,0.00221403672609526
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,-0.00977500747142796,0.00319590084708523,-0.016038973131715,-0.0035110418111409,0.00222813586069588
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,39990,-0.0143940723205824,0.00471077506109193,-0.0236271914403226,-0.00516095320084224,0.0022500490280255
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,39489,-0.0121452791853062,0.00397492154796617,-0.0199361254193199,-0.00435443295129255,0.00225081955644038
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,0.0148771622168303,0.00487607715059135,0.00532005100167123,0.0244342734319893,0.00228495530629773
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,39713,-0.00937072991469817,0.00307481746136699,-0.0153973721389775,-0.00334408769041887,0.00231077370749132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,39315,-0.0107330452973102,0.00352971517162149,-0.0176512870336883,-0.00381480356093207,0.00236370645068891
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,-0.00787161218919573,0.00258890341059221,-0.0129458628739565,-0.002797361504435,0.00236630821144401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,37388,-0.00789849357466423,0.00260286369487655,-0.0130001064166223,-0.00279688073270619,0.00241360378549932
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,-0.0271320156215303,0.00894992484516854,-0.0446738683180607,-0.00959016292499999,0.00243789692330131
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,-0.0259332674422515,0.00855726098804469,-0.0427054989788191,-0.00916103590568391,0.00244502340304263
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,-0.00821190430284651,0.00271278287207004,-0.0135289587321038,-0.00289484987358922,0.00247292650785676
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,39764,-0.0208215028564203,0.00688918535710165,-0.0343243061563395,-0.00731869955650103,0.0025122271816151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,0.0156440823215538,0.00518219503426118,0.00548698005440187,0.0258011845887057,0.00254252363061396
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,37088,0.00949316190170258,0.00314808045478052,0.00332292421033277,0.0156633995930724,0.00257009113604944
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,37021,0.021801004117637,0.00725054128765113,0.00758994319384076,0.0360120650414332,0.00264502517040115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,39913,0.00838823384142815,0.00279200397010913,0.00291590606001426,0.013860561622842,0.00266535470723076
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,37021,0.0166073493489883,0.00553090672302076,0.00576677217186765,0.027447926526109,0.00268147055981881
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,39788,-0.0127775197244832,0.00426322396961201,-0.0211334387049228,-0.0044216007440437,0.00272937004694002
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,39749,0.00374349776079628,0.00124992394212277,0.00129364683423564,0.00619334868735692,0.00274885356777532
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,39998,-0.0124248078708309,0.00416303707136057,-0.0205843605306977,-0.00426525521096422,0.00284417706924547
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,37021,0.014048244020188,0.00471390602416092,0.00480898821283261,0.0232874998275434,0.00288614278886403
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,-0.045209990718134,0.0151982198872622,-0.074998501697168,-0.0154214797391,0.00293722519127431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,39564,-0.0124228385012646,0.00417654595065132,-0.0206088685645412,-0.00423680843798804,0.00293980863766954
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,39558,-0.0127829755773242,0.00430666978376996,-0.0212240483535133,-0.00434190280113511,0.00300019986051431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,-0.00921614035138719,0.00311757824813035,-0.0153265937177227,-0.00310568698505171,0.00311931834600092
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,37437,-0.0140545257982536,0.00475512461662626,-0.0233745700468411,-0.00473448154966611,0.00312538254008425
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,39788,-0.00850744006899469,0.00288148199264193,-0.0141551447745729,-0.0028597353634165,0.00315720059327905
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,0.0103976061953638,0.00353329870707996,0.00347234072948703,0.0173228716612405,0.00325882479714477
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,0.0141380340603031,0.00480936747460718,0.00471167381007303,0.0235643943105332,0.00329015010973341
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,37445,-0.00826589210623278,0.00281207746472801,-0.0137775639370997,-0.00275422027536588,0.00329374901055074
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,-0.0136660314343839,0.00465109420774509,-0.0227821760815643,-0.00454988678720353,0.00330652522916325
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,39489,-0.00970199756319567,0.00332270608352285,-0.0162145014869005,-0.00318949363949089,0.00350634279957074
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,37021,0.0100746626601373,0.00345512266768372,0.00330262223147722,0.0168467030887974,0.00355305363380594
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,37437,0.00680022595433523,0.00233283052816121,0.00222787811913926,0.0113725737895312,0.00356257558087901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,37056,0.00824189363459813,0.00283255181265563,0.00269009208179311,0.0137936951874032,0.00362372861851237
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.00939199727616092,0.00323158238822753,0.00305809579523497,0.0157258987570869,0.00366209084979254
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,-0.0302200397165828,0.0103994259247164,-0.050602914529027,-0.00983716490413869,0.0036666479582028
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,40030,-0.00603125427200176,0.00208187623331402,-0.0101117316892972,-0.00195077685470628,0.00377221179580241
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,-0.0119063422982937,0.00413115726414044,-0.020003410536009,-0.00380927406057846,0.00395693449103155
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,-0.0190429646069905,0.00660820074246385,-0.0319950380622197,-0.0060908911517614,0.00396147148225691
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.00779604901415834,0.00271741628092088,-0.0131221849247633,-0.00246991310355343,0.00412417887568914
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,37021,0.0151971518547482,0.00530477085063694,0.00479980098749978,0.0255945027219966,0.00417922114737312
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,39720,0.0133638840526526,0.0046720167380913,0.00420673124599364,0.0225210368593115,0.00423646015242725
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C5,Complement C5,37453,-0.00443979905776914,0.0015526898507006,-0.00748307116514232,-0.00139652695039596,0.0042505669614468
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,37271,-0.0184117119591324,0.00644290765126742,-0.0310398109556165,-0.0057836129626482,0.00427419189940829
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,0.01189555131244,0.00417133054121898,0.00371974345165077,0.0200713591732292,0.00435362652119409
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_DRA,,39799,0.0102749606421259,0.00361298592184065,0.00319350823531818,0.0173564130489335,0.00446221344102638
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',37021,-0.0124129700165286,0.00436519546379813,-0.0209687531255729,-0.00385718690748423,0.00446725212301523
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,37445,-0.0153551279336283,0.00541500486483693,-0.0259685374687087,-0.00474171839854788,0.00457982715225133
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,39779,-0.00837212247553954,0.00295585015522995,-0.0141655887797903,-0.00257865617128883,0.00462593719568576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,36962,-0.0211477139944242,0.00746648495392867,-0.0357820245041244,-0.00651340348472404,0.00462774389440469
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,-0.00884776632273034,0.00312949749320645,-0.014981581409415,-0.0027139512360457,0.00470131372429694
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,37169,0.010633939834859,0.00376254577633239,0.00325935011324747,0.0180085295564704,0.00471649226683977
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,-0.0228283499448255,0.00809578431287432,-0.0386960871980592,-0.00696061269159186,0.0048126133829193
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,0.0124709085387309,0.00442438415428468,0.00379911559633293,0.0211427014811289,0.00482938393713836
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,-0.0405417046957604,0.0143933885643079,-0.0687527462818038,-0.012330663109717,0.00485822500176135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,39477,0.0240503816202293,0.0085453382091184,0.00730151873035723,0.0407992445101014,0.00489227068810242
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,-0.0157476234197094,0.00559842891500109,-0.0267205440931115,-0.00477470274630729,0.00491635935316966
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,0.00949046897388885,0.00337507341889638,0.00287532507285194,0.0161056128749258,0.00493181376887969
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,37368,-0.0125105162608345,0.00445892078038901,-0.021250000990397,-0.00377103153127207,0.00502749386813281
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,-0.0134819700208,0.00482074798185326,-0.0229306360652324,-0.0040333039763676,0.00516977276428245
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,37411,-0.0119505985267387,0.0042866534213594,-0.0203524392326031,-0.00354875782087428,0.00531310401015685
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,37411,-0.00780574699193523,0.00280010877802832,-0.0132939601968707,-0.00231753378699973,0.00531644194973007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,-0.0135657479862675,0.00486689123964064,-0.0231048548159631,-0.0040266411565718,0.00532165939350513
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,37368,-0.0103448658097302,0.00371469316199492,-0.0176256644072402,-0.00306406721222014,0.00536269266794753
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,36962,0.0124784578988428,0.00448513872874166,0.00368758599050914,0.0212693298071764,0.00540725118409358
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0134310274037515,0.00486366965223563,0.00389823488536964,0.0229638199221333,0.00576138398450882
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,39587,0.0111883827580435,0.00405320673296046,0.00324409756144103,0.019132667954646,0.00578013823583209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,-0.0197660079161051,0.00718443697781209,-0.0338475043926167,-0.00568451143959336,0.00594515763953233
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,-0.0102477510777982,0.00372724414920561,-0.0175531496102412,-0.00294235254535518,0.00597825965139119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,37039,-0.0184896861014136,0.00672645582668909,-0.0316735395217242,-0.00530583268110298,0.00598951862154505
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,-0.0118882362787779,0.0043259307470906,-0.0203670605430755,-0.00340941201448029,0.00600024072403937
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,-0.0152749243919649,0.00556670068439235,-0.0261856577333739,-0.00436419105055593,0.00607681772111662
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,37021,0.00976773193791006,0.00356730936405216,0.00277580558436783,0.0167596582914523,0.00618740233585379
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,37124,-0.0103926456409065,0.00379662204767894,-0.0178340248543572,-0.00295126642745574,0.00620207644417786
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,0.0156646608191463,0.00572647220855557,0.00444077529037737,0.0268885463479152,0.00623728447311306
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,0.00743449112372771,0.00274081749862249,0.00206248882642763,0.0128064934210278,0.00668465823432971
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",37169,-0.012761651835979,0.00471250604321452,-0.0219981636806795,-0.00352513999127855,0.00677684718120727
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,0.0165076966390754,0.00609675239091061,0.00455806195289064,0.0284573313252602,0.00678385233609004
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,39477,-0.00976151272814816,0.00362394282413208,-0.016864440663447,-0.00265858479284929,0.00707569065688245
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,39477,-0.0213727728849653,0.00793621982104389,-0.0369277637342113,-0.0058177820357193,0.00708735769583543
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,-0.0140211185063475,0.0052104687722645,-0.0242336372999859,-0.00380859971270908,0.00713244999202045
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,37056,0.00598439638120484,0.00222745239536537,0.00161858968628872,0.010350203076121,0.00722618242259723
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,0.0100789785656443,0.00375403914270297,0.00272106184594647,0.0174368952853421,0.00726562398992841
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,39868,-0.0208559730480087,0.00780450701936932,-0.0361528068059726,-0.00555913929004483,0.00754098842472386
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,-0.0200011074658955,0.00749020196192483,-0.0346819033112682,-0.00532031162052283,0.00758731259897008
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,-0.0150687369019539,0.00564333289238638,-0.0261296693710312,-0.00400780443287664,0.00759003079345224
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,37388,-0.0103349994881273,0.00387919599124579,-0.017938223630969,-0.00273177534528553,0.00772604668014141
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,0.00705655172653638,0.00265693559483343,0.00184895796066285,0.0122641454924099,0.0079192541816973
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,0.00851131908728857,0.00321395651921873,0.00221196430961986,0.0148106738649573,0.00809911815219001
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,-0.00756614530792365,0.00285870395680028,-0.0131692050632522,-0.00196308555259509,0.00813742501275729
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,0.0163022767477742,0.00616130878879538,0.00422611152173523,0.0283784419738131,0.00815682620656719
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,37368,-0.0136542442753367,0.00516648101800392,-0.0237805470706243,-0.00352794148004899,0.00823058288085439
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.00974758400665098,0.00368995616136702,0.00251526993037162,0.0169798980829303,0.00825998911402595
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,-0.0116974509411274,0.00442937756202351,-0.0203790309626935,-0.00301587091956133,0.00827886023046618
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLPS,Colipase,39836,0.0185703724171114,0.00703275351103747,0.0047861755354779,0.0323545692987448,0.00828508452378524
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,0.00900753415062133,0.00341522791769812,0.00231368743193303,0.0157013808693096,0.00836271531726721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,-0.00555354022052929,0.00210680820852933,-0.00968288430924679,-0.0014241961318118,0.00839717805776391
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,0.00785088924983995,0.00298123363490456,0.00200767132542701,0.0136941071742529,0.00846242181457773
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,-0.0117818302201474,0.00447696244561996,-0.0205566766135625,-0.00300698382673223,0.00850675608812809
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,36991,0.0258800606952337,0.0098355263452874,0.00660242905847036,0.045157692331997,0.00851623685796939
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,-0.0176167678225634,0.00669813785187746,-0.0307451180122433,-0.00448841763288363,0.0085459272727356
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,37021,-0.00980399254361418,0.00373390420178544,-0.0171224447791136,-0.00248554030811472,0.00865791832238089
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,37056,0.00916690768476099,0.0035097977704338,0.00228770405471075,0.0160461113148112,0.00901675618602937
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,-0.00834648305570917,0.00319682549331128,-0.0146122610225993,-0.00208070508881906,0.00904153937087578
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.00913627767851615,0.00350022353134479,0.00227583955708036,0.015996715799952,0.00905744002032427
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,-0.0128550233548043,0.0049315097665612,-0.0225207824972642,-0.00318926421234434,0.00915164349544146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,-0.00659343559755677,0.00253230798955344,-0.0115567592570815,-0.00163011193803202,0.00923168137096435
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,0.0115003854338871,0.00443027284059323,0.00281705066632435,0.0201837202014498,0.00944580864899893
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,37056,0.00711915709318212,0.00274457809425608,0.0017397840284402,0.012498530157924,0.00949993311805298
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,37124,-0.00744998409346678,0.00287666724694049,-0.0130882518974701,-0.00181171628946342,0.00961375183784943
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,36962,0.00684560089300301,0.0026438992061877,0.00166355844887512,0.0120276433371309,0.00963037587340036
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,37437,0.0131730957283374,0.00509309852965131,0.00319062261022086,0.023155568846454,0.00970704868337256
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,37056,0.015523146642063,0.00600391465475208,0.00375547391874892,0.0272908193653771,0.00973428835304246
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,39931,-0.00880206838196316,0.00341774393217552,-0.0155008464890272,-0.00210329027489915,0.0100211863576356
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,37411,-0.0162956406312573,0.00633474068449605,-0.0287117323728696,-0.00387954888964506,0.0101094538220073
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,37056,0.0110065121405351,0.00428252552265771,0.00261276211612604,0.0194002621649443,0.0101778329036911
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,-0.00711261427218692,0.00277420089284564,-0.0125500480221644,-0.00167518052220946,0.0103613142418612
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,36991,0.0124735138529899,0.00488261127013275,0.00290359576352967,0.02204343194245,0.0106396970379952
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00972528404281893,0.00380927828282069,0.00225909860849039,0.0171914694771475,0.0106895479317235
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0126039064892136,0.00494641472370171,-0.0222988793476689,-0.00290893363075821,0.0108407459693352
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,-0.00593674757627614,0.0023356736887653,-0.0105146680062561,-0.00135882714629615,0.0110386578000464
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,-0.0155439268054234,0.00612527533713735,-0.0275494664662126,-0.00353838714463415,0.0111687916105731
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,-0.0088438697652941,0.00348729260899279,-0.01567896327892,-0.00200877625166824,0.0112213879382771
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,37021,0.00914756729884827,0.00361504868612355,0.00206207187404611,0.0162330627236504,0.0114043815955118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,-0.012113608974579,0.00479511068804769,-0.0215120259231525,-0.00271519202600552,0.0115388096613127
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,36962,0.0115696305704169,0.004585178984662,0.00258267976047934,0.0205565813803544,0.0116387408602721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,37043,-0.0222017515754717,0.0087999897572654,-0.0394497314997118,-0.00495377165123148,0.0116498455997149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,-0.0224318073878198,0.00889469554696869,-0.0398654106598785,-0.00499820411576119,0.0116829644609023
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,39868,-0.0101700815716533,0.00404125240061578,-0.0180909362768602,-0.00224922686644634,0.0118601375235739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,0.0157363755004976,0.00626409955467964,0.00345874037332552,0.0280140106276697,0.0120116033136237
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,-0.0081625941114981,0.00325679283052974,-0.0145459080593364,-0.00177928016365981,0.0122108271882994
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,0.0122142511743171,0.00488748854832777,0.00263477361959472,0.0217937287290396,0.0124634863243005
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,40052,-0.00809342922464541,0.00325401949241737,-0.0144713074297834,-0.00171555101950737,0.0128849334283506
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,0.0214484317014882,0.00864418402764744,0.00450583100729926,0.0383910323956772,0.0131025666241067
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,37420,0.00899698185782978,0.00364044066181447,0.00186171816067341,0.0161322455549861,0.0134707437067673
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,37124,-0.00824991239838542,0.00334095468032039,-0.0147981835718134,-0.00170164122495745,0.0135492134200236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.010921805578419,0.00442728995648181,0.00224431726371468,0.0195992938931234,0.0136400504878885
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLU,Clusterin,37453,0.00794690771318103,0.00325085835743953,0.00157522533259956,0.0143185900937625,0.0145156386968866
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,39691,0.0118001310785753,0.00484524143192343,0.00230345787200537,0.0212968042851452,0.0148860416028349
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.00387874348705978,0.00159345865981998,0.000755564513812631,0.00700192246030693,0.0149368671652582
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,37388,0.00667009518333894,0.00274064297342845,0.00129843495541918,0.0120417554112587,0.0149553339331353
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,37388,0.00916278364252084,0.00377904601512804,0.00175585345286987,0.0165697138321718,0.0153370589133334
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,-0.0255582435314215,0.0105517997209292,-0.0462397709844429,-0.00487671607840021,0.0154412265723296
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,39344,-0.0147251893793529,0.00609027197029046,-0.0266621224411222,-0.00278825631758358,0.0156252101543169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,36703,0.0173001380900991,0.00715958146279157,0.00326735842302759,0.0313329177571705,0.0156903352821607
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,0.0227631733850389,0.00943063126203452,0.00427913611145121,0.0412472106586265,0.0158005021157707
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,37021,0.00992665879458968,0.00412962095355949,0.00183260172561309,0.0180207158635663,0.0162407198747275
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,-0.0142774470282099,0.00594031645996968,-0.0259204672897505,-0.00263442676666933,0.0162512428159194
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,0.0138622658741883,0.00577041838825009,0.0025522458332181,0.0251722859151584,0.0163062161008983
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,-0.00545125091070519,0.00227326702907162,-0.00990685428768557,-0.000995647533724801,0.0164991415443948
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,39862,0.00857533030622748,0.00357621464656422,0.0015659495989616,0.0155847110134934,0.0165016923452099
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,37021,0.0120689424489436,0.00504059464485315,0.00218937694503146,0.0219485079528558,0.0166638048780043
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,-0.0054810868210518,0.00230069830287422,-0.00999045549468527,-0.00097171814741834,0.0172158862488927
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,39489,-0.0108635091690962,0.00456842922709416,-0.0198176304542008,-0.00190938788399169,0.0174210049921168
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,-0.012759986819774,0.00536694754970474,-0.0232792040171953,-0.00224076962235273,0.0174436714680939
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,36962,0.0144299499425109,0.00607879658673847,0.00251550863250354,0.0263443912525184,0.0176196099280835
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,39788,0.0050221297260828,0.00211784619358952,0.00087115118664733,0.00917310826551826,0.0177356254908599
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00911969543781356,0.00384776372126715,0.00157807854412994,0.0166613123314972,0.0177941758932958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,0.00887111138344173,0.00376066692520489,0.00150020421004014,0.0162420185568433,0.018342749459159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.0124287868098915,0.00529137143949707,0.00205769878847722,0.0227998748313058,0.018844774141933
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,37424,-0.00348935832958444,0.00148606171663181,-0.00640203929418279,-0.000576677364986079,0.0188858926399778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.00687668668685581,0.0029345606023876,0.0011249479061761,0.0126284254675355,0.0191237515393006
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,37056,0.0111330026345563,0.00475304532070403,0.00181703380597641,0.0204489714631362,0.0191806855561334
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,39913,-0.0051307271197212,0.00220161508822415,-0.00944589269264054,-0.000815561546801858,0.0197953459323491
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,39587,0.00676130291379185,0.00290145796836609,0.00107444529579431,0.0124481605317894,0.0198022379239616
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,39766,-0.0124472004308764,0.00534268020864485,-0.0229188536398203,-0.00197554722193254,0.0198309134503277
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0115364020225582,0.00496146502543664,-0.021260873472414,-0.00181193057270233,0.0200736552309041
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,0.00454269850335377,0.00195518247569035,0.000710540851000675,0.00837485615570686,0.0201715934443289
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,36991,-0.0263691164756693,0.0113878589051718,-0.0486893199298061,-0.00404891302153249,0.0205983756206035
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,-0.00911788427261607,0.00394671932890131,-0.0168534541572626,-0.0013823143879695,0.0208896335110803
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,0.00758797011806647,0.00328986170140671,0.00113984118330933,0.0140360990528236,0.0210973625372369
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,39546,-0.0169264778359904,0.00734155066867232,-0.0313159171465881,-0.00253703852539264,0.0211475089928996
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,37411,-0.00859447982339631,0.00373777626563754,-0.0159205213040459,-0.00126843834274672,0.0214998424901262
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,37124,0.0219509648183063,0.009570742628676,0.0031923092661013,0.0407096203705112,0.0218319946682365
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,-0.00624005146052515,0.00272897637879064,-0.0115888451629548,-0.000891257758095492,0.0222329658829733
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,37169,0.00926198036874875,0.00406154595041434,0.00130135030593665,0.0172226104315609,0.0225992626953595
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,36931,0.00940429436313399,0.00412878711117038,0.00131187162524005,0.0174967171010279,0.0227582787479407
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,37267,0.00960032484217785,0.00421753439631958,0.00133395742539147,0.0178666922589642,0.0228444460234942
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,0.00592808973326042,0.00261290542754354,0.000806795095275083,0.0110493843712458,0.0232983165631382
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,-0.0199489015880733,0.00881474712722158,-0.0372258059574276,-0.00267199721871902,0.0236440889451814
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,37382,-0.026309087765538,0.0117062883506714,-0.0492534129328539,-0.00336476259822203,0.0246284820994463
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,-0.00880313974694548,0.00391920901602412,-0.0164847894183527,-0.0011214900755382,0.0247107372927791
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,0.0143826193380214,0.00641462835217057,0.00180994776776707,0.0269552909082757,0.0249676352991454
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,0.00951987348266319,0.00425032157396219,0.0011892431976973,0.0178505037676291,0.0251204443694958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,0.00834156652475132,0.00373098448718809,0.00102883692986267,0.01565429611964,0.0253845346700365
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0159029681053833,0.00712827034266887,0.00193155823375231,0.0298743779770143,0.0256969158156144
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,37056,0.00595645823218698,0.00267102610516966,0.000721247066054457,0.0111916693983195,0.025762456059219
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,-0.0140706199399125,0.00631246376694322,-0.0264430489231212,-0.00169819095670375,0.0258293019353933
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,39438,-0.00984770473138712,0.00442606206376958,-0.0185227863763755,-0.00117262308639874,0.0260998024250743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,0.00671554618247945,0.00301866267215279,0.000798967345059989,0.0126321250198989,0.0261193746490238
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,0.00719462634588414,0.0032466635376258,0.000831165812137577,0.0135580868796307,0.0267080991250671
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,36962,0.0110516758489124,0.00498761566541698,0.00127594914469513,0.0208274025531297,0.0267207153794374
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERVV_1,,37021,0.0108816689205092,0.00491138564852586,0.00125535304939851,0.0205079847916199,0.0267359167323342
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,0.010369422908793,0.00468266169150479,0.00119140599344363,0.0195474398241424,0.0268162892255825
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,-0.0198702600117982,0.00900624700494498,-0.0375225041414903,-0.00221801588210604,0.0273789147663844
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,-0.00807181894813353,0.00365986932682567,-0.0152451628287118,-0.000898475067555219,0.027433877683375
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,-0.0151955233292979,0.00689141426552195,-0.0287026952897209,-0.00168835136887486,0.0274713423669135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.0110624426346524,0.00502935474254916,0.00120490733925601,0.0209199779300487,0.0278514166506676
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,0.00846540491422868,0.00386692598622114,0.000886229981235245,0.0160445798472221,0.0286011137680244
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,39587,0.00658262340932268,0.00301659338358555,0.000670100377494989,0.0124951464411504,0.0291140876088059
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,39952,0.0087498960083807,0.00401266899807214,0.000885064772159301,0.0166147272446021,0.0292298479819933
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,-0.00578890015931377,0.00265699171605451,-0.0109966039227806,-0.000581196395846931,0.0293684704078222
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,37056,0.00953010450149748,0.00438470777742884,0.000936077257736952,0.018124131745258,0.029761419950396
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,37056,-0.00627990108288385,0.00289377641522921,-0.0119517028567331,-0.00060809930903461,0.0300139907621965
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,-0.00873538752197333,0.0040254779916911,-0.0166253243856879,-0.00084545065825877,0.0300196627113638
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,-0.00495691579781137,0.00228595234301195,-0.0094373823901148,-0.000476449205507942,0.0301411319818628
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,-0.00667578304059603,0.0030833563947545,-0.0127191615743149,-0.000632404506877213,0.0303949090948657
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,0.015801095104359,0.00730416259127871,0.00148493642545269,0.0301172537832652,0.0305360937148612
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,0.0136522898874996,0.0063158661868027,0.00127319216136635,0.0260313876136329,0.0306680478692681
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,36962,0.0140736047703413,0.00651788761238256,0.00129854505007149,0.0268486644906111,0.0308505817433072
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,0.0056097823996014,0.00260196706292004,0.000509926956278124,0.0107096378429247,0.0311029344029771
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,0.01353109760102,0.00630146028982884,0.00118023543295549,0.0258819597690845,0.0317880116966137
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,39587,-0.0135714952849365,0.00632713293631482,-0.0259726758401136,-0.00117031472975949,0.0319707068291295
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,37056,0.0148808350898186,0.00693776796372987,0.0012828098809081,0.0284788602987292,0.0319788532897616
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,37039,0.00758775176915401,0.00353915757532584,0.000651002921515365,0.0145245006167927,0.0320557025727008
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,-0.00732196515957421,0.00342410042744146,-0.0140332019973595,-0.000610728321788938,0.0325025524187805
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,-0.00645347427188835,0.00302232555719202,-0.0123772323639847,-0.000529716179791989,0.0327576386125281
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,0.00888840793768689,0.00416501863271925,0.000724971417557153,0.0170518444578166,0.0328561786258918
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,39754,-0.0112142474913186,0.00525824454450579,-0.0215204067985499,-0.000908088184087231,0.0329647891353336
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,-0.0257013632998082,0.0120560687570639,-0.0493312580636536,-0.00207146853596294,0.0330368738591466
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,37169,-0.0158280002309992,0.00742817457326375,-0.0303872223945962,-0.00126877806740229,0.0331233913022181
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,39913,-0.0169428648551938,0.00797661164450427,-0.0325770236784221,-0.00130870603196539,0.0336797091571854
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.00688847382159085,0.00325468823044835,-0.0132676627532696,-0.000509284889912075,0.0343228050195794
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,37106,0.00780892427014041,0.0036964251586535,0.000563930959179547,0.0150539175811013,0.0346570063181442
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,-0.00645078035917975,0.00305431182364972,-0.0124372315335332,-0.000464329184826296,0.0347002126603277
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,0.0149655860461565,0.00709255504983005,0.00106417814848958,0.0288669939438234,0.0348736406431403
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,-0.00592511418505952,0.00281685949974661,-0.0114461588045629,-0.000404069565556157,0.0354450780291167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,-0.0129700284202678,0.00616912260398547,-0.0250615087240793,-0.000878548116456272,0.0355362242300755
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,39587,-0.0126662957040177,0.00602859562117461,-0.0244823431215199,-0.000850248286515427,0.0356536901718401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,0.00738461199594884,0.00352255166317516,0.000480410736125515,0.0142888132557722,0.0360674757897358
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,-0.00791958221812302,0.00379258365320649,-0.0153530461784077,-0.000486118257838294,0.0367977339583515
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,-0.00803467711562296,0.00385931661036605,-0.0155989376719404,-0.000470416559305494,0.0373716357616828
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,-0.0165124699200206,0.00795686302862888,-0.0321079214561332,-0.000917018383907977,0.0379828345673598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,0.0132412229217603,0.00639075293749581,0.000715347164268498,0.0257670986792521,0.0382907438183521
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,39885,0.00670650086649261,0.00323817961702913,0.000359668817115518,0.0130533329158697,0.0383681025551193
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,39796,-0.00677497051563672,0.00327688138470489,-0.0131976580296583,-0.000352283001615145,0.0387026441044428
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,37368,-0.0110693025529565,0.0053610621439992,-0.021576984355195,-0.000561620750718101,0.0389648277562079
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,39866,-0.0136135499307808,0.00659388107313654,-0.0265375568341284,-0.000689543027433156,0.0389794756545128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00982163672438676,0.00477508268184365,0.000462474667973198,0.0191807987808003,0.0397195487782109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,0.00677353730368473,0.00329564227029885,0.000314078453898975,0.0132329961534705,0.0398696616698425
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,37039,-0.0103663507378861,0.00505224291419253,-0.0202687468497034,-0.000463954626068718,0.0402057643043562
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,37056,0.0213336392355476,0.0104120657209096,0.000925990422564752,0.0417412880485304,0.0404882679343483
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIM,Vimentin,39585,-0.0243318309552152,0.0118944431599448,-0.0476449395487069,-0.00101872236172346,0.0408077243885645
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.00544733846547111,0.00266527728542126,0.000223394986045448,0.0106712819448968,0.0409908831984336
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,37043,-0.0152088411956839,0.00744480277953231,-0.0298006546435673,-0.000617027747800614,0.0410841311835802
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,39761,-0.00749454740326214,0.00367183115278828,-0.0146913364627272,-0.000297758343797116,0.0412580993026858
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,36962,0.0124422866000558,0.00609724609592924,0.000491684252034457,0.0243928889480771,0.0413065877823926
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.0164996714934237,0.00809054222553373,-0.0323571342554698,-0.000642208731377616,0.0414291294181937
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,37368,0.0115669520282022,0.0056927730344439,0.000409116880692206,0.0227247871757123,0.042186752441608
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,0.00900855322060982,0.00443656400709508,0.000312887766703466,0.0177042186745162,0.0423233788321897
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,39868,0.0072755918827313,0.00358984225930136,0.00023950105450063,0.014311682710962,0.0427079758524726
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.00679771171718461,0.00335767859328561,0.000216661674344812,0.0133787617600244,0.042932658349292
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,0.00166936347372829,0.000825219649775093,5.19329601691076e-05,0.00328679398728747,0.0430999665141959
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,0.00847900016079906,0.00420283421267981,0.000241445103946619,0.0167165552176515,0.0436690243774705
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MB,Myoglobin,40052,-0.0105962161357078,0.00527299849255886,-0.0209312931811231,-0.000261139090292429,0.0444981706161071
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,37445,0.0046284010518738,0.00231425615069901,9.24589965037529e-05,0.00916434310724385,0.0455253278884859
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,-0.0096546076347396,0.00483713967298426,-0.0191354013937888,-0.000173813875690444,0.0459618127393295
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESPL1,Separin,36962,0.0109469320970132,0.00548569047311932,0.000194978769699348,0.0216988854243271,0.0460043407588158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIT,Vitrin,37437,-0.00747990757920098,0.00375556075771866,-0.0148408066643296,-0.000119008494072403,0.0464252332848195
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,0.0122061473886754,0.00613799777083753,0.00017567175783385,0.024236623019517,0.0467637410892305
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,-0.0131596417779756,0.00662453660981016,-0.0261437335332035,-0.000175550022747654,0.0469984855882586
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,-0.00971724307395345,0.00489794026258987,-0.0193172059886296,-0.000117280159277301,0.0472822022837177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALLD,Palladin,37056,0.00818088755617015,0.00415628841821521,3.45622564683432e-05,0.016327212855872,0.0490526309838148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,-0.00570117125249777,0.00290072972680054,-0.0113866015170268,-1.57409879687088e-05,0.0493853444636402
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,39477,-0.00610629430254485,0.00310879247208279,-0.0121995275478271,-1.30610572625757e-05,0.0495244569566182
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,37388,0.00747628586155879,0.00380679000417991,1.49774533661556e-05,0.0149375942697514,0.0495581455278982
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,-0.00956259868226928,0.0048766887022723,-0.019120908538723,-4.28882581557551e-06,0.0499107084280222
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,39587,-0.00863803203781575,0.00441008355858248,-0.0172817958126374,5.7317370059165e-06,0.0501655404684387
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,39841,0.0132049446450354,0.00677649476810752,-7.69851004553453e-05,0.0264868743905262,0.0513559808722449
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,37411,-0.00501203568393844,0.00258617713479822,-0.010080942868143,5.6871500266076e-05,0.0526428173009359
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,0.0104057549283954,0.00537002638651919,-0.000119496789182216,0.020931006645973,0.0526755529504482
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,39725,0.0096714264233506,0.00499554473137843,-0.000119841250151125,0.0194626940968523,0.0528841716031168
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,39749,-0.0109954997245336,0.00568702309834036,-0.0221420649972807,0.000151065548213472,0.0532001537722137
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,-0.00543433873388654,0.00281619149242307,-0.0109540740590358,8.53965912626748e-05,0.0536645745977485
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00550112293123933,0.00286474031476241,-0.000113768085694996,0.0111160139481737,0.0548394334506978
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,36991,0.00688075633275864,0.00359333974006419,-0.000162189557767173,0.0139237022232844,0.0555315736488588
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,-0.0111459715293108,0.0058247861283962,-0.0225625523409674,0.000270609282345711,0.0556963392064275
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,40009,-0.00495323348383812,0.00259172706145969,-0.0100330185242991,0.000126551556622861,0.0560002994178997
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,39587,-0.00962121086409739,0.00504796146572257,-0.0195152153369136,0.00027279360871885,0.0566736531868989
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,0.00862870206953203,0.00452795060864278,-0.000246081123407812,0.0175034852624719,0.0567167825996427
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,-0.00771199406933816,0.00405277173018809,-0.0156554266605068,0.000231438521830485,0.0570762084688372
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,-0.0090665890077426,0.00476752009795964,-0.0184109283997435,0.00027775038425829,0.0572268213921729
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,-0.00856360565932871,0.00450795279493135,-0.0173991931373942,0.000271981818736739,0.0574949806924515
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,37056,0.00922649542205227,0.0048577980291364,-0.000294788715055073,0.0187477795591596,0.0575446742378801
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.00858906449363238,0.00452738501703656,-0.017462739127024,0.00028461013975929,0.0578278314467981
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,39866,-0.0123450236157453,0.00652526027188051,-0.025134533748631,0.00044448651714054,0.0585247139977323
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,-0.00500813027370207,0.00264951069229538,-0.010201171230601,0.000184910683196885,0.0587480847246615
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,0.00899757130376626,0.00476039714885949,-0.000332807107998339,0.0183279497155309,0.0587640402344747
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,0.00897212937668329,0.00474992957293977,-0.000337732586278658,0.0182819913396452,0.0589269648370999
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARTN,Artemin,39587,-0.00857382351435329,0.00455642165209008,-0.0175044099524498,0.000356762923743275,0.0598950661268106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.0107832763529917,0.0057371290690484,-0.00046149662234316,0.0220280493283266,0.0601902405647116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,-0.00802289212414837,0.00428749186408969,-0.0164263761777642,0.000380591929467416,0.0613348205863083
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,39489,-0.0115580030544358,0.00617780662596537,-0.023666504041328,0.000550497932456291,0.0613788565866606
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,37411,-0.00558442116112672,0.00298878464974539,-0.0114424390746277,0.000273596752374254,0.061719700047882
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,0.00689480687851618,0.00369122674176293,-0.000339997535339171,0.0141296112923715,0.0617959365266208
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,40052,0.00517429622366709,0.00277497677234431,-0.00026465825012775,0.0106132506974619,0.0622518038263581
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,37382,-0.00582603332710275,0.0031289349927275,-0.0119587459128486,0.000306679258643144,0.0626267322123211
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,36962,0.00793395164533014,0.00427010594988745,-0.000435456016449271,0.0163033593071095,0.0631882766947816
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00511763049154174,0.00277409702183367,-0.000319599671252249,0.0105548606543357,0.0650862692642253
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,37043,-0.0112883591306469,0.00612139326044195,-0.0232862899211131,0.000709571659819313,0.0651934249559841
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,37039,-0.0174295753402758,0.00945326029351426,-0.0359579655155638,0.00109881483501212,0.0652400636814653
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,36962,0.00774010524374508,0.00420435404635243,-0.00050042868710569,0.0159806391745958,0.0656480080000365
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,37039,-0.00588224246966889,0.00319935669035739,-0.0121529815827694,0.0003884966434316,0.066000888573842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,39456,-0.0116184522531613,0.0063231590572313,-0.0240118440053346,0.000774939499012063,0.0661633523839933
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,-0.00787271150682023,0.00428916417311572,-0.016279473286127,0.000534050272486588,0.0664553130724501
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,37039,0.00540495921995339,0.00294734045005484,-0.000371828062154109,0.0111817465020609,0.0666998609904026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,-0.0177199130900281,0.00966842552599853,-0.0366700271209852,0.00123020094092906,0.0668566873878146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,-0.005922084457659,0.00324244030066317,-0.0122772674469588,0.000433098531640805,0.0678046181814549
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00418688794777524,0.0022988723603569,-0.000318901878524273,0.00869267777407476,0.0685870890110844
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,-0.00551446008003715,0.00303087424077911,-0.0114549735919642,0.000426053431889913,0.0688686758127319
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,0.00756000509530449,0.00416291927032655,-0.000599316674535541,0.0157193268651445,0.0693879219311478
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,37411,-0.0149514675902358,0.00824269190744109,-0.0311071437288203,0.00120420854834875,0.0697143197823901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.00619947655296706,0.00342510676898281,-0.000513732714239251,0.0129126858201734,0.0703171814986173
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,0.0101668801392388,0.00562596457635988,-0.000860010430426512,0.0211937707089042,0.0707639250160263
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,0.00602641087306352,0.00335352299396346,-0.000546494195104857,0.0125993159412319,0.0723524847411917
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,37124,-0.00617687075122996,0.00343780038298418,-0.012914959501879,0.000561217999419033,0.0723979255406607
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,36991,0.00797137256981792,0.00444557260329673,-0.000741949732643667,0.0166846948722795,0.0729793538707054
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,-0.00456522854291984,0.00254688613907802,-0.00955712537551275,0.000426668289673083,0.0730793308617869
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,0.00837956770644554,0.00468404023336114,-0.000801151150942299,0.0175602865638334,0.0736399170826246
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,0.00592232194045337,0.00331618481821788,-0.000577400303253677,0.0124220441841604,0.0741410847685353
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,39720,0.0227377304107564,0.0127773269217242,-0.00230583035582308,0.0477812911773358,0.0751708521002694
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FST,Follistatin,39908,-0.00925794298882217,0.00522955498430513,-0.0195078707580602,0.000991984780415886,0.0766941924682444
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,37031,0.0126187717266275,0.00713684813542533,-0.00136945061880615,0.0266069940720612,0.07706474456808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,-0.013987578096808,0.00793116774961984,-0.0295326668860629,0.00155751069244691,0.0778188900585454
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,0.00713285873864516,0.00404786475416115,-0.000800956179510698,0.015066673656801,0.0780700514469692
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00530631628894504,0.00302341149498897,-0.0112322028191234,0.000619570241233332,0.079265362103844
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,39918,0.0069779619592387,0.00397744849345191,-0.00081783708792704,0.0147737610064044,0.0793842352824386
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,39788,-0.0332030207495611,0.0189296978150927,-0.0703052284671428,0.00389918696802051,0.0794467429727743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,0.00793596151087442,0.00453116932159533,-0.000945130359452434,0.0168170533812013,0.079897606952821
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.00578250296376532,0.00331857736522632,-0.000721908672078264,0.0122869145996089,0.0814505317381007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,37021,0.0147331777132046,0.0084615971209369,-0.00185155264383174,0.0313179080702409,0.0816751078097731
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,37021,0.00881929424365128,0.00507148517062519,-0.0011208166907741,0.0187594051780767,0.0820587855395144
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,40018,-0.00367843211782665,0.00211600717431063,-0.00782580617947549,0.00046894194382219,0.0821622974006756
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,-0.010586317926565,0.00610082193659199,-0.0225439289222853,0.00137129306915534,0.0827232102531
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,40030,0.00758537958309692,0.00440064038399677,-0.00103987556953676,0.0162106347357306,0.0847813042225985
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,40009,0.00505178090089616,0.00293090473303839,-0.000692792375859081,0.0107963541776514,0.0847946883069714
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,39489,-0.00822051103076479,0.00478627719512512,-0.01760161433321,0.00116059227168044,0.0859046147725557
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,-0.00516691858159733,0.0030114022562349,-0.0110692670038177,0.00073542984062306,0.0862249181220282
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,39908,0.00534517558177565,0.0031165564311425,-0.000763275023263655,0.011453626186815,0.0863479844522388
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0060589485906647,0.00354602324875252,-0.00089125697689025,0.0130091541582196,0.0875330857784658
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,36991,0.00823265370205446,0.00482229506000648,-0.00121904461555824,0.0176843520196672,0.0878073092317192
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,39489,-0.00528379239891965,0.0031021020773371,-0.0113639124705004,0.000796327672661059,0.0885329115338717
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,-0.00350057585482936,0.00205563210917234,-0.00752961478880716,0.000528463079148435,0.0886066969343433
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00549649448240643,0.00322860397256764,-0.000831569303826137,0.011824558268639,0.0886932651133716
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,37021,0.00941435298004511,0.00553591280806599,-0.00143603612376423,0.0202647420838545,0.089042439591555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,0.00837259498606047,0.00492990244480952,-0.0012900138057662,0.0180352037778871,0.0894694257676883
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,0.00742534864629681,0.00438124236602057,-0.00116188639110351,0.0160125836836971,0.090136251953385
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,37083,-0.0142481869090435,0.00844378767483189,-0.030798010751714,0.002301636933627,0.0915468723021266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BSND,Barttin,36962,0.0057968331809116,0.00343805576346089,-0.000941756115471738,0.0125354224772949,0.0918044186941948
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,0.00903204677097694,0.00536008238556604,-0.0014737147047325,0.0195378082466864,0.092000970746341
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,-0.0103697918008813,0.0061575411350452,-0.0224385724255699,0.00169898882380729,0.0921860554019013
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,37169,-0.0074026821208534,0.0044056252219914,-0.0160377075559565,0.00123234331424974,0.0929263991594312
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,37382,-0.010529953694587,0.0062680035912464,-0.0228152407334299,0.00175533334425592,0.0929894904609367
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,36991,0.00582824484824813,0.00347172029328953,-0.00097632692659934,0.0126328166230956,0.0932192686096501
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,36931,0.0135198505609941,0.00806029827859778,-0.00227833406505754,0.0293180351870457,0.0935001707676495
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,-0.00981081404900424,0.00586493501199288,-0.0213060866725103,0.0016844585745018,0.0943914509415855
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,37368,-0.00911834437944068,0.00545386424228782,-0.0198079182943248,0.00157122953544344,0.0945661639923029
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,0.0111665823529243,0.00671838594489906,-0.00200145409907788,0.0243346188049265,0.0965180478229232
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,39456,-0.00604458542683379,0.00364109810450836,-0.0131811377116702,0.00109196685800258,0.0969145253950711
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,39477,0.00951559042227617,0.00574517975909929,-0.00174496190555844,0.0207761427501108,0.0976864836295151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,39913,-0.00494962330314157,0.00298895566239369,-0.0108079764014332,0.000908729795150066,0.0977472770642602
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,37021,-0.00648902645195988,0.00391869318152956,-0.0141696650877578,0.00119161218383807,0.0977626857995453
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,-0.0104193015674044,0.00629477215143474,-0.0227570549842165,0.00191845184940766,0.0978976184208403
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,36962,0.00506179800212995,0.00305858291600793,-0.000933024513245589,0.0110566205175055,0.0979588436005659
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,-0.00952155606140514,0.00578037963614965,-0.0208511001482585,0.00180798802544816,0.0995328464061446
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,39489,-0.00927146797071541,0.00568064181554618,-0.0204055259291859,0.0018625899877551,0.102675139581428
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,0.0104371731692947,0.0064110404950869,-0.00212846620107563,0.023002812539665,0.103548901780576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,37453,-0.00301349682772301,0.00186345498241716,-0.00666586859326065,0.000638874937814636,0.10586788224555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.00805109442445811,0.00498791658948385,-0.0178274109398465,0.00172522209093023,0.106521120753475
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,-0.00382271947123776,0.00237311595293132,-0.00847402673898315,0.000828587796507639,0.107233554220734
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00672385923015847,0.00417729326643411,-0.00146363557205239,0.0149113540323693,0.107500100860985
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,37056,0.00561782226956272,0.00349626939739011,-0.00123486574932189,0.0124705102884473,0.108121132019472
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,-0.00924398660747354,0.00575385410984833,-0.0205215406627763,0.00203356744782919,0.10817206113089
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,36991,0.0123350481242684,0.00768846046881211,-0.00273433439460332,0.0274044306431401,0.108659067322571
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,0.0117353141639669,0.00731563266549626,-0.00260332586040574,0.0260739541883396,0.108706734125737
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,-0.00892048854725975,0.00556158623138309,-0.0198211975607706,0.00198022046625111,0.10874973779588
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,39564,-0.00878936155166878,0.00548907399295504,-0.0195479465778607,0.0019692234745231,0.109342405716462
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,37043,-0.0115981486077295,0.00725806698287754,-0.0258239598941695,0.00262766267871048,0.11007437714364
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,40052,0.0118739599687734,0.00743174647183157,-0.00269226311601647,0.0264401830535633,0.11012152319083
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,-0.0160662349188793,0.0100613574454443,-0.0357864955119502,0.00365402567419163,0.110324231524997
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,37021,-0.0179141989389576,0.0112669894152436,-0.039997498192835,0.00416910031491984,0.111865110740588
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,0.00597515773303147,0.0037587082691233,-0.00139191047445019,0.0133422259405131,0.111929419934983
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,40017,-0.00973299542704784,0.00612773524484536,-0.0217433565069447,0.00227736565284906,0.112226520366193
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,39844,-0.0201306716837738,0.0126838051118579,-0.0449909297030154,0.00472958633546779,0.112506125507831
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,39587,0.00650458166894045,0.0041030387801603,-0.00153737434017374,0.0145465376780546,0.11291639650552
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00829049391243439,0.00525286071711605,-0.00200511309311306,0.0185861009179818,0.114524325152274
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,-0.00791864585881238,0.00501761870431486,-0.0177531785192695,0.00191588680164475,0.114547246561351
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,-0.00409775768766554,0.00260430184588414,-0.00920218930559846,0.00100667393026738,0.115636369284996
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,-0.0112951800373263,0.00718651987345074,-0.0253807589892898,0.00279039891463715,0.116039821201973
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,0.0117389939397555,0.00749960874944876,-0.00296023920916404,0.0264382270886751,0.117541169172319
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,0.00550732086798042,0.00352852077665167,-0.00140857985425685,0.0124232215902177,0.118594614221032
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,39858,-0.00695832903413696,0.00447867200893989,-0.0157365261716591,0.00181986810338523,0.120285560971848
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,-0.00688068950799936,0.00443333307546634,-0.0155700223359134,0.00180864331991468,0.120674021210464
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,39749,-0.0227106547475882,0.0147286425705724,-0.0515787941859102,0.00615748469073383,0.123108557199511
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,-0.00473506121672546,0.00307788111203293,-0.01076770819631,0.00129758576285908,0.12396655846912
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,-0.0101315742873441,0.00662573656889048,-0.0231180179623694,0.00285486938768124,0.126256992398425
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00552094135160753,0.00361403273182977,-0.00156256280277882,0.0126044455059939,0.126625885492617
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.00963598796779387,0.00632331574480904,-0.0220296868276196,0.00275771089203185,0.127557758745706
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,39489,-0.00550119828979605,0.00361134509534369,-0.0125794346766697,0.00157703809707758,0.127701385550919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,-0.00803320320033432,0.00530790397454689,-0.0184366949904462,0.00237028858977758,0.130191245574079
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,-0.00597006525572465,0.00395622791125539,-0.0137242719617852,0.00178414145033592,0.131311417877309
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,37388,0.00464564751237697,0.00308722450215951,-0.00140531251185566,0.0106966075366096,0.13239950938216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00502352080794309,0.00334249519693667,-0.00152776977805278,0.011574811393939,0.132882284970728
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.0071982816301667,0.00479216664243204,-0.0165909282493335,0.00219436498900011,0.133096954396984
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,0.0129866626033787,0.00868115788198201,-0.00402840684530603,0.0300017320520634,0.134688127548757
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,0.0100982578908487,0.00675212030830957,-0.00313589791343803,0.0233324136951355,0.134790190127514
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.0053031368907492,0.00355108533787875,-0.00165699037149316,0.0122632641529915,0.135356689787729
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,37043,-0.00349029106553376,0.00234382447843148,-0.00808418704325945,0.00110360491219194,0.136473497668698
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,37368,0.0164636634205974,0.0110863865547714,-0.00526565422675459,0.0381929810679494,0.137558094360883
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,-0.00428937859082039,0.00288847580434363,-0.0099507911673339,0.00137203398569311,0.137564456732839
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,39489,-0.00493147610800568,0.00332283497605744,-0.0114442326610783,0.00158128044506691,0.137798031716791
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,39585,-0.00731914633484181,0.00493569019242926,-0.0169930991120032,0.00235480644231954,0.138120410755658
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,-0.00701942564989725,0.00473923730626604,-0.0163083307701787,0.00226947947038419,0.138595924979565
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,39453,-0.00516642389259656,0.00350569680163398,-0.0120375896237992,0.00170474183860603,0.140576536570029
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,-0.0105524754808887,0.00717625842301738,-0.0246179419900027,0.0035129910282254,0.141458267101859
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,37056,0.00413232330972293,0.00281344693348362,-0.00138203267990496,0.00964667929935082,0.141917394909974
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,-0.0125033056364205,0.00853697945031634,-0.0292357853590405,0.00422917408619955,0.143048617152611
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00598748510534497,0.00408871625856254,-0.00202639876143762,0.0140013689721275,0.143106246043704
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,37380,-0.00472501171511815,0.00323092018288021,-0.0110576152735634,0.00160759184332705,0.143645206935219
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,0.00417373390945929,0.00287584132689047,-0.00146291509124602,0.00981038291016461,0.146714012758399
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.0123165607454396,0.00850460313417681,-0.0289855828884261,0.00435246139754696,0.147574318635989
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.0040281106999551,0.00278555085187844,-0.00143156896972665,0.00948779036963684,0.148176000154669
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,0.00607159108991795,0.00424920547306765,-0.00225685163729465,0.0144000338171306,0.153063488125539
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,-0.0101436524059572,0.00712890913283159,-0.0241163143063071,0.00382900949439273,0.154788049972692
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.0168111047122536,0.0118199674439135,-0.0399782409023242,0.00635603147781693,0.154972874634054
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,39885,-0.00429878275492926,0.00302553998827121,-0.0102288411319408,0.00163127562208232,0.155385185313512
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,-0.00405230652899268,0.00285600121980181,-0.00965006891980424,0.00154545586181887,0.155958725078255
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,37124,-0.0071605639657739,0.00505727357753404,-0.0170728201777406,0.00275169224619282,0.156829984902144
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,0.00386543025335358,0.00273630430903939,-0.00149772619236363,0.00922858669907079,0.157782742830497
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,0.00711492031576958,0.00504031866565666,-0.00276410426891746,0.0169939449004566,0.158087315897014
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,-0.00612493755069292,0.00434926686510728,-0.0146495006063032,0.00239962550491735,0.159075169140811
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,40012,0.00418409140537552,0.00297390178353028,-0.00164475609034384,0.0100129389010949,0.159465416211654
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,-0.0144226386105558,0.0102584094634477,-0.0345291211589133,0.00568384393780168,0.159767532138062
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,0.0077470030894251,0.00551593292110058,-0.00306422543593203,0.0185582316147822,0.160200391833029
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,0.00694982526596873,0.00495030187205578,-0.00275276640326059,0.0166524169351981,0.160366527915787
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,-0.00979347912882646,0.00701998614294219,-0.0235526519689932,0.00396569371134023,0.163009957197897
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,39489,0.00453493103173603,0.0032657399452368,-0.00186591926092811,0.0109357813244002,0.164962603407752
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,37056,-0.00555243601940103,0.00400980653165745,-0.0134116568214496,0.00230678478264757,0.166163288464841
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,-0.0170268149237863,0.0123218033856468,-0.041177549559654,0.00712391971208132,0.167039112260832
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,-0.00749965939378368,0.00542746895728992,-0.0181374985500719,0.00313817976250455,0.167057514746658
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,39587,-0.00438939437645703,0.00319281478046336,-0.0106473113461652,0.00186852259325116,0.169221531740078
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.00351535557768271,0.00256208649450246,-0.00150633395154211,0.00853704510690753,0.170061463536731
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.0113816105647656,0.00830222768447929,-0.027653976826345,0.00489075569681383,0.17042636029306
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,39585,-0.00836997066414383,0.00611499373099675,-0.0203553583768975,0.00361541704860981,0.17109325467398
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,36991,-0.00812267729506192,0.00594382430859181,-0.0197725729399019,0.00352721834977802,0.17178218882337
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,39585,-0.00832525211702199,0.0060927716435224,-0.0202670845383259,0.00361658030428192,0.171828407071146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,37056,-0.00232060159720296,0.00169855999057857,-0.00564977917873695,0.00100857598433104,0.171894132176512
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,36991,0.00621247990808114,0.0045508277125168,-0.00270714240845178,0.0151321022246141,0.172234997065784
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,39477,0.0191282319501971,0.0140216429076592,-0.00835418814881491,0.046610652049209,0.172526380744611
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,-0.0134982172804922,0.00995697521349609,-0.0330138886989446,0.00601745413796013,0.17523181789253
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,0.00638348347661645,0.00470940360215727,-0.0028469475836118,0.0156139145368447,0.175289320479012
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00890170309742913,0.00657730617540125,-0.0217932232012156,0.00398981700635733,0.175952241728667
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00355589059100115,0.0026402995906621,-0.00161909660669655,0.00873087778869886,0.178071727987561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,37056,-0.0100215815785612,0.00744582072525705,-0.024615390200065,0.00457222704294261,0.178346998004798
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,0.0127672319390798,0.00950142835053865,-0.00585556762797592,0.0313900315061356,0.179062982883876
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGN,Cingulin,37039,-0.0053207288051241,0.00397410175975433,-0.0131099682542426,0.00246851064399438,0.180642384225577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,-0.0045470653100122,0.00339879640783857,-0.0112087062693758,0.00211457564935139,0.180966073355376
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,-0.0125939738744236,0.00945251319227239,-0.0311208997312775,0.00593295198243033,0.182771228318504
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00403707309827987,0.00304693097854724,-0.0100090578162325,0.00193491161967272,0.185205472591888
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,-0.0114583755951864,0.00865690393224396,-0.0284259073023846,0.00550915611201175,0.185655140129589
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,-0.00483893416061945,0.00366624106851021,-0.0120247666548995,0.00234689833366056,0.186903625769769
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,37311,0.00968923546883213,0.00735770911653072,-0.00473187439956808,0.0241103453372323,0.187900580368139
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,39587,0.00632739020314216,0.00482560301928492,-0.00313079171465629,0.0157855721209406,0.189805179397644
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,-0.00553870732406213,0.00423612942892683,-0.0138415210047587,0.00276410635663446,0.191064624613466
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.00785222698946153,0.00600869415810105,-0.00392481356041653,0.0196292675393396,0.191299829653134
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,0.00652568454759476,0.00500271826853411,-0.00327964325873209,0.0163310123539216,0.19211064023364
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,-0.00701584776828487,0.00539287309312806,-0.0175858790308159,0.00355418349424612,0.193298758010671
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,0.00937985146473711,0.00731257621520971,-0.00495279791707392,0.0237125008465481,0.199619312503357
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,0.00984465791273724,0.00768471899050226,-0.0052173913086472,0.0249067071341217,0.200191934565578
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,37411,-0.0205654736866276,0.0160575849180025,-0.0520383401259125,0.0109073927526573,0.200309497975815
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,37039,-0.00790369178959086,0.00619092574324373,-0.0200379062463486,0.00423052266716684,0.20174568617251
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,-0.00602096260633733,0.00471930022341662,-0.0152707910442339,0.00322886583155924,0.202042545942783
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,0.00705745344645438,0.00554274699881536,-0.00380633067122374,0.0179212375641325,0.202942280035565
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,-0.00605464379355709,0.00476394683640081,-0.0153919795929027,0.00328269200578851,0.203775952913474
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,37235,0.00443297978022495,0.00349144549975584,-0.00241025339929651,0.0112762129597464,0.204224684030737
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,-0.00600424473042763,0.00473101801992147,-0.0152770400494737,0.00326855058861845,0.204416040596746
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,37382,-0.0147444574462902,0.0116207042472208,-0.0375210377708428,0.0080321228782625,0.204530933460822
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00486512272615419,0.00383519963670972,-0.00265186856179687,0.0123821140141052,0.204625709463658
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,-0.0027592100498595,0.00218244871103316,-0.00703680952348448,0.00151838942376549,0.20615400152266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,0.0032671631212622,0.00258734919158397,-0.00180404129424238,0.00833836753676678,0.206702481227345
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,39885,-0.00302462187221188,0.0023999100796504,-0.00772844562832667,0.00167920188390291,0.207577227566935
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,37368,0.0057830973168558,0.00460489051961289,-0.00324248810158546,0.0148086827352971,0.209188493227174
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,37169,-0.00365680601545915,0.00291578618212907,-0.00937174693243214,0.00205813490151384,0.209812909223739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,39931,-0.00577399981840189,0.00461486666142683,-0.0148191384747985,0.00327113883799469,0.210889322423412
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F2,Prothrombin,37453,-0.00186885770750717,0.00149896427356387,-0.00480682768369235,0.00106911226867801,0.212504789720592
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,37368,-0.0101960509430115,0.00822223065951303,-0.0263116230356571,0.00591952114963402,0.214975121123194
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,-0.00871091629147372,0.00703145283908133,-0.0224925638560731,0.00507073127312569,0.215422851683801
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,-0.00285219416410489,0.00230790949034632,-0.00737569676518367,0.0016713084369739,0.216538017583783
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,39587,-0.00774346510132619,0.00628320139981945,-0.0200585398449723,0.00457160964231993,0.217815290116967
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00966732792552489,0.00786197010152834,-0.00574213347347065,0.0250767893245204,0.218856992250022
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,37437,0.0132250988415321,0.0107708493141654,-0.00788576581423212,0.0343359634972963,0.219520681264291
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,-0.00567325496308721,0.0046235072663809,-0.0147353292051938,0.00338881927901935,0.219826779575879
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,-0.00803851566037289,0.00657597943941362,-0.0209274353616236,0.0048504040408778,0.22157262663245
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,-0.00465608673884552,0.00382479321987252,-0.0121526814497957,0.00284050797210462,0.223495361342021
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,39587,0.00384284340281875,0.00316866412965826,-0.00236773829131144,0.0100534250969489,0.225238083894511
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,39908,-0.0101259717233757,0.00838220650839579,-0.0265550964798315,0.00630315303308001,0.227052845698195
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,-0.00311477480071406,0.00257958655728547,-0.00817076445299359,0.00194121485156546,0.227268610501016
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.00479783467093762,0.00397575144480217,-0.00299463816087463,0.0125903075027499,0.227540597140007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,36962,-0.00881762925742223,0.00730753008105573,-0.0231403882162915,0.005505129701447,0.227588849263349
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,0.0077178134243154,0.00640308245233618,-0.00483222818226351,0.0202678550308943,0.228098493726485
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,36991,0.00652183708638798,0.00542064491738202,-0.00410262695168078,0.0171463011244567,0.228940816711177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00728971212725352,0.00606664047264435,-0.0191803274536364,0.0046009031991294,0.229537852661932
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,39489,-0.0084512232029265,0.00704988534670438,-0.0222689984824671,0.00536655207661408,0.230633792950562
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.00431860595495752,0.00363080015781342,-0.00279776235435678,0.0114349742642718,0.234288775310603
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,0.00526266967455757,0.00443377132513929,-0.00342752212271543,0.0139528614718306,0.235268340088466
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,37391,0.00287360678723433,0.00242741388355485,-0.00188412442453318,0.00763133799900184,0.236507454556026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_A,,37411,-0.00390225658420845,0.00329980311570772,-0.0103698706909956,0.00256535752257867,0.236999345465801
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,37039,0.0043646638993181,0.00370997557601314,-0.00290688822966765,0.0116362160283038,0.239429554156066
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,-0.00480421915000892,0.00411446951896197,-0.0128685794071744,0.00326014110715654,0.242973165048209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.00886512345295829,0.0075978325229714,-0.0237568751979822,0.00602662829206565,0.243310427093149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,37056,0.006836365495901,0.00586294970889932,-0.00465501593354168,0.0183277469253437,0.243624062673326
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,-0.00840830910516814,0.00721295128653067,-0.0225456936267683,0.00572907541643197,0.243743344205178
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,39964,-0.00394629233036362,0.00339008690229639,-0.0105908626588646,0.00269827799813731,0.244413623174816
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,36991,-0.00877798101828507,0.00756365995886307,-0.0236027545376567,0.00604679250108654,0.24584736821387
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,0.00623323793773309,0.00539073034312423,-0.00433259353479039,0.0167990694102566,0.247584325753926
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,0.00313247257155203,0.00271609675731836,-0.00219107707279196,0.00845602221589602,0.24880845449928
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00457225576885778,0.00397431367503053,-0.00321739903420206,0.0123619105719176,0.249978793707003
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,-0.00587034164539551,0.00510693354878826,-0.0158799314010205,0.00413924811022947,0.250377058549633
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,37388,0.00264423778799712,0.00230047714762904,-0.00186469742135579,0.00715317299735004,0.250398975309467
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,0.0075162850744636,0.00653947650885302,-0.00530108888288833,0.0203336590318155,0.2504201396885
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,-0.00509853358711734,0.00444274787263541,-0.0138063194174828,0.00360925224324807,0.251151279087986
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00367221400290735,0.00323362012379161,-0.0026656814397242,0.0100101094455389,0.25612979939353
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,37021,-0.0055286089003568,0.00487490436274726,-0.0150834214513414,0.00402620365062783,0.256774992489916
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,0.00631158454298094,0.00558037902161898,-0.00462595833939227,0.0172491274253541,0.25806252900583
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",37368,0.00503879102390646,0.0044749839386292,-0.00373217749580677,0.0138097595436197,0.260189391229711
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,37039,-0.00387708525505724,0.00344379065853874,-0.0106269149457932,0.00287274443567869,0.260262604192342
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,36962,-0.00828294310893571,0.00737407209241744,-0.0227361244100739,0.00617023819220248,0.261350956255202
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,36991,0.00387788887930524,0.00346367707278309,-0.00291091818334961,0.0106666959419601,0.262910146251525
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRL,Prolactin,40009,0.00858854205018482,0.00770981407508972,-0.00652269353699103,0.0236997776373607,0.265306384594667
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,37039,-0.00681627918847373,0.00612391726355468,-0.0188191570250409,0.00518659864809345,0.265703534764386
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,37021,-0.0076514084344158,0.00687891654780558,-0.0211340848681147,0.00583126799928314,0.26603015304968
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,0.00764731368808674,0.00689675161064198,-0.00587031946877154,0.021164946844945,0.267524500731428
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,37388,-0.00641865532018312,0.00579560316989518,-0.0177780375331777,0.00494072689281143,0.26809565379615
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,37056,0.0118657000629406,0.0107185802903432,-0.00914271730613205,0.0328741174320133,0.268304762148256
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,39788,-0.00947926593726071,0.00856318930181527,-0.0262631169688186,0.00730458509429723,0.268319967135899
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,-0.00386160752254889,0.00349415345162887,-0.0107101482877415,0.00298693324264369,0.269105578067652
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,37021,-0.00849888011461739,0.00772528519133117,-0.0236404390896265,0.0066426788603917,0.271292103335056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00283643297968334,0.00257973275430257,-0.0022198432187497,0.00789270917811639,0.271567425286762
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,37437,0.005555890607663,0.00505772354552841,-0.00435724754157269,0.0154690287568987,0.27200731139058
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,37039,-0.00671563257413361,0.00614559541887609,-0.0187609995951307,0.00532973444686353,0.274521183317043
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,39489,-0.00633661186310083,0.00579976858666953,-0.0177041582929731,0.00503093456677146,0.274602609265581
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,37056,0.00605977050376456,0.00554743831715803,-0.00481320859786519,0.0169327496053943,0.274697153447516
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,36962,-0.00886857989832335,0.00813240214262995,-0.0248080880978781,0.00707092830123136,0.275502432184783
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,0.00436521982888519,0.00400409221136655,-0.00348280090539326,0.0122132405631636,0.275648965945353
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,0.00602328516184234,0.00552617455858674,-0.00480801697298767,0.0168545872966724,0.275752416290604
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,36991,0.0104516629711126,0.00964047203781288,-0.0084436622230006,0.0293469881652259,0.27832072125351
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,0.00958146609004179,0.0088515114839324,-0.00776749641846572,0.0269304285985493,0.279064832611737
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,0.0038821748615274,0.00358665333312535,-0.00314766567139828,0.0109120153944531,0.279093424302884
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,37021,0.00525102894825705,0.00485428609514353,-0.00426337179822427,0.0147654296947384,0.27939215062245
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,36962,0.00434947938150264,0.00402548503225217,-0.00354047128171162,0.0122394300447169,0.279945798647124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTN,Titin,37021,-0.00752504100693758,0.00698384424818996,-0.0212133757333899,0.00616329371951474,0.281279971296722
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00330007513048926,0.00306465851080838,-0.00270665555069517,0.00930680581167369,0.281578729037886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,-0.00781925991143825,0.00726190612169827,-0.0220525959099669,0.00641407608709036,0.281611524284324
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,-0.00348837025754929,0.00326483257202456,-0.00988744209871743,0.00291070158361884,0.285328943335176
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,-0.00651943671093877,0.00611214114499443,-0.0184992333551278,0.0054603599332503,0.2861552393523
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,0.00786422134390202,0.00740161855832133,-0.00664295103040779,0.0223713937182118,0.28802793682957
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,37056,0.00443101777174733,0.00418228092935582,-0.00376625284979007,0.0126282883932847,0.289403370502674
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,0.00688507692439157,0.00650024197471861,-0.00585539734605691,0.01962555119484,0.289526699139215
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,39788,-0.00202479487422455,0.0019184100460903,-0.00578487856456154,0.00173528881611244,0.291233431773394
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,37021,0.00632117433993467,0.00603101540856901,-0.00549961586086059,0.0181419645407299,0.294606658594383
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,0.0054375218644404,0.0052065196901177,-0.00476725672819029,0.0156423004570711,0.296334192593837
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,39866,0.00357686092414597,0.00342818781971673,-0.00314238720249882,0.0102961090507908,0.29679371965755
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,37039,0.00631256559802442,0.00605125353087893,-0.00554789132249829,0.0181730225185471,0.296882619946722
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,37411,0.00559292491055341,0.00536178631629376,-0.00491617626938236,0.0161020260904892,0.296916650084096
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,-0.00455942325017312,0.00438269120366514,-0.0131494980093568,0.00403065150901055,0.298204925324692
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,0.00911181338006783,0.00876068828085928,-0.00805913565041635,0.026282762410552,0.298321802921928
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,0.00258278415424003,0.00248422055323385,-0.00228628813009832,0.00745185643857838,0.298506221429573
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,-0.00366105087893318,0.00352738332478402,-0.0105747221955099,0.00325262043764349,0.299337808807337
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,37056,-0.00308853209332692,0.00298495377704537,-0.00893904149633585,0.002761977309682,0.300827931330842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,37169,0.00606095311854076,0.00585839902004558,-0.00542150896074858,0.0175434151978301,0.30088623591425
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,37039,0.00355543560838042,0.00343731674133717,-0.00318170520464044,0.0102925764214013,0.300985154663971
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,37056,0.00324582739477278,0.00314112363343728,-0.00291077492676429,0.00940242971630985,0.301466923609338
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,37039,-0.00677010594040128,0.0065668749716541,-0.0196411808848433,0.00610096900404075,0.302584172971489
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,-0.00521757380175414,0.00506385904866785,-0.0151427375371431,0.00470758993363484,0.302861621936058
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.00892589823280058,0.00870471016454056,-0.0259871301553001,0.00813533368969892,0.305188511424104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,39587,0.00292648786327259,0.00286019132278545,-0.00267948712938688,0.00853246285593207,0.306238930476682
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,37056,0.00398290363996995,0.00389674249922557,-0.00365471165851216,0.0116205189384521,0.306747072157537
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,37039,0.00688603094979586,0.00674809059131972,-0.00634022660919078,0.0201122885087825,0.307537903371515
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.00316596644504215,0.00310531662047004,-0.00925238702116343,0.00292045413107913,0.307966646108567
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,-0.0052481554620817,0.00517549356746716,-0.0153921228543173,0.00489581193015394,0.310582578932908
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,0.00180926378141317,0.0017883368954137,-0.00169587653359769,0.00531440409642403,0.311695912311845
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,39587,0.00501772088147091,0.00496519523319383,-0.004714061775589,0.0147495035385308,0.312233629412847
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.00380835394781627,0.00378368438877698,-0.0036076674541866,0.0112243753498191,0.31418109833972
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,0.00385204502842001,0.00383283636020205,-0.00366031423757601,0.011364404294416,0.314909712791851
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,39587,-0.00529497207394441,0.00527857011949774,-0.01564096950816,0.00505102536027115,0.315824539461537
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,37039,-0.00523019004931123,0.00524891593664973,-0.0155180652851447,0.00505768518652224,0.319058378047456
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,37043,0.00180769007103885,0.00182359488885855,-0.00176655591112391,0.0053819360532016,0.321567891687005
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,37169,0.00356401134503518,0.00362262740437833,-0.00353633836754635,0.0106643610576167,0.325222172410584
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,36991,-0.00622179413741171,0.00633961393458481,-0.0186474374491979,0.00620384917437453,0.326406063724613
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,-0.00896893833081908,0.009172831143741,-0.0269476873725514,0.00900981071091329,0.328204979382936
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,39489,-0.00441841501163017,0.00453113491428151,-0.0132994394436219,0.00446260942036159,0.329514218310123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,37169,0.0163950774660797,0.0168645890374159,-0.0166595170472554,0.0494496719794148,0.330988666007012
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,0.00367648055328691,0.00378741155308022,-0.00374684609075033,0.0110998071973241,0.331710329622459
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,37368,-0.00338344834579551,0.00348628237934715,-0.0102165618093159,0.00344966511772491,0.331813087510842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,39477,-0.00867359517222622,0.0089574433684745,-0.0262301841744362,0.0088829938299838,0.332903832565838
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,-0.00530240220429025,0.00549356293801143,-0.0160697855627927,0.00546498115421216,0.334458190487496
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,39587,-0.0046340782919393,0.00480149776324386,-0.0140450139078973,0.00477685732401866,0.334493629279975
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,36962,0.00400092897334076,0.00415970098244516,-0.00415208495225176,0.0121539428989333,0.336152299695249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,39415,-0.00295316023311007,0.00307897890909862,-0.00898795889494335,0.00308163842872322,0.337505026839231
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,39858,-0.00346098338549668,0.00360878607505281,-0.0105342040926002,0.00361223732160682,0.337551247157437
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,-0.00559941104066986,0.00585913479409089,-0.017083315237088,0.0058844931557483,0.339252479079598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,39123,-0.00273145563415589,0.00285918903596064,-0.00833546614463875,0.00287255487632697,0.339428345197906
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,0.00627991473727445,0.00659697266857392,-0.00665015169313044,0.0192099811676793,0.341145464359219
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,0.00484423341457325,0.00511129836120346,-0.00517391137338553,0.014862378202532,0.343274180514471
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,37021,0.00388072313746475,0.00411073123204373,-0.00417631007734097,0.0119377563522705,0.345163004455169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,-0.0047015983673296,0.0049865778479141,-0.0144752909492412,0.00507209421458204,0.345771853265321
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,-0.0037753182952808,0.00400492852099364,-0.0116249781964283,0.00407434160586674,0.345867982684812
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,39587,-0.00862914110710996,0.00917976892695641,-0.0266214882039445,0.0093632059897246,0.347223151600115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.00745747263142315,0.00796823075661283,-0.008160259651538,0.0230752049143843,0.349341472613949
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,-0.00548376478003218,0.00587283217958952,-0.0169945158520276,0.00602698629196328,0.350449394842768
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.00339216576413725,0.00366113929632384,-0.00378366725665747,0.010567998784932,0.354186108888287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,0.00434591343185894,0.00470837920252064,-0.00488250980508152,0.0135743366687994,0.356014900355372
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.0022456357891523,0.00244100377755921,-0.00703000319316835,0.00253873161486374,0.357607907317783
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,39906,-0.0140724487653085,0.0153128759544984,-0.0440856856361254,0.0159407881055085,0.358112263522459
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,0.00234228531507647,0.00255061863517252,-0.00265692720986167,0.00734149784001462,0.358467424494949
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,37021,-0.00831313700339923,0.00905916720634801,-0.0260691047278413,0.00944283072104287,0.358819397777959
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0159644510163103,0.0174490078111107,-0.0182356042934666,0.0501645063260873,0.36024746650297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,0.0044120817552875,0.00484137608315282,-0.00507701536769203,0.013901178878267,0.362139350821069
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,-0.00693704034626851,0.00764624542294001,-0.0219236813752309,0.00804960068269391,0.364292350374334
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,37437,0.00268894338796614,0.00296656344420036,-0.00312552096266658,0.00850340773859885,0.364731290530253
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,-0.00348448211790766,0.0038451337668026,-0.0110209443008408,0.00405198006502544,0.364843153047712
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00367296590721791,0.00405494637847483,-0.0116206608090286,0.00427472899459275,0.36505889341757
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,37021,0.00590191739228873,0.00657603571214339,-0.00698711260351231,0.0187909473880898,0.369474646035506
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00841005536851107,0.00937952726095208,-0.00997381806295502,0.0267939287999772,0.369927709314055
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,39971,-0.0103639077756531,0.0116095191496256,-0.0331185653089193,0.0123907497576132,0.372027029755214
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,0.00431207857772864,0.00483053502319119,-0.0051557700677261,0.0137799272231834,0.372049700756838
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,39931,0.00182278215023665,0.00205197742398979,-0.00219909360078333,0.00584465790125664,0.374389915194004
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,0.0037492500759838,0.00422849818165571,-0.00453860636006139,0.012037106512029,0.375276880218192
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,-0.00392211930034431,0.00444887059630954,-0.012641905669111,0.00479766706842239,0.378009686141017
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,0.00239098578196592,0.00271512271786291,-0.00293065474504539,0.00771262630897723,0.378537831273883
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,0.00737493768033115,0.00846281617399338,-0.00921218202069587,0.0239620573813582,0.383523361877247
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,37056,-0.00296982967667281,0.00340862572867351,-0.00965073610487288,0.00371107675152727,0.38362318355446
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,37445,0.00551172783788105,0.00632747746466473,-0.00689012799286182,0.0179135836686239,0.383726835418299
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,0.00676235800789234,0.00777215347948929,-0.00847106281190666,0.0219957788276913,0.384275213188945
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,36962,-0.00529963502085284,0.00609123701100921,-0.0172384595624309,0.00663918952072521,0.384293123091484
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,-0.00456705964933477,0.00528565657193279,-0.014926946530323,0.0057928272316535,0.38757814926253
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,-0.00524871228471057,0.00607744012997613,-0.0171604949394638,0.00666307037004264,0.387802226001504
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,37056,0.00191336560879073,0.00222219675148596,-0.00244214002412176,0.00626887124170321,0.389240252618204
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,37411,0.00393754030823843,0.0045738156877538,-0.00502713843975902,0.0129022190562359,0.389315291950564
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00599637892608726,0.00696584019354208,-0.00765666785325521,0.0196494257054297,0.389349339485415
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,36991,0.00468045734062756,0.00543752351876479,-0.00597708875615144,0.0153380034374065,0.389380424893134
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,0.00515748451509164,0.00599372125722531,-0.00659020914906996,0.0169051781792532,0.389539485862296
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,39587,0.00529090986735824,0.00615686527914898,-0.00677654607977376,0.0173583658144902,0.390159855645543
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,-0.00476002852454504,0.00556702674376402,-0.0156714009423225,0.00615134389323244,0.392542321846138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00335145428202174,0.00392341347997272,-0.0110413447027683,0.00433843613872479,0.392999192348836
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00522109739311956,0.00613473580318387,-0.00680298478112083,0.01724517956736,0.39474520647675
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,36962,-0.00514899792996892,0.00610594246667323,-0.0171166451646484,0.00681864930471061,0.399089204557826
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,37056,0.00508616590361989,0.00606634735686879,-0.00680387491584294,0.0169762067230827,0.401808292996178
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,37039,-0.00300593658442388,0.00358751880198514,-0.0100374734363148,0.004025600267467,0.402109174900532
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,36991,-0.00544212401418686,0.0065622514552634,-0.0183041368665031,0.00741988883812942,0.406945531813398
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,36991,-0.00765681993253848,0.0092505682826526,-0.0257879337665376,0.0104742939014606,0.40784783360157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,0.00334475855273092,0.00404592320402838,-0.00458525092716471,0.0112747680326265,0.408422946765906
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,-0.00408126920741127,0.00498419669872147,-0.0138502947369053,0.00568775632208281,0.412891054382124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00251452066450089,0.00307152125092346,-0.00853470231631087,0.00350566098730908,0.412994647725411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,39866,0.00322173063134946,0.00393586149980859,-0.00449255790827539,0.0109360191709743,0.413050865704594
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,40030,0.0024078849993355,0.00294825189237971,-0.00337068870972874,0.00818645870839974,0.414102679224398
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,-0.00320714566867861,0.0039305624265975,-0.0109110480248097,0.00449675668745248,0.414542625870567
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.00348890261605691,0.00427908572886696,-0.00489810541252234,0.0118759106446362,0.414893407888594
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,-0.00877159031043275,0.010759406297604,-0.0298600266537365,0.012316846032871,0.414944842758497
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,-0.00284573954613217,0.0034976515856018,-0.0097011366539117,0.00400965756164736,0.415877941175159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,0.00249173344037729,0.00307201394519168,-0.0035294138921984,0.00851288077295299,0.417318660997381
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,39315,-0.00208908586528664,0.00258618822948234,-0.00715801479507202,0.00297984306449875,0.419226391865828
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,36991,-0.00350976989092171,0.00435529748669982,-0.0120461529648534,0.00502661318300994,0.420336865228974
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,37056,0.00213733396085146,0.00266184799506461,-0.00307988810947517,0.00735455603117808,0.422017420196343
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00281443548766774,0.00350561017100867,-0.00405656044750925,0.00968543142284472,0.422082970726399
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,40011,0.00249847101578401,0.0031301367635672,-0.00363659704080771,0.00863353907237573,0.424766942429288
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,-0.00637368163672165,0.00798931881375994,-0.0220327465116911,0.00928538323824784,0.425015240403882
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,0.00456377788046926,0.00574728001395088,-0.00670089094687447,0.015828446707813,0.42716542913248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,39587,0.00621773266753005,0.00788098518739753,-0.00922899829976911,0.0216644636348292,0.430150942719039
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,36962,-0.00435112282422483,0.00554827614896935,-0.0152257440762048,0.0065234984277551,0.432919530922311
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,37056,0.00698765571870869,0.00897665581610519,-0.0106065896808575,0.0245819011182749,0.43633230399297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,39587,-0.00517761739971125,0.00668930652854303,-0.0182886581956556,0.00793342339623309,0.438934103205181
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,37382,0.0200390839034887,0.0259085532420338,-0.0307416804508977,0.070819848257875,0.43926704019138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,37411,-0.00301087554316567,0.00390005402292925,-0.010654981428107,0.00463323034177565,0.440122751703169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,39858,0.00396811646626688,0.00517930196924912,-0.00618331539346139,0.0141195483259952,0.443599018200561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,36962,0.00554246764569533,0.0072781545536282,-0.00872271527941595,0.0198076505708066,0.446359637901755
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,37169,0.00237804784209332,0.00314813674039594,-0.00379230016908273,0.00854839585326937,0.450032794075749
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,-0.0022884017335113,0.00303395022531249,-0.00823494417512378,0.00365814070810118,0.450703718349146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,39477,0.0126040740854569,0.0167317557249899,-0.0201901671355232,0.0453983153064371,0.451279488734763
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,39992,0.003240795295292,0.0043053417232903,-0.00519767448235698,0.011679265072941,0.451618217626899
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,0.00586653223556977,0.00782464696000065,-0.00946977580603151,0.0212028402771711,0.453418100212302
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,37039,-0.00568300599560083,0.00766722013576289,-0.0207107574616961,0.00934474547049444,0.458580453752617
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,-0.00750125037862083,0.0102258875096377,-0.0275439898975107,0.0125414891402691,0.463233093676464
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,39489,-0.00375334106559714,0.00512484303082553,-0.0137980334060152,0.0062913512748209,0.463946629938521
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,37039,0.00201845165493595,0.00276301381103145,-0.0033970554146857,0.0074339587245576,0.465082104186413
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,-0.00344557105625309,0.00472897275601595,-0.0127143576580444,0.00582321554553818,0.466253972105789
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,-0.0041778221789655,0.0057500549776067,-0.0154479299350746,0.00709228557714364,0.467501887136498
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,40030,-0.00228706087176526,0.00315297331199096,-0.00846688856326755,0.00389276681973703,0.468237783042048
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,-0.00296128171453119,0.00409502109014716,-0.0109875230512196,0.00506495962215725,0.469603330155088
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,39587,-0.00363888335229497,0.00503421291246118,-0.0135059406607189,0.00622817395612895,0.469794688017045
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,0.00672260540625883,0.00931891632581209,-0.0115424705923329,0.0249876814048505,0.470680334199203
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,-0.00564775714329715,0.00784121398170359,-0.0210165365474362,0.0097210222608419,0.47137420283179
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,-0.0027035480388195,0.00376532047651589,-0.0100835761727906,0.00467648009515164,0.472762164492784
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,-0.00381527812463551,0.00532722274163972,-0.0142566346982494,0.00662607844897833,0.473889561610761
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,-0.00265826637836012,0.0037143369950512,-0.00993836688866048,0.00462183413194023,0.474203049860818
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,0.00286364133381696,0.00401743028855239,-0.00501052203174572,0.0107378046993797,0.475979197460666
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,0.00290254856349565,0.00407293498523103,-0.00508040400755717,0.0108855011345485,0.476077092420409
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.00294840857271689,0.00416811053042115,-0.0111179052123423,0.00522108806690857,0.479347277597583
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,0.00490825615074726,0.00695462492325937,-0.00872280869884111,0.0185393210003356,0.480353325373827
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,39489,0.0045798794183288,0.00652874754249605,-0.00821646576496345,0.0173762246016211,0.483005013469887
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPGN,Epigen,37368,0.00356624935077441,0.00509195197432411,-0.00641397651890085,0.0135464752204497,0.483708458010908
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00446261933554289,0.00637495033864494,-0.00803228332820119,0.016957521999287,0.483924581930126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,-0.00376642125111424,0.00539424868580989,-0.0143391486753016,0.00680630617307316,0.485046340234352
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,39587,0.00378068055433983,0.00542981276088077,-0.00686175245698648,0.0144231135656661,0.486262571903009
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,37056,-0.00245423277413867,0.00354826316243592,-0.00940882857251307,0.00450036302423574,0.489155769516552
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,40052,-0.0013545862410156,0.00197403305772795,-0.00522369103416239,0.00251451855213118,0.492595303928884
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,-0.00220321761750327,0.00322522341444188,-0.00852465550980935,0.00411822027480281,0.494540317312167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,39749,0.0024340740539475,0.0035884293794304,-0.00459924752973609,0.00946739563763109,0.497583885747689
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,-0.00265891935446987,0.0039488876772491,-0.0103987392018781,0.00508090049293836,0.500744754379077
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00344623051866442,0.00512098312807265,-0.00659089641235798,0.0134833574496868,0.50098285112928
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,-0.00376217485251112,0.00559655370017769,-0.0147314201048594,0.00720707039983715,0.50144870818586
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,37169,0.00508089170822469,0.00759069028003882,-0.0097968612406514,0.0199586446571008,0.503278542567157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,0.00368052454304776,0.00552707586420571,-0.00715254415079544,0.014513593236891,0.505479444450599
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,37021,0.00318953197310539,0.00479823988291384,-0.00621501819740574,0.0125940821436165,0.506235118676192
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,37368,-0.00255151140548463,0.00384113723436544,-0.0100801403848409,0.00497711757387163,0.506535657813553
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,37437,0.00300248309631527,0.00453681583830063,-0.00588967594675398,0.0118946421393845,0.508108041909951
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,39587,0.00354303199750509,0.00536035081369806,-0.0069632555973431,0.0140493195923533,0.508641124766644
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.00963667418145869,0.0146819582374897,-0.0384133123269386,0.0191399639640212,0.511602992976139
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00265437120090957,0.00407370140113634,-0.0106388259471368,0.00533008354531765,0.514678988167934
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.00386068381135914,0.00601076381102662,-0.0156417808809713,0.00792041325825304,0.520692818678442
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.00177110908899864,0.00275872522950471,-0.00717821053882786,0.00363599236083058,0.520880587062819
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00316857771638859,0.00493720407244702,-0.0128454976983848,0.00650834226560757,0.521029976025391
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,37021,-0.00319395399095054,0.00497914062750599,-0.0129530696208623,0.0065651616389612,0.521230538857277
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,36962,0.00523854188038159,0.00819957189669448,-0.0108326190371396,0.0213097027979028,0.522912216428073
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,37249,0.00203545076522967,0.00319518608453473,-0.0042271139604584,0.00829801549091774,0.524111837220745
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,37021,0.00394744926079436,0.0062246643482623,-0.00825289286179976,0.0161477913833885,0.5259857413841
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,37368,0.0022360310274691,0.00353894614812089,-0.00470030342284784,0.00917236547778605,0.527505210734766
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,36991,0.00499450908624602,0.00791856931202626,-0.0105258867653255,0.0205149049378175,0.528225590707359
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,-0.00284017462905573,0.00463512084944161,-0.0119250114939613,0.00624466223584983,0.540049898578145
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,0.00258316502302174,0.00424568249736621,-0.00573837267181604,0.0109047027178595,0.542918259002203
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.00220713348903966,0.0036438298320593,-0.00493477298179655,0.00934903995987588,0.544712159953545
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00317922088510859,0.00527880387944175,-0.0135256764888144,0.00716723471859724,0.547010377029432
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,37169,-0.00139143799958218,0.002321956495557,-0.00594247273087389,0.00315959673170954,0.549014785827194
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,-0.0032246922982276,0.0053870932550333,-0.0137833950780929,0.00733401048163767,0.549452633603359
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,0.00287486624170087,0.00482680517909208,-0.00658567190931961,0.0123354043927213,0.5514497864919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,-0.00228310066769734,0.00383616692393509,-0.00980198783861012,0.00523578650321545,0.551750740035582
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,39587,0.00394027420441827,0.00663494848183941,-0.00906422481998698,0.0169447732288235,0.552609890513689
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0021779946685306,0.00367033078512521,-0.0050158536703148,0.00937184300737601,0.552918162743513
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,39246,0.00282984746767621,0.00478614104944153,-0.00655098898922919,0.0122106839245816,0.554355792621666
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,0.00306441294076737,0.00518733999792917,-0.0071027734551738,0.0132315993367085,0.554699139642969
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,0.00336489762068855,0.00574371896907968,-0.00789279155870762,0.0146225868000847,0.557993425308559
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,40009,0.00765379399595565,0.013120231853429,-0.0180618604367652,0.0333694484286765,0.559660380425907
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,-0.00204358848368175,0.00350316963072952,-0.00890980095991159,0.0048226239925481,0.559663351777295
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,39524,-0.00278212598752283,0.00477072510317685,-0.0121327471897494,0.00656849521470379,0.559789767432542
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,-0.00293598907166125,0.00503664743979167,-0.0128078180536529,0.00693583991033042,0.559952018289327
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,39477,0.00558033968585388,0.00957324332607225,-0.0131832172332477,0.0243438966049555,0.559962275465895
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,37039,-0.00418360383478544,0.00718211594694407,-0.0182605510907958,0.00989334342122494,0.560237910195972
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,37039,-0.0028677641858697,0.0049291007137119,-0.012528801584745,0.00679327321300563,0.560709525313266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,39587,-0.00230223949496299,0.00398050034154428,-0.0101040201643898,0.0054995411744638,0.56301626435731
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,37368,0.00162516873084557,0.00282793978061778,-0.00391759323916528,0.00716793070085643,0.565515321763959
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,0.00499969947655,0.0087254347439949,-0.01210215262168,0.02210155157478,0.566652537116163
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,37056,-0.00271493368018574,0.0047597575459138,-0.0120440584701768,0.0066141911098053,0.568420703394219
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,-0.00636805938384626,0.0111848064161117,-0.0282902799594253,0.0155541611917327,0.569128947849717
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,36962,0.00385196184126682,0.00677935144812259,-0.00943556699705346,0.0171394906795871,0.569915483616718
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00269001479234816,0.00474329568136451,-0.0119868743278226,0.00660684474312628,0.570642787470014
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00295900797686546,0.0052208226459033,-0.0131918203628359,0.007273804409105,0.570879804693422
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,-0.00334293348482461,0.00590312429011874,-0.0149130570934573,0.00822719012380812,0.57120020633765
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00256385284403522,0.00453047732234482,-0.00631588270776064,0.0114435883958311,0.57146279977544
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,39858,0.0108493158693619,0.0192253137640128,-0.0268322991081032,0.048530930846827,0.572541211707611
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,36991,-0.00416133650920984,0.00742584977068729,-0.0187160020597569,0.0103933290413373,0.575226266419453
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,39695,0.00150019671173697,0.00268024481850098,-0.00375308313252495,0.00675347655599889,0.575675789200329
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.00324806783156048,0.00580499225090871,-0.0146258526433415,0.00812971698022058,0.575807826019603
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,0.00374946727199306,0.00671243171422238,-0.0094068988878828,0.0169058334318689,0.576454010391244
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,0.00100235812704291,0.00179649326918802,-0.00251876868056561,0.00452348493465143,0.576885926859741
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,37021,0.00241531819713462,0.00433083070926989,-0.00607310999303437,0.0109037463873036,0.577056549555041
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,37411,-0.00200072353529539,0.00359815524028174,-0.0090531078062476,0.00505166073565683,0.578191685012409
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,-0.00158724422906584,0.00288399513385856,-0.00723987469142861,0.00406538623329693,0.582078120998765
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NENF,Neudesin,37368,-0.00613788947104859,0.0112027406310664,-0.0280952611079387,0.0158194821658415,0.583775268591572
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00216279591509483,0.00402418001526252,-0.0100501887450094,0.00572459691481971,0.590965736477093
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,-0.0023168139152307,0.00432081582056708,-0.0107856129235422,0.00615198509308077,0.591829072168603
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,37039,-0.00363626667861856,0.00679535885922242,-0.0169551700426945,0.00968263668545738,0.592582600076305
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,36962,0.00247695565666002,0.00465720550030267,-0.00665116712393321,0.0116050784372533,0.594835797030555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,-0.00214112079107431,0.00403254121180597,-0.010044901566214,0.00576265998406539,0.595454712601711
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,37039,0.00367143179563783,0.00693335965151851,-0.00991795312133845,0.0172608167126141,0.596445772377685
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.00195117758669887,0.00373405135474314,-0.00536756306859767,0.00926991824199542,0.601304086691988
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,-0.00296460640193765,0.00569614967204792,-0.0141290597591516,0.00819984695527626,0.602753220676877
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,0.00336254643808912,0.00649551939264022,-0.0093686715714857,0.0160937644476639,0.60469610044922
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,-0.00469408037278297,0.00911544536107323,-0.0225603532804865,0.0131721925349206,0.606588782735076
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEB,Nebulin,37021,-0.00197233126818074,0.00383347738950451,-0.00948594695160959,0.0055412844152481,0.606909795858057
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,39489,-0.00183061079397176,0.00355926099334885,-0.00880676234093551,0.00514554075299198,0.607033259249091
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,0.00405994138719581,0.00789786845037388,-0.011419880775537,0.0195397635499286,0.607221688276447
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.00255318852908037,0.00497667813757022,-0.012307477678718,0.00720110062055726,0.607937072410618
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00205498749347157,0.0040325627362047,-0.00584883546948963,0.00995881045643278,0.610341147943059
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,37021,0.00319216765337123,0.00636131710664726,-0.0092760138756574,0.0156603491823999,0.615810112582323
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,-0.00283382732275249,0.0056560576665618,-0.0139197003492136,0.00825204570370864,0.616361555863506
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,0.00171348320687864,0.00342205199394699,-0.00499373870125747,0.00842070511501474,0.616577698412169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,-0.00951533413191249,0.0190064133987752,-0.0467679043935119,0.0277372361296869,0.616632775904399
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.00425800431123207,0.00851254442162895,-0.0209425913776248,0.0124265827551607,0.616940211946294
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,37169,0.002583223039527,0.00524986398133922,-0.00770651036389787,0.0128729564429519,0.622688414669879
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,37056,0.00245901782116926,0.00501951570433506,-0.00737923295932746,0.012297268601666,0.624218858327921
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,0.00384325626616639,0.00784854442925741,-0.0115398908151781,0.0192264033475109,0.624370137918413
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,37368,-0.00198547760346767,0.00405477906159338,-0.0099328445641907,0.00596188935725535,0.624379934102875
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,36991,-0.00480949305719927,0.00982609131929384,-0.0240686320430152,0.0144496459286167,0.624523205522731
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,-0.00217949556471891,0.00448915255785654,-0.0109782345781177,0.0066192434486799,0.627326461830888
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,37169,-0.00260989779097016,0.00540873343655976,-0.0132110153266273,0.00799121974468697,0.629434586072252
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,37021,-0.00164099881532995,0.00342498943017592,-0.00835397809847474,0.00507198046781485,0.631857509260051
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,37056,-0.00198936527149641,0.00415565901584914,-0.0101344569425607,0.00615572639956789,0.632151213937329
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,0.00248188260614058,0.0051874012881365,-0.00768542391860696,0.0126491891308881,0.632341953271678
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,0.00375688965729621,0.00785347648171641,-0.011635924246868,0.0191497035614604,0.632392842705031
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,37351,-0.00243824047790497,0.00514072550620775,-0.0125140624700722,0.00763758151426222,0.635294448709761
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,37056,-0.00231082908182533,0.00492926882802931,-0.0119721959847628,0.00735053782111212,0.639222105365464
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,39903,0.00255114111644012,0.00556097900563933,-0.00834837773461295,0.0134506599674932,0.646414494814408
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,0.00180607400819457,0.0040568915483501,-0.00614543342657163,0.00975758144296078,0.656192186370695
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,0.00226089024074962,0.00518170140715466,-0.00789524451727351,0.0124170249987728,0.662610229101068
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,37437,-0.00347447300342735,0.00799170473453475,-0.0191382142831154,0.0121892682762608,0.663743601399545
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,37021,0.00228293205705807,0.00526502537591417,-0.0080365176797337,0.0126023817938498,0.664583688999906
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,37100,-0.00249254747760005,0.00580452039988215,-0.0138694074613691,0.00888431250616897,0.667628308552401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,38832,0.00209156399505246,0.00489064085150063,-0.00749409207388877,0.0116772200639937,0.668899983665285
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,-0.00338652661973555,0.00795687633952254,-0.0189820042451997,0.0122089510057286,0.670397832867038
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,39699,-0.00292228507845752,0.00687145979119096,-0.0163903462691918,0.0105457761122768,0.670639339952286
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,0.0111209816178961,0.0263987327901151,-0.0406205346507296,0.0628624978865218,0.673565149158003
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.00251115330138718,0.00597516119802914,-0.00920016264674994,0.0142224692495243,0.674298485477784
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,39585,-0.00115114447133701,0.00277394747095544,-0.00658808151440967,0.00428579257173565,0.678159104838414
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.00144069261446528,0.00348098454118133,-0.00538203708625013,0.0082634223151807,0.678972162184043
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,37039,-0.00336082209178673,0.00815372556831066,-0.0193421242056756,0.0126204800221022,0.680212447649249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,37445,-0.00257421275902077,0.00626911947600396,-0.0148616869319885,0.009713261413947,0.681359202311935
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.00181210112992438,0.00441517065292612,-0.00684163334981081,0.0104658356096596,0.681499929920248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,37388,-0.00212090220457921,0.0051845161629164,-0.0122825538838953,0.00804074947473693,0.682484551165808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,-0.0014720252125118,0.00359848234158969,-0.00852505060202758,0.00558100017700399,0.682496153982792
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,0.0034853443529493,0.00854286704636027,-0.0132586750579168,0.0202293637638154,0.683292636803629
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,-0.0015056338547194,0.00370697319415439,-0.008771301315262,0.00576003360582319,0.684629727840785
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,-0.00201629045302562,0.00496642329051863,-0.0117504801024421,0.0077178991963909,0.684760667286255
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,-0.0042329133863573,0.0105753509648091,-0.024960601277383,0.0164947745046684,0.68896988367272
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.00168718604706212,0.00422267272450268,-0.00658925249296314,0.00996362458708737,0.689491313165364
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,37002,-0.00338399619568463,0.00849212118452316,-0.02002855371735,0.0132605613259808,0.690278033764027
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,39780,0.00270424811484868,0.00682078919036474,-0.0106644986982662,0.0160729949279636,0.69176258656333
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,37039,0.00196478075027051,0.00497236467745518,-0.00778105401754163,0.0117106155180827,0.69274588032424
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,39585,-0.00507039406113294,0.0128484475617293,-0.0302533512821224,0.0201125631598566,0.69312067860497
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,36991,0.00195697656550004,0.00497409444253644,-0.00779224854187138,0.0117062016728715,0.694005543537684
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,39489,-0.00187042374635223,0.00481548468269992,-0.0113087737244441,0.00756792623173962,0.697711583627996
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,37299,-0.00112606517085977,0.00290257817307014,-0.00681511839007724,0.0045629880483577,0.698056638520965
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,37039,0.00182096689717421,0.00471824591222021,-0.0074267950907774,0.0110687288851258,0.699546225572673
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,-0.00284686646232803,0.00738600345505739,-0.0173234332342405,0.0116297003095845,0.699917164711663
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,37368,-0.00233174491673405,0.00607239447182624,-0.0142336380815135,0.00957014824804537,0.700991150908903
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,37161,0.00381338340850645,0.00999671424244867,-0.0157801765066929,0.0234069433237058,0.702865309417806
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,0.0022266297169836,0.00584806324570396,-0.00923557424459617,0.0136888336785634,0.703397335147082
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,-0.0023746987040363,0.00626881678109064,-0.014661579594974,0.00991218218690136,0.704833213847024
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,37169,-0.00333486821328223,0.00896774905305706,-0.0209116563572741,0.0142419199307096,0.709992957929583
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,37056,0.00287919873873231,0.0077988805225383,-0.0124066070854428,0.0181650045629074,0.711998718456987
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00435936416093479,0.0118286888575571,-0.0275435943217467,0.0188248659998771,0.712475344595969
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,-0.00141981793025012,0.003886666180807,-0.00903768364463184,0.00619804778413161,0.71488872360701
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,37169,0.00219816571952696,0.00601810587117594,-0.00959732178797789,0.0139936532270318,0.714924084752829
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,36991,-0.00176901794934677,0.0048493282151964,-0.0112737012511317,0.00773566535243817,0.715269194366182
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,-0.00431330678842251,0.0119203050608489,-0.0276771047076863,0.0190504911308413,0.717473433763808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,37043,-0.00106997942020937,0.00300011552380869,-0.0069502058468744,0.00481024700645566,0.721362489293854
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTTG1,Securin,37169,0.00151564897914696,0.00426939790516196,-0.00685237091497048,0.00988366887326439,0.722592984023194
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,0.00344806586018664,0.0097625713861341,-0.0156865740566362,0.0225827057770095,0.723949858958935
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,36991,0.00268604694197852,0.00767124054969923,-0.012349584535432,0.017721678419389,0.726235455673506
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,0.0012962536381046,0.00371577316232837,-0.00598666176005901,0.00857916903626821,0.727206250144415
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,39913,0.00134010292143889,0.0038571582325529,-0.00621992721436479,0.00890013305724257,0.728270820974803
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,39585,-0.00246922445128196,0.00723370728121274,-0.0166472907224589,0.011708841819895,0.732844831198532
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,0.00167335515338384,0.00494175781221961,-0.00801249015856659,0.0113592004653343,0.734904896280854
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,-0.000843702501599619,0.00250817808248281,-0.00575973154326593,0.00407232654006669,0.736588271740408
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,39866,-0.00197679424535902,0.00587692308460306,-0.013495563491181,0.00954197500046297,0.736599662390331
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.00113507375048305,0.00337462875129976,-0.00774934610303059,0.00547919860206448,0.736608287675278
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,37437,0.00267753842333423,0.00802504615159866,-0.0130515520337992,0.0184066288804676,0.73865055012412
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,39587,-0.00175697072228301,0.00530249268683999,-0.0121498563884894,0.00863591494392337,0.740385999677075
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,0.0009816807257881,0.00297914155226957,-0.00485743671666025,0.00682079816823645,0.741769284368584
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,39775,0.00112411286989251,0.00341445515797094,-0.00556821923973053,0.00781644497951556,0.741992423778895
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,36962,0.00166762187553595,0.00510848279297894,-0.00834500439870278,0.0116802481497747,0.74409539592858
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,39889,-0.000972419099974897,0.00300497253968302,-0.00686216527775361,0.00491732707780381,0.746242593471484
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,-0.00276710835449264,0.00863518544509971,-0.0196920718268881,0.0141578551179028,0.748634743683097
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,0.00103683946123011,0.00325937429325312,-0.005351534153546,0.00742521307600623,0.750406554441236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.00173952845392799,0.00548095601300362,-0.00900314533155911,0.0124822022394151,0.75096258508487
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,-0.00234850098730592,0.00747209286905754,-0.0169938030106587,0.0122968010360469,0.75329586858042
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,-0.00203294782124634,0.00646865929010318,-0.0147115200298486,0.0106456243873559,0.753315945223253
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,0.00188838404284009,0.00601515489611786,-0.00990131955355091,0.0136780876392311,0.753573324488574
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,39585,0.00341309713487094,0.0109770367371573,-0.0181018948699573,0.0249280891396992,0.75585746680736
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,36931,-0.00111170068159072,0.0036018922256996,-0.00817140944396193,0.00594800808078049,0.757597633484182
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,-0.0014389290523572,0.00466253545527808,-0.0105774985447022,0.00769964043998784,0.757619171058361
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,-0.000719169774557586,0.00233444216141045,-0.00529467641092206,0.00385633686180689,0.758033644864341
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,37056,-0.000999149383794585,0.00327458740265442,-0.00741734069299724,0.00541904192540807,0.760277879417193
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,37124,0.00134855269286754,0.00447808734086164,-0.00742849849522126,0.0101256038809563,0.76330880471397
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,-0.00121199888766525,0.00403046396776757,-0.00911170826448969,0.00668771048915919,0.763640008150267
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,-0.00148784831164682,0.00500051554337618,-0.0112888587766641,0.00831316215337049,0.766059746503946
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,-0.00108077917528207,0.00364535273662568,-0.00822567053906841,0.00606411218850427,0.766866406964274
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.0016723769486776,0.00566488169453486,-0.0127755450699659,0.00943079117261072,0.767831746154427
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,37039,-0.000681527098375389,0.00231252436244675,-0.00521407484877101,0.00385102065202024,0.76821905988813
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,-0.00203745528645646,0.00695075681373668,-0.0156609386413804,0.0115860280684674,0.769429562542181
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,0.00118244864201597,0.00404034901761783,-0.00673663543251498,0.00910153271654692,0.76978664214857
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,-0.00102037479827173,0.0035553314198332,-0.0079888243811448,0.00594807478460134,0.774117842887624
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,37169,-0.00174356427961757,0.00609206942303042,-0.0136840203487572,0.0101968917895221,0.774727636973492
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,39749,-0.00121470116458395,0.00427667016103883,-0.00959697468022005,0.00716757235105215,0.776391353162027
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,0.00249899191871691,0.00884529999692724,-0.0148377960752605,0.0198357799126943,0.777547736306158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,36991,-0.00135140934904387,0.00478889735244305,-0.0107376481598322,0.00803482946174451,0.777797405087888
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,0.000914185364261142,0.00325072709038946,-0.0054572397329022,0.00728561046142449,0.778541616392517
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,0.00116948014201173,0.00417064539142222,-0.00700498482517582,0.00934394510919929,0.779169302986858
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,-0.00112945956274856,0.00404922791577826,-0.00906594627767395,0.00680702715217684,0.780301351635737
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00138528638996623,0.00497496846642544,-0.0111362245841601,0.00836565180422763,0.780670345669747
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,39477,-0.00284535758490175,0.0103394460779682,-0.0231106718977195,0.017419956727916,0.783170535289561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,40030,0.000689946841349446,0.0025314502909824,-0.00427169572897607,0.00565158941167496,0.785202611918431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,0.00177099249498373,0.00659299159200888,-0.0111512710253537,0.0146932560153211,0.788228266408066
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00145919596745603,0.00556226568496352,-0.00944284477507247,0.0123612367099845,0.793063983380165
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,36962,0.00210048683720331,0.00811549801601758,-0.0138058892741912,0.0180068629485978,0.795774993197603
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,36868,-0.00114332757325837,0.00445384263904744,-0.00987285914579136,0.00758620399927462,0.7974098954691
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.00120752961586403,0.00472726641139898,-0.00805791255047797,0.010472971782206,0.798387074573124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,36962,-0.00157886000228895,0.00622015929964418,-0.0137703722295915,0.0106126522250136,0.799631255295602
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,37169,-0.00107633632064839,0.00428435944310386,-0.00947368082913195,0.00732100818783517,0.801644374882015
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,0.00138921452599216,0.00555309478676539,-0.00949485125606801,0.0122732803080523,0.802460196596563
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,37021,-0.00130617158134085,0.00526052718481106,-0.0116168048635705,0.00900446170088883,0.803908719988268
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,39788,-0.000792433555349079,0.00324187876782217,-0.00714651594028053,0.00556164882958237,0.806895911217253
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,37056,-0.00116538227303537,0.00478215366185975,-0.0105384034502805,0.00820763890420974,0.807471589646151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.00137957324039389,0.00566908818219195,-0.00973183959670232,0.0124909860774901,0.807737273763078
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.00313577094456912,0.0129234243895184,-0.022194140858887,0.0284656827480252,0.808285604493072
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.00207722991793765,0.00858342959547775,-0.018900751925074,0.0147462920891987,0.808780321718855
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,0.0041730038072105,0.0173852649480253,-0.029902115490919,0.0382481231053401,0.810309806016694
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.000976042107563669,0.00407563410177329,-0.00701220073191198,0.00896428494703932,0.810735373787875
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,37437,0.00218914104569019,0.0091984148126428,-0.0158397519870897,0.0202180340784701,0.8118915727601
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,-0.000776604505705982,0.00335607857259302,-0.0073545185079883,0.00580130949657633,0.81700582238521
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.000658802439623263,0.0028514304325243,-0.00624760608737089,0.00493000120812436,0.817284501566619
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,37411,-0.000503109706327887,0.00220823060025977,-0.00483124168283703,0.00382502227018126,0.819778838053362
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,-0.00133962403229844,0.00588643781101513,-0.0128770421418881,0.0101977940772912,0.819977265735218
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,0.00144269154083041,0.00647223109052522,-0.011242881396599,0.0141282644782598,0.823613055572728
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00177679120671411,0.00801390049846021,-0.0174840361836961,0.0139304537702679,0.824540197614344
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,-0.0009276505710763,0.00418518186537051,-0.00913060702720249,0.00727530588504989,0.824588779531768
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,-0.00114222852950683,0.00516296243239296,-0.011261634896997,0.00897717783798337,0.824912809661967
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0026825361006622,0.0122518188580781,-0.0213310288611708,0.0266961010624952,0.826691835119739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.000665196049907462,0.00304192293109211,-0.006627364994848,0.00529697289503308,0.826905607999648
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,36818,-0.000866061467172095,0.00399480685805073,-0.00869588290895152,0.00696375997460733,0.828370094711419
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,-0.00107070041961181,0.00501402562368091,-0.0108981906420264,0.00875678980280278,0.830908262716669
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,37388,0.00153263885292175,0.00739962681610388,-0.0129706297066418,0.0160359074124853,0.835916289866516
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.00123105340034089,0.00596884413468551,-0.0129299879043245,0.0104678811036427,0.836600935236059
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,0.000527201053815072,0.00260357851717034,-0.00457581283983879,0.00563021494746893,0.839535976867059
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,0.00106027993098612,0.00528398642666143,-0.00929633346527028,0.0114168933272425,0.840968247666244
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,37437,0.000532919743554356,0.00267561490553133,-0.00471128547128706,0.00577712495839577,0.842127625592561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,37056,0.0012725428328076,0.0064486049165748,-0.011366722803679,0.0139118084692942,0.843567535365297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,39892,-0.000891923115634586,0.00455049892421468,-0.00981090100709537,0.0080270547758262,0.844608293939573
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.00043972703150147,0.00226376020171615,-0.00399724296386218,0.00487669702686512,0.845985503645622
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,37445,0.000507916353617071,0.00261942228772528,-0.00462615133032447,0.00564198403755861,0.846253982315013
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,0.000612582898457325,0.00319368694097928,-0.00564704350586206,0.00687220930277671,0.847893088250628
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.00113002910265539,0.00597163492907834,-0.0105743753583382,0.0128344335636489,0.849913259476972
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,39868,0.00138219376838939,0.00761851198661413,-0.0135500897253743,0.0163144772621531,0.856035755362663
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.000656749202203438,0.00368442627618927,-0.00656472629912753,0.0078782247035344,0.858529262048028
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,0.000775743132737208,0.00437496926940726,-0.00779919663530103,0.00935068290077544,0.859264509754771
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,-0.000698221043804371,0.0039822571328884,-0.00850344502426563,0.00710700293665689,0.860820689491502
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.000850491103029493,0.00513856046131225,-0.00922108740114251,0.0109220696072015,0.868543895610582
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,0.000695569283897228,0.00422202988813135,-0.00757960929684022,0.00897074786463468,0.86914517672828
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.000539108778597976,0.00328259368265344,-0.00697299239659873,0.00589477483940277,0.869550599783451
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,39830,0.0013191549290519,0.00803271851056496,-0.0144249733516554,0.0170632832097592,0.869557889699724
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,37039,0.000711628666423518,0.00434589723229638,-0.00780632990887739,0.00922958724172443,0.869932640163505
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,0.000467644875746627,0.00295250228473262,-0.00531925960232931,0.00625454935382256,0.874152120102616
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,36903,0.000550040881749613,0.00349863436451131,-0.00630728247269256,0.00740736423619179,0.875077146701058
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,39477,-0.000630219075292018,0.00404871684191171,-0.00856570408543897,0.00730526593485493,0.876303855408354
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.000431033460990986,0.00283503090045515,-0.00512562710390111,0.00598769402588308,0.87915900129094
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,-0.00139566779064169,0.00928433382559585,-0.0195929620888096,0.0168016265075262,0.880510481288608
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,37056,0.000650923142863022,0.0044538775929404,-0.00807867693930017,0.00938052322502621,0.883807169795657
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,39489,-0.000554152194769712,0.00382157159332862,-0.00804443251769381,0.00693612812815438,0.884707718385252
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,36962,0.000761277702425289,0.00541600244584836,-0.00985408709143751,0.0113766424962881,0.888219068941813
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.000701605655086302,0.00502733222811598,-0.00915196551202101,0.0105551768221936,0.889011174877998
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,-0.000851075526486172,0.00624630217894995,-0.0130938277972281,0.0113916767442557,0.891623546752316
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,36962,-0.00158437168240117,0.0117863005762837,-0.0246855208119173,0.021516777447115,0.893068697584778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.000926357443345259,0.00698002489688355,-0.0127544913545465,0.014607206241237,0.894420413388089
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.000764690155997172,0.00600422252695891,-0.0125329663088366,0.0110035859968423,0.898658090495606
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,39587,-0.00184729771532258,0.0146727081330063,-0.0306058056560149,0.0269112102253698,0.899812489082609
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,36991,-0.000485890388666349,0.00387824838962645,-0.00808725723233419,0.00711547645500149,0.900299020330277
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,37056,0.000864248562959077,0.00697710180258629,-0.01281087097011,0.0145393680960282,0.901420664753496
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,39985,-0.000376693296646327,0.00305598759525838,-0.00636642898335274,0.00561304239006009,0.901899572673631
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,39477,0.00107323722077034,0.009008515011051,-0.0165834522008896,0.0187299266424303,0.905169249926064
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,0.000995947411473329,0.00856994443802991,-0.0158011436870653,0.0177930385100119,0.907484705250344
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,-0.000274787354648499,0.00240270552188282,-0.00498409017753882,0.00443451546824182,0.90894925121434
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,37021,-0.000515248383183636,0.00473701976169707,-0.0097998071161099,0.00876931034974263,0.913386117929009
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.000764091546233502,0.00709644083659534,-0.0131449324934934,0.0146731155859604,0.914256816263426
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,-0.000281658128902289,0.00273175928291227,-0.00563590632341034,0.00507259006560576,0.91788113394842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,36962,0.000966077479365705,0.00940407358761454,-0.0174659067523588,0.0193980617110902,0.918179088443346
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,39587,-0.000502296477684655,0.00495712413646397,-0.010218259785154,0.00921366682978473,0.919291220867938
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,0.000421984889995333,0.00417829426625567,-0.00776747187186578,0.00861144165185645,0.919556334099695
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,0.000660887741770355,0.00659058469082694,-0.0122566582522504,0.0135784337357911,0.920125498726076
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.000346118804955197,0.00361245308467267,-0.00742652685091363,0.00673428924100323,0.923670535243033
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,-0.000508384258244709,0.00533996451720486,-0.0109747147119662,0.00995794619547683,0.924154269792746
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.000253749420411137,0.00267607347643612,-0.00499135459340366,0.00549885343422593,0.924458023924936
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,-0.000389160800207522,0.0041453714646698,-0.00851408887096032,0.00773576727054528,0.925207187179186
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,37039,-0.000556034474837382,0.00615959994148446,-0.0126288503601469,0.0115167814104722,0.92807307802268
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,40052,-0.000373979318234827,0.00416078354916316,-0.00852911507459463,0.00778115643812497,0.928382140556143
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.000474692533647551,0.00578904858016767,-0.0108718426834811,0.0118212277507762,0.934649264082743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,37388,0.000724946604463164,0.00888093564945422,-0.0166816872684671,0.0181315804773934,0.934942525588156
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.000271271403625337,0.0034559203612889,-0.0065023325045009,0.00704487531175158,0.937435526564402
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,0.000505883540010805,0.00648805625727842,-0.0122107067242549,0.0132224738042765,0.93785190677051
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,0.00109880534021461,0.0148773091328169,-0.0280607205601065,0.0302583312405357,0.941124626336393
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,39585,0.000240608836187435,0.0032921845722012,-0.00621207292532691,0.00669329059770178,0.941739521933495
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,37039,-0.000291561688367481,0.00427654556582569,-0.00867359099738584,0.00809046762065087,0.945645836740622
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,39868,-0.00017127919599962,0.00266779245350938,-0.005400152404878,0.00505759401287876,0.948809713523984
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,36991,-0.000413559732608188,0.00657189944044811,-0.0132944826358865,0.0124673631706701,0.949824402919587
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.000577351697298915,0.00994485477632574,-0.0200692670588974,0.0189145636642995,0.953705447505216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,39405,0.000372087545524297,0.00685613958307689,-0.0130659460373064,0.013810121128355,0.95672018463046
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,37021,-0.000231950212798262,0.00427733114912964,-0.00861551926509235,0.00815161883949582,0.956754503591119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,37169,0.000245278855441046,0.00458208192422782,-0.00873560171604548,0.00922615942692757,0.957310430050093
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,39587,-0.000179532048569608,0.00344545677817249,-0.00693262733378768,0.00657356323664846,0.9584441821836
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,0.000180370248155137,0.00364612198349403,-0.00696602883949316,0.00732676933580344,0.960546218024904
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,37437,0.000234745898160729,0.00478637236150264,-0.00914654393038445,0.00961603572670591,0.960884444428276
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.000312133921101066,0.00670220202395306,-0.0134484498880491,0.0128241820458469,0.962855169995647
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,37056,0.000138758983521982,0.00302021480189239,-0.0057808620281871,0.00605837999523107,0.963356045340104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,37039,0.000312950941702054,0.00687952473878951,-0.0131709175463254,0.0137968194297295,0.963717276991884
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,37043,0.000289101087142367,0.00641087078323346,-0.0122762056479952,0.0128544078222799,0.964031913085977
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,37368,-0.000178385116507553,0.00425970987669683,-0.00852741647483334,0.00817064624181824,0.966597137401051
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,37056,-0.00010925473388384,0.00266306091288703,-0.00532885412314241,0.00511034465537474,0.967275789906916
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.000106221803684246,0.00298230473987096,-0.00573909548646284,0.00595153909383133,0.971587909651546
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,0.000267063971421469,0.0077999757441938,-0.0150208884871984,0.0155550164300413,0.972687010012907
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,-0.000138178760523839,0.00425618340142672,-0.00848029822732022,0.00820394070627254,0.974101390823801
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,39585,0.000169712922447484,0.00545123651069488,-0.0105147106385145,0.0108541364834094,0.97516392933874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,39866,-0.000161909987385586,0.00563373655896312,-0.0112040336429533,0.0108802136681821,0.977072822279447
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,37380,0.000115151463648462,0.00477052281602865,-0.00923507325576769,0.00946537618306461,0.980742791123606
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,39782,-0.000100683451726711,0.00419593339707893,-0.0083247129100014,0.00812334600654798,0.980856511801291
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,39489,0.000126652037113728,0.00535902922101898,-0.0103770452360835,0.0106303493103109,0.981145338511512
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,-0.000227018261511179,0.0101145379789064,-0.0200515127001678,0.0195974761771454,0.982093521838402
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,40052,-6.106624361904e-05,0.00272618733326609,-0.00540439341682057,0.00528226092958249,0.982129259550887
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,37169,-0.000125291768770873,0.00605599847330777,-0.0119950487764541,0.0117444652389124,0.983494157237301
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,37437,-8.68265702804607e-05,0.00438236646039633,-0.00867626483265727,0.00850261169209635,0.984193067262986
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,37348,-0.000109521908304918,0.00591730997384125,-0.0117074494570338,0.0114884056404239,0.985233284879522
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,0.00024104889123747,0.0137141247495954,-0.0266386356179696,0.0271207334004445,0.985976812396546
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,7.79290658380755e-05,0.00499737055412007,-0.00971691722023725,0.0098727753519134,0.987558524081444
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,1.55905858892103e-05,0.00190133840359396,-0.00371103268515495,0.00374221385693337,0.993457703497636
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,2.22476581995349e-05,0.00301656442776207,-0.00589021862021413,0.0059347139366132,0.994115615573828
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,-1.70786675876796e-05,0.00273303331149274,-0.00537382395811345,0.0053396666229381,0.99501416062431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,-3.49614737980054e-05,0.00596153554483318,-0.011719571141671,0.011649648194075,0.995320899643819
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,-1.46839648205796e-05,0.00412625706317595,-0.00810214780864544,0.00807277987900429,0.997160655810971
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,37056,1.0434125864196e-05,0.00650608574287758,-0.0127414939301759,0.0127623621819043,0.998720418547881
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,-1.17551686914236e-06,0.00230244919422155,-0.00451397593754339,0.0045116249038051,0.999592645848065
